18.08.16 Bibliography Master List · Steward CG, Groves SJ, Spence CT, Maisenbacher MK, Versluys B,...

SCNIRBibliography

of 87

Year Citation Publication Type First Author

2019

Dale DC, Bolyard AA, Marrero T, Kelley ML, Makaryan V, Tran E, Leung J, Boxer LA, Kishnani PS, Austin S, Wanner C, Ferrecchia IA, Khalaf D, Maze D, Kurtzberg J, Zeidler C, Welte K, Weinstein DA. Neutropenia in glycogen storage disease Ib: Outcomes for patients treated with granulocyte colony-stimulating factor. Curr Opin Hematol. 2019;26(1):16-21. PMID: 30451720

Journal Article Dale DC

2019Dale DC, Dick E, Kelley ML, Makaryan V, Connelly J, Bolyard AA. Family Studies of Whim Syndrome. (ASH Annual Meeting Abstracts). Annual Meeting Abstracts. Blood 2019

Abstract Dale DC

2019

Dale DC, Shannon JA, Bolyard AA, Connelly J, Link DC, Bonilla MA, Newburger PE. Severe Chronic Neutropenia in the Large Granular Lymphocyte Syndrome: Outcomes in Response to Granulocyte Colony Stimulating Factor (G-CSF) and Immunosuppressive Therapies. (ASH Annual Meeting Abstracts). Blood Annual Meeting Abstracts. 2019

Abstract Dale DC

2019

Michniacki TF, Merz LE, McCaffrey H, Connelly JA, Dale D, Bolyard AA, Walkovich K. Quality of life and patient reported outcomes in severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood Annual Meeting Abstracts. 2019

Abstract Michniacki TF

2019

Nasri M, Ritter M, Mir P, Dannenmann B, Amend D, Makaryan V, Xu Y, Zeidler C, Dale DC, Klimiankou M, Welte K, Skokowa J. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of HSPCs and iPSCs of severe congenital neutropenia patients. . (European Hematology Association [EHA] Meeting Abstracts). 2019

Abstract Nasri M

2018

Dale D, Firkin F, Bolyard A, Dick E, Hartmann S, Brown K, Ebrahim T, Gorelick KJ, Parasuraman S. Determination of phase 3 Dose for X4P-001 in patients with WHIM syndrome. (ASH Annual Meeting Abstracts). Blood 2018

Abstract Dale, David C

2018

Dale DC, Bolyard AA, Alter B, Bonilla MA, Connelly J, Link D, Rosenberg P, Shimamura A, Walkovich KJ, Newburger P. Myelodysplasia, hematological malignancies and other cancers in patients with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood 2018


2018

Dale DC, Crawford J, Klippel Z, Reiner M, Osslund T, Fan E, Morrow PK, Allcott K, Lyman GH. A systematic literature review of the efficacy, effectiveness, and safety of filgrastim. Support Care Cancer. 2018 Jan;26(1):7-20. PMID: 28939926. PMCID: PMC5827957.

Journal Article Dale, David C

2018

Dale DC, Firkin F, Bolyard AA, Dick E, Kelley ML, Makaryan V, Niland K, Ebrahim T, Parasuraman S. Phase 2 study of X4P- 001: A targeted oral therapy for patients with WHIM syndrome. (European Hematology Association [EHA] Meeting Abstracts). Haematologica. (in press)


SCNIRBibliography

of 87


2018

Dale DC, Kelley ML, Navarro-De La Vega M, Parthasarathy D, Bodapati D, Tandon T. A novel device suitable for home monitoring of white blood cell and neutrophil counts. (ASH Annual Meeting Abstracts). Blood 2018


2018Dale DC. Editorial: myeloid biology issue 2018. Curr Opin Hematol. 2018;25(1):1-2(Editorial). PMID: 29049086

Editorial Dale, David C

2018

Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC. Cyclic thrombocytopenia with statistically significant neutrophil oscillations. Clin Case Rep. 2018;6(7):1347-52. PMID: 29988661. PMCID: PMC6028424.

Journal Article Langlois, GP

2018Link DC, Makaryan V, Spencer D, Xia J, Bolyard AA, Dale DC. Extended genetic testing in SCN may identify mutations that inform therapy. (ASH Annual Meeting Abstracts). Blood 2018

Abstract Link, Daniel C

2018

Makaryan V, Fletcher B, Kelley ML, Nasri M, Skokowa J, Welte K, MD2, Dale DC. CRISPR/Cas9 knock-in HL60 cells closely simulate cellular and functional abnormalities of ELANE associated Neutropenia; Phenotype rescue with MK- 0339 Neutrophil Elastase inhibitor. (ASH Annual Meeting Abstracts). Blood 2018

Abstract Makaryan, Vahagn

2018

Michniacki TF, Sturza J, Connelly JA, Merz LE, Marsh R, Dale D, Garabedian E, Walkovich K, Neutropenia is an under- recognized finding in pediatric primary immunodeficiency diseases: an analysis of the United States Immunodeficiency Network Registry. (ASH Annual Meeting Abstracts). Blood 2018;

Abstract Michniacki, TF

2018

Xia J, Miller C, Baty J, Ramesh A, Jotte MRM, Fulton RS, Vogel TP, Cooper MA, Walkovich KJ, Makaryan V, Bolyard AA, Dinauer MC, Wilson DB, Vlachos A, Myers KC, Rothbaum RJ, Bertuch AA, Dale DC, Shimamura A, Boxer LA, Link DC. Somatic mutations and clonal hematopoiesis in congenital neutropenia. Blood. 2018;131(4):408-416. PMID: 29092827. PMC5790127.

Journal Article Xia, J

2017

Dale DC, Bolyard AA, Dick E, Kelley ML, Makaryan V, Johnson R, Gan L, Parasuraman S. X4P-001: a novel molecularly-targeted oral therapy for WHIM syndrome. (ASH Annual Meeting Abstracts). Blood 2017; 130:995


2017Dale DC, Bolyard AA, Leung J, Tran E, Marrero T, Newburger P. Cyclic neutropenia congenital and idiopathic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2017; 130:2275


2017

Dale DC, Bolyard AA, Marrero T, Bonilla MA, Link DC, Newburger P, Shimamura A, Boxer LA, C Spiekerman. Long-term effects of G-CSF therapy in cyclic neutropenia. N Engl J Med. 2017;377(23):1-2. (Letter to the Editor) PMID: 29211670. PMCID: PMC5777346.

Letter to the Editor Dale, David C

SCNIRBibliography

of 87


2017

Dale DC, Bolyard AA, Marrero T, Weinstein D, Zeidler C, Welte K. Long-term outcomes for G-CSF treatment of patients with glycogen-storage disease type 1b. (ASH Annual Meeting Abstracts). Blood. 2017; 130:996


2017

Dale DC, Bolyard AAB. An update on the diagnosis and treatment of chronic idiopathic neutropenia. Curr Opin Hematol. 2017;24(1):46-53. PMID: 27841775; NIHMS853991; PMCID: PMC5380401


2017 Dale DC. Editorial for myeloid biology 2017. Curr Opin Hematol. 2017;24:1-2. (Editorial). PMID: 7820737 Editorial Dale, David C

2017 Dale DC. How I manage children with neutropenia. Br J Haematol. 2017;178:351- 363. PMID: 28419427 Review Dale, David C

2017

Koch C, Samareh B, Morishima T, etal. GM- CSF treatment is not effective in congenital neutropenia patients due to its inability to activate NAMPT signaling. Ann Hematol.2017;96:345-53. PMID: 27966038;

Journal Article Koch, C

2017

Makaryan V, Fletcher B, Kelley ML, Dale DC. The effect of the MK-0339 neutrophil elastase inhibitor on proliferation and maturation of iPSC derived from the patients with ELANE, TCIRG1 and CXCR4 associated neutropenia. (ASH Annual Meeting Abstracts). Blood. 2017;130:545


2017

Makaryan V, Kelley MK, Fletcher B, Bolyard AA, Aprikyan A, Dale, DC. Elastase inhibitors as potential therapies for ELANE- associated neutropenia. J Leukoc Biol.2017;102(4):1143-1151. PMCID: PMC5597518

Journal Article Makaryan, Vahagn

2017

Myers KC, Nelson A, Sheehan B, Malsch M, Furutani E, Gloude N, Sandella R, Levesque A, Towers G, Bolyard AA, Moore J, Loveless S, Butts A, Davies SM, Keel S, Hanna R, Fleming M, Lorsbach R, Dale DC, Shimamura A. Germline and somatic genetic characterization of Shwachman-Diamond syndrome. (American Society of Pediatric Hematology / Oncology [ASPHO] Annual Meeting Abstracts). Pediatr Blood Cancer. 2017: 64(S1):206

Abstract Myers, Kasiani C

2017Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers. 2017;8(3):17032. PMCID: PMC5821468

Journal Article Skokowa, J

2017

Steward CG, Groves SJ, Spence CT, Maisenbacher MK, Versluys B, Newbury- Ecob R, Ozsahin H, Hamilton L, Damin MK, Bowen VM, McCurdy KR, Apostu R, Mackey MC, Bolyard AA, Dale DC. Intermittent, persistent or cyclic neutropenia in Barth syndrome: characteristics, risks and management. Orphanet J Rare Dis. 2017 (submitted)

Journal Article Steward, CG

2016Bolyard AA, Marrero T, Boxer LA, Newburger P, Bonilla MA, Dale DC. Peg- filgrastim for the treatment of severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2016; 128:1332.

Abstract Bolyard, Audrey Anna

SCNIRBibliography

of 87


2016

Dale D, Bolyard AA, Kelley M, Makaryan V, Boxer L, Bonilla MA, Cavieres M, Tan P, Firkin F. ELANE mutation C223ter predisposes patients with severe congenital neutropenia to acute myeloid leukemia. (European Hematology Association [EHA] Meeting Abstracts). Haematologica. 2016;101(s1): 679,Abstract PB1661.


2016

Dale DC, Makaryan V, Kelley ML, Bolyard AA, Boxer L, Newburger P, Bonilla MA, Klimiankou M, Skokowa J, Zeidler C, Welte K. Termination and frameshift mutations in ELANE are associated with adverse outcomes in patients with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2016;128:1326


2016

Dale DC, Welte K. Neutropenia and Neutrophilia. In: Kaushansky K, Lichtman MA, Prchal JT, Levi MM, Press OW, Burns LJ, Caligiuri M, eds. Williams Hematology. 9th ed. New York, NY: McGraw-Hill; 2016:991-1004.

Book Chapter Dale, David C

2016 Dale DC. How I diagnose and treat neutropenia. (Review) Curr Op Hematol. 2016;23:1-4. PMCID: PMC4668211 Review Dale, David C

2016

Dannenmann B, Klimiankou M, Lindner C, etal. Analysis of leukemogenic effects of RUNX1 & CSF3R mutations using congenital neutropenia (CN)/AML patient- derived induced pluripotent stem cells (IPSCS). Blood. 2016;128:404

Abstract Dannenmann, B

2016

Duncavage E, Qualls D, Cottrell C, Heusel J, Corliss M, Pfeifer J, Dale D, Link D. Exome sequencing based diagnostics for severe congenital neutropenia. Association of Molecular Pathology (AMP) 2016 Annual Meeting. J. Mol Diagn. 2016;18:962, abstract H45

Abstract Duncavage, E

2016Klimiankou M, Mellor-Heineke S, Klimenkova O, etal. Two cases of cyclic neutropenia with acquired CSF3R mutations, with 1 developing AML. Blood. 2016;127:2638-41. PMID: 27030388;

Journal Article Klimiankou, M

2016

Klimiankou M, Zeidler C, Mellor-Heineke S, etal. Optimization of CSF3R mutation detection in severe congenital neutropenia and cyclic neutropenia patients for routine diagnostics using next generation sequencing. Blood. 2016;128:3685;

Abstract Klimiankou, M

2016

Makaryan V, Fletcher B, Kelley ML, Bolyard AA, Duncavage E, Qualls D, Link DC, Dale DC. TCIRG1 Mutations as a cause for chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2016; 128:2511


2016

Makaryan V, Kelley ML, Fletcher B, Dale DC. The effects of the neutrophil elastase inhibitors MK0339 and sivelestat on the survival, proliferation and maturation of iPSC and HL60 cells expressing mutant neutrophil elastase. (ASH Annual Meeting Abstracts). Blood. 2016;128:406


2016Mir P, Klimiankou M, Dannenmann B, etal. Impaired DNA damage repair in severe congenital neutropenia patients. Blood. 2016;128:1334;

Abstract Mir, P

SCNIRBibliography

of 87


2016

Myers KC, Bolyard AA, Leung J, Moore J, Loveless S, Mount L, Harris RE, Davies SM, Keel S, Dale DC, Shimamura A. North American Shwachman-Diamond syndrome registry: genetically undefined Shwachman-Diamond syndrome. 8th International Congress on Shwachman-Diamond Syndrome Abstracts, April 2016.

Abstract Myers, Kasiani

2016

Myers KC, Nelson A, Sheehan B, Malsch M, Towers G, Bolyard AA, Moore J, Loveless S, Mount L, Davies SM, Keel S, Hanna R, Fleming M, Dale DC, Shimamura A. Germline and somatic genetic characterization of Shwachman-Diamond syndrome. (ASH Annual Meeting Abstracts). Blood. 2016;128(22):2681. DOI: https://doi.org/10.1182/blood.V128.22.2681.2681


2016Newburger PE. Autoimmune and other acquired neutropenias. Hematology Am Soc Hematol Educ Program. 2016;2016:38-42. PMID: 27913460

Journal Article Newburger, Peter E

2016Nustede R, Klimiankou M, Klimenkova O, etal. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia. Br J Haematol. 2016;172:219- 27. PMID: 26567890;

Journal Article Nustede, R

2016

Rosenthal EA, Makaryan V, Burt AA, Crosslin DR, Kim DS, Smith JD, Nickerson DA, Reiner AP, Rich SS, Jackson RD, Ganesh SK, Polfus L, Qi L, Dale DC, University of Washington Center for Mendelian Genomics, Jarvik GP. Association between absolute neutrophil count and variation at TCIRG1: the NHLBI Exome Sequencing Project. Genet Epidemiol. 2016;40:470-474. PMCID: PMC5079157

Journal Article Rosenthal, EA

2016Steward, CG, Groves SJ, Bolyard AA, Dale, DC. Incidence, characteristics and management of neutropenia in Barth syndrome. Barth Syndrome Foundation Meeting Abstracts, July 2016.

Abstract Steward, CG

2016Xia J, Shimamura A, Myers KC, Boxer LA, Dale DC, Ramesh A, Jotte M, Link DC. Mutation burden in hematopoietic stem cells is not increased in congenital neutropenia. Blood. 2016;128:405.

Abstract Xia, J

2015

Boxer LA, Bolyard AA, Kelley ML, Marrero TM, Phan L, Bond, JA, Alter BP, Bonilla MA, Link D, Newburger PE, Rosenberg PS, Dale DC. Use of granulocyte colony-stimulating factor during pregnancy in women with chronic neutropenia. Obstet Gynecol. 2015;125:197-203. PMCID: PMC4286310

Journal Article Boxer, Laurence A

2015

Boxer LA, Bolyard AA, Marrero TM, Tran EL, Bonilla MA, Newburger PE, Dale DC. Is there a role for anti-neutrophil antibody testing in predicting spontaneous resolution of neutropenia in young children? (ASH Annual Meeting Abstracts). Blood. 2015;126:2211.

Abstract Boxer, Laurence A

SCNIRBibliography

of 87


2015

Dale DC, Bolyard AA, Kelley ML, Makaryan V, Bonilla MA, Boxer LA, Mellor-Heineke S, Welte KH, Newburger PE, Zeidler C. Long term outcomes for patients with cyclic neutropenia on treatment with granulocyte colony-stimulating factor (G-CSF). (ASH Annual Meeting Abstracts). Blood. 2015;126:996.


2015Dale DC. Intersections of hematology, immunology, dermatology and infectious diseases. Curr Op Hematol. 2015;22:1-2. (Editorial) PMID: 25469835


2015Dale DC. Neutropenia. In: Encyclopedia of Life Sciences. Chichester, England: John Wiley & Sons, Ltd.; Oct 15 2015. Available at: http://www.els.net/WileyCDA/ElsArticle/refId- a0002179.html


2015

Dobbins NJ, Bolyard AA, Chang RT, Self J, Provencher Langlois G, Mackey MC, Dale DC. Application of spectral density/periodogram analysis to serial neutrophil counts to diagnose cyclic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2015:126:4608

Abstract Dobbins, NJ

2015

Hastrup N, Khalilieh S, Dale DC, Hanson LG, Magnusson P, Tzontcheva A, Tseng J, Huyck S, Rosenberg E, Krogsgaard K. The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects. Cytokine. 2015;72:197-203. PMID: 25661195

Journal Article Hastrup, N

2015

Makaryan V, Zeidler C, Bolyard AA, Skokowa J, Rodger E, Kelley ML, Boxer LA, Bonilla MA, Newburger PE, Shimamura A, Zhu B, Rosenberg PS, Link DC, Welte K, Dale DC. The diversity of mutations and clinical outcomes for ELANE associated neutropenia. Curr Op Hematol. 2015;22:3-11. PMCID: PMC4380169


2015

Myers K, Bolyard AA, Wong T, Biggins C, Moore J, Loveless S, Mount L, Harris R, Davives S, Keel S, Dale D, Shimamura A. The North American Shwachman-Diamond syndrome registry: 5 years of follow-up. (American Society of Pediatric Hematology/Oncology [ASPHO] Annual Meeting Abstracts). Pediatr Blood Cancer. 2015;S26:#4020


2015

Myers KC, Bolyard AA, Leung J, Moore J, Loveless S, Mount L, Harris RE, Davies SM, Keel S, Dale DC, Shimamura A. North American Shwachman-Diamond Syndrome Registry: Genetically undefined Shwachman- Diamond Syndrome. (ASH Annual Meeting Abstracts). Blood. 2015;126:3614.


2015

Steward CG, Groves SJ, Taylor C, Maisenbacher MK, Versluys B, Newbury- Ecob R, Ozsahin H, Hamilton L, Damin MK, Bowen VM, McCurdy KR, Mackey MC, Bolyard AA, Dale DC. Barth Syndrome: an under-recognized cause of chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2015;126:2195.

Abstract Steward, CG

http://www.els.net/WileyCDA/ElsArticle/refId-



SCNIRBibliography

of 87


2014

Kishnani PS, Austin SL, Adbenur JE, Arn P, Bali DS, Boney A, Chung WK, Dagli AI, Dale DC, Koeberl D, Somers MJ, Burns Wechsler SB, Weinstein DA, Wolfsdorf J, Watson MS for the ACMG Work Group. Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genet Med. Genet Med. 2014;16:e1. PMID: 25356975

Journal Article Kishnani, PS

2014

Dale DC, Bolyard AA, Zeidler C, Marrero TM, Boxer LA, Newburger PE, Alter BP, Morrow PK, Bonilla MA, Dror Y, Firkin F, Kinsey S, Levine JE, Link DC, Reeves L, Rosenberg PS, Shimamura A, Welte K. Understanding neutropenia: The 20 year experience of the Severe Chronic Neutropenia International Registry. (ASH Annual Meeting Abstracts). Blood.2014;124:2730.


2014Dale DC, Mackey M. Understanding, treating and avoiding hematological disease: better medicine through mathematics? Bull Math Biol. 2014;76(9):2091-121. PMCID: PMC4362913


2014 Dale DC. Understanding neutropenia. Curr Op Hematol. 2014;21:1-2. (Editorial) PMID: 24275692 Editorial Dale, David C

2014

Makaryan V, Rosenthal E, Bolyard AA, Kelley ML, Chi E, Jarvik GP, Dale DC. TCIRG1 associated congenital neutropenia. European Hematology Association (EHA) Annual Meeting Abstracts. June 2014.


2014

Makaryan V, Rosenthal EA, Bolyard AA, Kelley ML, Below JE, Bamshad MJ, Bofferding KM, Smith JD, Buckingham K, Boxer LA, Skokowa J, Welte K, Nickerson DA, Jarvik GP, Dale DC, for the UW Center for Mendelian Genomics. TCIRG1 associated congenital neutropenia. Hum Mutat. 2014;35(7):824-7. PMCID: PMC4055522


2014

Myers KC, Bolyard AA, Jones A, Otto B, Dobbins N, Moore J, Harris RE, Davies SM, Dale DC, and Shimamura A. Shwachman-Diamond syndrome in adults. (American Society of Pediatric Hematology/Oncology 27th Annual Meeting). May 2014.


2014

Myers KC, Bolyard AA, Otto B, Wong TE, Jones AT, Harris RE, Davies SM, Dale DC, Shimamura A. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman- Diamond Syndrome Registry. J Pediatr. 2014;164:866-70. PMCID: PMC4077327

Journal Article Myers, Kasiani

2014

Myers, Kasiani, Bolyard, Audrey Anna, Jones, Amanda, Otto, Barbara, Dobbins, Nicholas, Moore, Joan, Harris, Richard, Davies, Stella, Dale, David, Shimamura, Akiko. Shwachman-Diamond Syndrome in Adults. Pediatric Blood & Cancer.2014;61:S9-S9.


SCNIRBibliography

of 87


2014

Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, Watz H, Lu S, Stryszak P, Rosenberg E, Staudinger H. CXCR2 antagonist MK-7123 – a phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. (American Thoracic Society 2014 International Conference). May 2014.

Abstract Rennard, SI

2014

Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, Unalan M, Kandabarau S, Makaryan V, Beekman R, Behrens K, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan CM, Touw IP, van den Heuvel- Eibrink MM, Dale DC, Welte K. Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. 2014;123:2229-37. PMID: 24523240


2014

Skokowa J, Steinemann D, Zeidler C, Makaryan V, Beekman M, Klimiankou M, Ünelan S, Kandabarau S, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Schegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Touw IP, Dale DC, Welte K. The association of mutations in RUNX1 and CSF3R with the development of leukemia in severe congenital neutropenia: a new pathway in leukemogenesis. Blood. 2014 Apr 3;123(14):2229-37. Epub 2014 Feb 12.


2014

Starzyk K, Dale D, Groft S, Harrison M, Richesson R, Rubenstein Y, Strange C. Rare Disease Registries. In: Gliklich RE, Dreyer NA, Leavy MB, eds. Registries for Evaluatin Patient Outcomes: A User’s Guide. 3rd ed. Rockville, MD: Agency for Healthcare Research and Quality. 2014 Apr AHRQ Publication No. 13(14)-EHC111. Available at: http://www.effectivehealthcare.ahrq.gov/registries-guide-3.cfm

Book Chapter Starzyk, K

2013

Allenspach EJ, Bellodi C, Jeong D, Kopmar N, Nakamura T, Ochs HD, Ruggero D, Skoda-Smith S, Shimamura A, Torgerson TR. Common variable immunodeficiency as the initial presentation of dyskeratosis congenita. J Allergy Clin Immunol. 2013 132(1):223-6. PMID: 23403051

Journal Article Allenspach, EJ

2013

Alter BP, Rosenberg PS, Day T, Menzel S, Giri N, Savage SA, Thein SL: Genetic Regulation of Fetal Hemoglobin in Inherited Bone Marrow Failure Syndromes. British Journal of Haematology 162:542-546, 2013. PMCID: PMC3720816.

Journal Article Alter Blanche, P

2013 Alter BP, Rosenberg PS: VACTERL-H Association and FANCONI ANEMIA. Molecular Syndromology 4:87-93, 2013. Journal Article Alter Blanche, P

SCNIRBibliography

of 87


2013

Ballew BJ, Yeager M, Jacobs K, Giri N, Alter BP, Boland J, Burdett L, Savage SA: Genetic Regulation of Fetal Hemoglobin in Inherited Bone Marrow Failure Syndromes. Human Genetics 132:473-480, 2013. PMCID: PMC3720816.

Journal Article Ballew, BJ

2013

Ballew BJ, Yeager M, Jacobs K, Giri N, Alter BP, Boland J, Burdett L, Savage SA: Regulator of Telomere Elongation Helicase 1, RTEL1, Is Mutated In Dyskeratosis Congenita. Human Genetics 132:473-480, 2013.

Journal Article Ballew, BJ

2013

Bellodi C, McMahon M, Contreras A, Juliano D, Kopmar N, Nakamura T, Maltby D, Burlingame A, Savage SA, Shimamura A, Ruggero D. H/ACA Small RNA Dysfunctions in Disease Reveal Key Roles for Noncoding RNA Modifications in Hematopoietic Stem Cell Differentiation. Cell Rep. 2013 May 30;3(5):1493-502. PMID: 23707062

Journal Article Bellodi, C

2013

Bessler M, Mason PJ, Link DC, and Wilson DB. Inherited bone marrow failure syndromes. In: Orkin SH, Nathan DG, Ginsburg D, Look AT, Fisher DE, eds. Nathan and Oski’s Hematology of Infancy and Childhood. 7th ed. Elsevier. 2013.

Book Chapter Bessler, M

2013

Boonyawat B, Dhanraj S, al Abbas F, Zlateska B, Gruenbaum E, Roifman CM, Steele L, Meyn S, Blanchette V, Scherer S, Swierczek S, Prchal J, Zhu Q, Torgerson TR, Ochs HD, Dror Y. Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. J Clin Immunol.2013;33:1150-5. PMID: 23943155.

Journal Article Boonyawat, B

2013 Boxer, LA. Neutropenia. Conn’s Current Therapy 2013. Elsevier. Waltham, MA. 825-830, 2013. Book Chapter Boxer, Laurence A

2013Dale DC, Bolyard AA, Marrero T, Bonilla MA, Phan L, Steward CG. Barth syndrome and neutropenia. (ASH Annual Meeting Abstracts). Blood. 2013;122:3465.


2013

Dale DC, Bolyard AA, Marrero T, Kelley ML, Phan L, Boxer LA, Kishnani PS, Kurtzberg J, Weinstein D. Neutropenia in glycogen storage disease 1b (GSD1b). Blood (ASH Annual Meeting Abstracts) 2013;122;2265.


2013

Dale DC, Kelley ML, Makaryan V, Rodger E, Otto B, Bolyard AA. A feasibility study of home monitoring of blood neutrophil counts in patients with chronic neutropenia. (European Hematology Association [EHA] Annual Meeting Abstracts). 2013; Abstract P1027. June 2013.


2013

Dale DC, Quniton, LJ, Nelson, S. Colony- stimulating factors for prevention and treatment of neutropenia and infectious diseases. In: Gabrilovich DI, ed. The Neutrophils: New Outlook for Old Cells. 3rd ed. London England: Imperial College Press; 2013:399-417


SCNIRBibliography

of 87


2013 Dale DC. Improving care of patients with immunodeficiency diseases. Curr Opin Hematol. 2013 Jan;20(1):1-2. PMID: 23196896. Journal Article Dale, David C

2013Dale, DC. A framework for improving care of patients with immunodeficiencies and marrow failure disorders. Curr Opin Hematol. 2013;20:1–2. (Editorial) PMCID: PMC4066809


2013

Dhanraj S, Manji A, Pinto D, Scherer SW, Favre H, Mignon L, Chetty R, Wei AC, Dror Y. Molecular characteristics of a pancreatic adenocarcinoma associated with Shwachman-Diamond syndrome. Pediatric Blood and Cancer. May 2013;60(5):754-60. PMID: 23303473.

Journal Article Dhanraj, S

2013Donadieu J, Beaupain B, Mahlaoui N, Bellanne-Chantelot C Epidemiology of congenital neutropenia. Hematol Oncol Clin North Am 2013;27: 1-17 PMID: 23351985.

Journal Article Donadieu, Jean

2013

Fargo JH, Kratz CP, Giri N, Savage SA, Wong C, Backer K, Alter BP, Glader B: Erythrocyte Adenosine Deaminase: Diagnostic Value for Diamond-Blackfan Anemia. British Journal of Haematology 160:547-554, 2013.

Journal Article Fargo, JH

2013

Greenbaum A, *Hsu MS. Day RB, Schuettpelz LG, Christopher MJ, Borgerding JN, Nagasawa T, Link DC. CXCL12 production by early mesenchymal progenitors is required for hematopoietic stem cell maintenance. Nature, 495:227-30, 2013. PMCID: PMC3600148.

Journal Article Greenbaum, A

2013

Harris AC, Kitko CL, Couriel DR, Braun TM, Choi SW, Magenau J, Mineishi S, Pawarode A, Yanik G, Levine JE. Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes. Haematologica, 98:179-84, 2013. PMCID: PMC3561423

Journal Article Harris, AC

2013

Hauet Q, Bequpain B, Micheau M, Blayo M, Gandemer V, Gottrand F, Blin N, Fouyssac F, Lethor JP, Bellanne-Chantelot C, Bonnet D, Donadieu J. Cardiomyopathies and congenital heart diseases in Shwachman-Diamond syndrome: A national survey. Int J Cardiol. 2013;167:1048-50. PMID: 23164595.

Journal Article Hauet, Q

2013

Landowski M, O'Donohue MF, Buros C, Ghazvinian R, Montel-Lehry N, Vlachos A, Sieff CA, Newburger PE, Niewiadomska E, Matysiak M, Glader B, Atsidaftos E, Lipton JM, Beggs AH, Gleizes PE, Gazda HT. Novel deletion of RPL15 identified by array- comparative genomic hybridization in Diamond-Blackfan anemia. Hum Genet. 2013 Nov;132(11):1265-74. Epub 2013 Jun 30.

Journal Article Landowski, M

2013

Levine JE, Huber E, Hammer STG, Harris AC, Greenson JK, Braun TM, Ferrara JLM, Holler E. Low Paneth cell numbers at onset of gastrointestinal GVHD identify patients at high risk for non-relapse mortality. Blood, prepublished online ahead of print June 12, 2013.

Journal Article Levine, JE

SCNIRBibliography

of 87


2013

Makaryan V, Rosenthal E, Bolyard AA, Kelley ML, Below J, Bamshad M, Bofferding KM, Smith JD, Buckingham K, Boxer LA, Skokowa J, Welte K, Nickerson DA, Jarvik GP, Dale DC, for the UW Center for Mendelian Genomics. TCIRG1 associated congenital neutropenia. Blood (ASH Annual Meeting Abstracts) 2013;122:440.


2013

Myers K, Bolyard AA, Otto B, Wong T, Jones A, Dobbins N, Moore J, Harris R, Davies S, Dale D, Shimamura A. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. J Pediatr. 2014 Apr;164(4):866-70. Epub 2013 Dec 31. PMID: 24388329 PMCID: PMC4077327


2013

Myers KC, Bolyard AA, Jones A, Otto B, Dobbins N, Moore J, Harris RE, Davies SM, Dale DC, Shimamura A. Adults with Shwachman-Diamond syndrome. (7th International Congress on Shwachman- Diamond Syndrome) Nov 2013.


2013

Myers KC, Bolyard AA, Jones A, Otto B, Dobbins N, Moore J, Harris RE, Davies SM, Dale DC, Shimamura A. Shwachman- Diamond Syndrome in Adults. (ASH Annual Meeting Abstracts) Dec 2013 (submitted)


2013

Myers KC, Bolyard AA, Otto B, Dobbins N, Jones A, Wong TE, Harris RE, Davies SM, Dale DC, Shimamura, A. Presentation of Shwachman-Diamond syndrome: update from the North American Shwachman-Diamond Syndrome Registry. (American Society of Pediatric Hematology/Oncology 26th Annual Meeting). April 2013.


2013

Myers KC, Bolyard AA, Otto B, Wong TE, Jones A, Dobbins N, Moore J, Harris RE, Davies SM, Dale DC, Shimamura A. Update from the North-American Shwachman-Diamond syndrome registry: variable clinical presentation of Shwachman-Diamond syndrome. 7th International Congress on Shwachman-Diamond Syndrome). Nov 2013.


2013

Myers KC, Davies SM, Shimamura A. Clinical and molecular pathophysiology of Shwachman-Diamond syndrome: an update. Hematol Oncol Clin North Am. 2013 Feb;27(1):117-28. PMID: 23351992


2013Newburger PE, Dale DC. Evaluation and management of patients with isolated neutropenia. Sem Hematol. 2013;50:198- 206. PMCID: PMC3748385. NIHMS490811.


2013

Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, Watz H, Lu S, Stryszak P, Rosenberg E, Staudinger H. CXCR2 antagonist MK-7123 - A phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. (American Thoracic Society International Conference Abstracts). 2013; Abstract #44953.

Abstract Rennard, SI

SCNIRBibliography

of 87


2013

Rigaud C, Lebre AS, Touraine R, Beaupain B, Ottolenghi C, Chabli A, Ansquer H, Ozsahin H, Di Filippo S, De Lonlay P, Borm B, Rivier F, Vaillant MC, Mathieu-Dramard M, Goldenberg A, Viot G, Charron P, Rio M, Bonnet D, Donadieu J. Natural history of Barth syndrome: a national cohort study of 22 patients. Orphanet J Rare Dis. 2013;8:70. PMCID: PMC3656783.

Journal Article Rigaud, C

2013 Shimamura A. Invited Speaker, Myeloid Biology Scientific Committee, American Society of Hematology, New Orleans, LA 2013 Presentation Shimamura, A

2013

Shimamura, A. Shwachman-Diamond Syndrome. In Clinical Decision Support: Hematology, Benz EJ, Berliner, N, Brodsky R, LaCasce A, Moake J , Eds. 2013. Decision Support in Medicine, LLC. Wilmington, DE. https://www.clinicaladvisor.com/hematology/ shwachman-diamond- syndrome/article/598066/

Journal Article Shimamura, A

2013Skokowa J, Welte K. Defective G-CSFR signaling pathways in congenital neutropenia. Hematol Oncol Clin North Am. 2013;27(1):75-88. PMID: 23351989.

Journal Article Skokowa, Julia

2013

Steinemann D, Katsman-Kuipers J, Zeidler C, Klimenkova O, Klimiankou M, Uenalan M, Kandabarau S, Makaryan V, Beekman R, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof M, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan M, Touw IP, van den Heuvel-Eibrink MM, Dale DC, Welte K. Cooperativity of RUNX1 and CSF3R mutations in the development of leukemia in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis. Blood. (ASH Annual Meeting Abstracts) 2013;122:444.

Abstract Steinemann, D

2013

Tulpule A, Kelley JM, Lensch MW, McPherson J, Park IH, Hartung O, Nakamura T, Schlaeger TM, Shimamura A, Daley GQ. Pluripotent stem cell models of Shwachman-Diamond syndrome reveal a common mechanism for pancreatic and hematopoietic dysfunction. Cell Stem Cell. 2013 June 6; 12(6): 727–736. PMID: 23602541 PMCID: PMC3755012.

Journal Article Tulpule, A

2013Usmani GN, Woda B, Newburger PE. Advances in understanding the pathogenesis of hemophagocytic lymphohistiocytosis. Br J Haematol 161:609- 22, 2013.

Journal Article Usmani, GN

2013

Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong CH, Wang H, Chin A, Gomez A, Harris AC, Levine JE, Choi SW, Couriel D, Reddy P, Ferrara JLM, Paczesny S. ST2 and Therapy- Resistant Graft-Versus-Host Disease and Mortality. New Engl J Med, 2013, 369:529- 39. PMID: 23924003.

Journal Article Vander Lugt, MT

http://www.clinicaladvisor.com/hematology/





SCNIRBibliography

of 87


2013

Welte K, Zeidler C, Dale DC. Introduction to Granulocyte Disorders. In: Ochs HD, Smith CIE, Puck M, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. 3rd ed. New York, NY: Oxford University Press; 2013;50:672- 75.

Book Chapter Welte, Karl

2013 Zeidler C. [Primary and secondary neutropenia.]. Z Rheumatol. 2013 Aug 17. [Epub ahead of print] German. PubMed PMID: 23949279. Journal Article Zeidler, Cornelia

2013

Zhang, MY, Keel, SB, Walsh, T, Lee, M, Pritchard, C, Jeng, M, Watts, A, Abkowitz, JL, King, MC, and Shimamura, A.Comprehensive Genomic Evaluation for Inherited Bone Marrow Failure and Myelodysplastic Syndromes, American Society of Hematology, 2013

Abstract Zhang, MY

2013

Zhao H, Zhang X, Frazão JB, Condino-Neto A, Newburger PE. HOX antisense lincRNA HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells. J Cell Biochem May 3 2013. [Epub ahead of print] PMID: 23649634.

Journal Article Zhao, H

2012

Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA: Telomere Length is Associated with Disease Severity and Declines with Age in Dyskeratosis Congenita. Haematologica 2012, March 97(3):353-359. PMIC: PMC3291588.


2012

Badolato R, Dotta L, Tassone L, Amendola G, Porta F, Locatelli F, Notarangelo LD, Bertrand Y, Bachelerie F, Donadieu J. Tetralogy of fallot is an uncommon manifestation of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome. J Pediatr. 2012;161(4):763-5. PMCID: PMC3458406.

Journal Article Badolato, R

2012

Beaussant Cohen S, Fenneteau O, Plouvier E, Rohrlich PS, Daltroff G, Plantier I, Dupuy A, Kerob D, Beaupain B, Bordigoni P, Fouyssac F, Delezoide AL, Devouassoux G, Nicolas JF, Bensaid P, Bertrand Y, Balabanian K, Chantelot CB, Bachelerie F, Donadieu J. Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry. Orphanet J Rare Dis. 2012;7:71. PMCID: PMC3585856.

Journal Article Beaussant, Cohen S

2012 Boxer, LA. How to Approach Neutropenia Hematology. American Society of Hematology Education Program. 2012; 174-182, 2012. Other Boxer, Laurence A

2012

Boztug K, Rosenberg PS, Böhm M, Moulton T, Curtin J, Rezaei N, Corns J, Innis J, Avci Z, Tran HC, Pellier I, Pedini A, Fruge R, Parvaneh N, Darbyshire P, Buchanan GR, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C: Extended molecular and clinical phenotype of human G6PC3 deficiency. Journal of Pediatrics 160:679-683, 2012. PMCID: PMC3718741.

Journal Article Boztug, K

SCNIRBibliography

of 87


2012

Boztug K, Rosenberg PS, Dorda M, Banka S, Moulton T, Curtin J, Rezaei N, Corns J, Innis JW, Avci Z, Tran HC, Pellier I, Pierani P, Fruge R, Parvaneh N, Mamishi S, Mody R, Darbyshire P, Motwani J, Murray J, Buchanan GR, Newman WG, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C. Extended spectrum of human glucose-6- phosphatase catalytic subunit 3 deficiency: novel genotypes and phenotypic variability in severe congenital neutropenia. J Pediatr 2012.160: 679-683 PMID: 22050868.


2012

Burwick, N, Coats, SA, Nakamura, T, and Shimamura, A. Impaired Ribosomal Subunit Association in Shwachman-Diamond Syndrome. Blood. 2012 December 20;120(26): 5143–5152. PMID: 23115272. PMCID: PMC3537309

Journal Article Burwick, N

2012

Choi SW, Stiff P, Cooke K, Ferrara JLM, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE. TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcome. Biol Blood and Marrow Transplant, 2012, 18:1525-32. PMCID: PMC3443302.

Journal Article Choi, SW

2012Connelly JA, Choi SW, Levine JE. Hematopoietic stem cell transplantation for severe congenital neutropenia. Curr Opin Hematol. 2012:19:44-51. (Review) PMCID: PMC3291495

Review Connelly, JA

2012

Dale DC, Bolyard AA, Marrero T, Bonilla MA, Link DC, Newburger P, Shimamura A, Boxer LA, for the Severe Chronic Neutropenia International Registry and Repository (SCNIR). The natural history of cyclic neutropenia: long-term prospective observations and current perspectives. (ASH Annual Meeting Abstracts). Blood. 2012;120:2141.


2012

Dale DC, Bolyard AA. rHuG-CSF for the Treatment of Severe Chronic Neutropenia. In: Molineux G, Arvedson T, Foote MA, eds. Twenty Years of G-CSF: Clinical and Nonclinical Discoveries, Basel, Switzerland: Springer-Basel; 2012:279-291.


2012Dale DC, Boxer LA. Guidelines for pediatric management of severe chronic neutropenia. Am J Hematol. 2012;87:133. (Commentary) PMID: 22237723

Commentary Dale, David C

2012

Dale DC, Liles WC. Early studies of AMD3100/plerixafor in healthy volunteers. In: Freuhauf S, Zeller WJ, Calandra G, eds. Novel Developments in Stem Cell Mobilization: Focus on CXCR4. New York, NY: Springer; 2012:89-102


2012 Dale DC. Do G-CSF schedules make a difference? Am J Clin Oncol. 2012;35:307. (Letter to the Editor) PMID: 22609734

Letter to the Editor Dale, David C

2012 Dale DC. Twenty years of the colony stimulating factors. Curr Op Hematol. 2012;19:1-2 (Editorial) PMID: 22143076. Editorial Dale, David C

SCNIRBibliography

of 87


2012

de Vries Y, Lwiwski N, Levitus M, Kuyt B, Israels SJ, Arwert F, Zwaan M, Greenberg CR, Alter BP, Joenje H, Meijers-Heijboer: A Dutch FANCC mutation in Canadian Manitoba Mennonites. Anemia. Article 865170, 2012.

Journal Article de Vries, Y

2012

Donadieu J, Fenneteau O, Beaupain B, Beaufils S, Bellanger F, Mahlaoui N, Lambilliotte A, Aladjidi N, Bertrand Y, Mialou V, Perot C, Michel G, Fouyssac F, Paillard C, Gandemer V, Boutard P, Schmitz J, Morali A, Leblanc T, Bellanne-Chantelot C. Classification of and risk factors for hematologic complications in a French national cohort of 102 patients with Shwachman-Diamond syndrome. Haematologica 2012:97: 1312-1319 PMCID: PMC3436231.


2012

Gadalla SM, Katki HA, Shebl FM, Giri N, Alter BP, Savage SA: Epigenetic regulation of telomere length in patients with dyskeratosis congenita and unaffected relatives. Aging Cell 11:24-28, 2012. PMCID: PMC3257380.

Journal Article Gadalla, SM

2012

Gazda HT, Preti M, Sheen MR, O'Donohu MF, Vlachos A, Davies SM, Kattamis A, Doherty L, Landowski M, Buros C, Ghazvinian R, Siff CA, Newburger PE, Niewiadomska E, Matysiak M, Glader B, Atsidaftos E, Lipton JM, Gleizes PE, Beggs AH. Frameshift mutation in p53 regulator RPL26 is associated with multiple physical abnormalities and a specific pre-rRNA processing defect in Diamond-Blackfan anemia. Hum Mutat 33:1037-44, 2012.

Journal Article Gazda, HT

2012

Goh ES, Perez IC, Canales CP, Ruiz P, Agatep R, Yoon G, Chitayat D, Dror Y, Shago M, Goobie S, Sgro M, Walz K, Mendoza-Londono R. Definition of a critical genetic interval related to kidney abnormalities in the Potocki-Lupski syndrome. Am J Med Genet A. 2012: 158A(7): pp 1579-88.

Journal Article Goh, ES

2012

Jaeger BN, Donadieu J, Cognet C, Bernat C, Ordonez-Rueda D, Barlogis V, Mahlaoui N, Fenis A, Narni-Mancinelli E, Beaupain B, Bellanne-Chantelot C, Bajenoff M, Malissen B, Malissen M, Vivier E, Ugolini S. Neutrophil depletion impairs natural killer cell maturation, function, and homeostasis. J Exp Med. 2012;209:565-80. PMCID: PMC3302230.

Journal Article Jaeger, BN

2012 Kahr WH, Dror Y. Gray platelet syndrome: macrothrombocytopenia with deficient α-granules. Blood. 2012: 120(13): pp 2543. Journal Article Kahr, WH

2012

Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar- Rodriguezs J, Hsu AP, Dyack S, Fernandez CV, Chong C-E, Babic M, Bardy PG, Shimamura A, Zhang M,, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott HS, Harvey NL. Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood. 2012;119(5):1283-91. PMID: 22147895.

Journal Article Kazenwadel, J

SCNIRBibliography

of 87


2012

Levine JE, Logan BR, Wu J, Alousi AM, Bolaños Meade J, Ferrara JLM, Ho VT, Weisdorf DJ, Paczesny S. Acute graft- versus-host disease biomarkers measured during therapy can predict treatment outcomes: A Blood and Marrow Transplant Clinical Trials Network study. Blood 2012, 119:3854-60. PMCID: PMC3335389


2012

Makaryan V, Kulik W, Vaz F, Allen C, Dror Y, Dale DC, Aprikyan AA. The cellular and molecular mechanisms of neutropenia in Barth syndrome. Eur J Haematol.2012;88:195-209. Epub 2011 Dec 4. PMCID: PMC4445723. PMID: 22023389.


2012

Makaryan V, Zeidler C, Bolyard AA, Skokowa J, Kelley ML, Boxer LA, Bonilla MA, Newburger P, Shimamura A, Welte K, Dale DC,, for the Severe Chronic Neutropenia International Registry (SCNIR). Clinical outcomes for patients with severe chronic neutropenia due to mutations in the gene for neutrophil elastase, ELANE . (ASH Annual Meeting Abstracts). Blood.2012;120:3275.


2012

Makaryan V, Zeidler C, Boylyard AA, Skokowa J, Rodger E, Kelley ML, Boxer LA, Bonilla MA, Newburger PE, Shimamura A, Zhu B, Rosenberg PS, Link DC, for the Severe Chronic Neutropenia International Registry (SCNIR). Clinical outcomes for patients with neutropenia attributable to mutations in the gene for neutrophil elastase, ELANE. Blood 2012 120:3275


2012

Myers K, Bolyard AA, Otto B, Dobbins N, Jones A, Wong T, Harris R, Davies S, Dale D, Shimamura A. Variable clinical presentation of Shwachman-Diamond syndrome: update from the North American Shwachman Diamond syndrome registry. (ASH Annual Meeting Abstracts). Blood. 2012;120:2367.


2012

Pasquet M, Bellanne-Chantelot C, Tavitian S, Prade N, Beaupain B, Larochelle O, Petit A, Rohrlich P, Ferrand C, Van Den NE, Poirel HA, Lamy T, Ouachee-Chardin M, Mansat-De M, V, Corre J, Recher C, Plat G, Bachelerie F, Donadieu J, Delabesse E. High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. Blood 121: 822-829.2012. PMCID: PMC3714670.

Journal Article Pasquet, M

SCNIRBibliography

of 87


2012

Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, Magri G, Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baro T, de Heredia CD, Toran N, Catala A, Torrebadell M, Fortuny C, Cusi V, Carreras C, Diaz GA, Blander JM, Farber CM, Silvestri G, Cunningham-Rundles C, Calvillo M, Dufour C, Notarangelo LD, Lougaris V, Plebani A, Casanova JL, Ganal SC, Diefenbach A, Arostegui JI, Juan M, Yague J, Mahlaoui N, Donadieu J, Chen K, Cerutti A B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012:13: 170-180 PMCID: PMC3262910.

Journal Article Puga, I

2012

Rackley S, Pao M, Seratti GF, Giri N, Rasimas JJ, Alter BP, Savage SA: Neuropsychiatric Conditions among Patients with Dyskeratosis Congenita: A Link with Telomere Biology? Psychosomatics 53:230- 235, 2012. PMCID: PMC3348420.

Journal Article Rackley, S

2012

Rogers ZR, Alter BP: Bone Marrow Failure Syndromes. In de Alarcon P, Werner EJ, Christensen RD, eds, Neonatal Hematology, Pathogenesis, Diagnosis, and Management of Hematologic Problems, 2nd Ed., Cambridge University Press, pp 47-64, 2012.

Book Chapter Rogers, ZR

2012

Schuettpelz L, Gopalan PK, Romine M, Fiuste F, and Link DC. Kruppel like factor 7 suppresses hematopoietic stem andprogenitor cell function. Blood, 120:2981-9,2012. PMCID: PMC3471512.

Journal Article Schuettpelz, L

2012

Skokowa J, Klimiankou M, Klimenkova O, Lan D, Gupta K, Hussein K, Carrizosa E, Kusnetsova I, Li Z, Sustmann C, Ganser A, Zeidler C, Kreipe HH, Burkhardt J, Grosschedl R, Welte K. Interaction among HCLS1, HAX1, and LEF-1 proteins is essential for G-CSF triggered granulopoiesis. Nat Med. 2012; 18:1550-9. PMID: 23001182.


2012

Skokowa J, Steinemann D, Makaryan V, Klimiankou M, Schnittger,S, Kohlmann A, Schlegelberger B, Zeidler C, Dale DC, Welte K. RUNX1 mutations are the most frequent leukemia associated mutations in congenital neutropenia patients. (ASH Annual Meeting Abstracts). Blood. 2012;120:7.

Abstract Skokowa, J

2012

Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM: Incidence of neoplasia in Diamond Blackfan anemia: A report from the Diamond Blackfan Anemia Registry. Blood 119(16):3815-3819, 2012.

Journal Article Vlachos, A

SCNIRBibliography

of 87


2012

Welch, J.S., Ley, T.J., Link, D.C. (co-first author), Miller, C.A., Larson, D.E., Koboldt, D.C., Wartman, L.D., Lamprecht, T.L., Liu, F., Xia, J., et al. The origin and evolution of mutations in acute myeloid leukemia. Cell, 150:264-78, 2012. PMCID: PMC3407563

Journal Article Welch, JS

2012

Xia J, Boxer LA, Link DC. ER stress-induced expression of CCAAT/enhanced binding protein gamma (C/EBPG) may contribute to the block in granulocytic differentiation in severe congenital neutropenia. Presented at the 54th Annual ASH Meeting and Exposition, Atlanta, GA, 2012.

Abstract Xia, J

2012

Zeng X-L, Fleisig HB, Hukezalie KR, Savage SA, Giri N, Alter BP, Wong JMY: The accumulation and not the specific activity of telomerase ribonucleoprotein determines telomere maintenance deficiency in X-linked dyskeratosis congenita. Human Molecular Genetics 21:721-729, 2012. PMCID: PMC3263989.

Journal Article Zeng, X-L

2011Aprikyan AA, Makaryan V, Kulik W, Vaz F, Allen C, Dror Y, Dale DC. The cellular and molecular mechanisms of neutropenia in Barth syndrome. Blood (ASH Annual Meeting Abstracts). 2011;118:1105.

Abstract Aprikyan, Andrew AG

2011

Batista LFZ, Pech MF, Zhong FL, Nguyen HN, Xie KT, Zaug AJ, Crary SM, Choi J, Sebastiano V, Cherry A, Giri N, Wernig M, Alter BP, Cech TR, Savage SA, Reijo Pera RA, Artandi SE: Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474(7361): 399-402, 2011. PMCID: PMC3155806.

Journal Article Batista, LFZ

2011

Biswas K, Das R, Alter BP, Kuznetsov SG, Stauffer S, North SL, Burkett S, Brody L, Meyer S, Byrd A, Sharan S: A comprehensive Functional Characterization of BRCA2 variants associated with Fanconi anemia using mouse ES cell-based functional assay. Blood 118:2430-2442, 2011.

Journal Article Biswas, K

2011

Blackwood, R.A. and Boxer, L.A. Disorders of Granulocytes in Rudolph’s Pediatrics, 22nd edition. Rudolph C, Rudolph A, First L, Lister, G., Gershon A.A. (eds). New York, McGraw-Hill, pp 1590-1596, 2011.

Book Chapter Blackwood, RA

2011

Boxer LA and Newburger PE. Disorders of phagocyte function in Nelson Textbook of Pediatrics. 19th edition. Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE (eds). Philadelphia, W.B. Saunders. pp 741-746, 2011.

Book Chapter Boxer, Laurence A

2011

Boxer LA and Newburger PE. Eosinophils in Nelson Textbook of Pediatrics. 19th edition. Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE (eds). Philadelphia, W.B. Saunders, pp 739-741, 2011.


2011

Boxer LA and Newburger PE. Leukocytosis in Nelson Textbook of Pediatrics. 19th edition. Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE (eds). Philadelphia, W.B. Saunders. p 752, 2011.


SCNIRBibliography

of 87


2011

Boxer LA and Newburger PE. Leukopenia in Nelson Textbook of Pediatrics. 19th edition. Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE (eds). Philadelphia, W.B. Saunders. pp 746-752., 2011.


2011

Boxer LA and Newburger PE. Neutrophils in Nelson Textbook of Pediatrics. 19th edition. Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE (eds). Philadelphia, W.B. Saunders. p. 739, 2011.


2011

Boxer LA, Bolyard AA, Marrero TM, Phan L, Bond JM, Alter BP, Bonilla MA, Link D, Newburger PE, Rosenberg PS, Shimamura A, Dale DC. Impact of G-CSF on outcomes of pregnancy in women with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2011;118:4786.


2011

Boxer LA, Newburger PE. Disorders of phagocyte function. In: Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: W.B. Saunders;2011:741-746.


2011

Boxer LA, Newburger PE. Leukopenia. In: Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE. eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: W.B. Saunders;2011:746-752.


2011

Boxer LA, Newburger PE. Neutrophils. In: Kliegman RM, Stanton BE, St. Geme J, Schor N, Behrman RE, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia: W.B. Saunders; 2011:739


2011Burwick N, Coats S, Shimamura A. SBDS and eIF6 modulate ribosome subunit joining in Shwachman-Diamond syndrome. Blood (ASH Annual Meeting Abstracts). 2011;118:3438.

Abstract Burwick, N

2011

Burwick N, Shimamura A, Liu JM Non-Diamond-Blackfan anemia disorders of ribosome function: Shwachman-Diamond syndrome and 5q- syndrome. Semin Hematol. 2011 48 (2): 136-143. PMID: 21435510. PMCID: PMC3072806.

Journal Article Burwick, N

2011

Christopher JM, Rao M, Liu F, Woloszynek JR, and Link DC. Expression of the G-CSF receptor in monocytic cells is sufficient to mediate hematopoietic progenitor mobilization by G-CSF in mice. JEM, 208:251-60, 2011. PMCID: PMC3039862

Journal Article Christopher, JM

2011

Dale DC, Bolyard AA, Kelley ML, Westrup EC, Makaryan V, Aprikyan A, Wood B, Hsu FJ. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome. Blood. 2011 Nov 3;118(18):4963-6. doi: 10.1182/blood-2011-06-360586. Epub 2011 Aug 11. PMID: 21835955; PMCID: PMC3673761.


SCNIRBibliography

of 87


2011

Dale DC, Bolyard AA, Kelley ML, Westrup EC, Makaryan V, Aprikyan A, Wood B, Hsu F. Plerixafor is a potential therapy for myelokathexis, WHIM syndrome. The 16th Congress of European Hematology Association. June 2011.


2011

Dale DC, Bolyard AA, Kelley ML, Westrup EC, Makaryan V, Aprikyan A, Wood B, Hsu F. The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome: Brief Reports. Blood. 2011;118:4963-6. PMCID: PMC3673761


2011

Dale DC, Bolyard AA, Marrero TM, Phan L, Boxer LA, Kishnani PS, Kurtzberg J, Weinstein DA. Neutropenia in glycogen storage disease 1b (GSD1b). (ASH Annual Meeting Abstracts). Blood. 2011;118:4791.


2011

Dale DC, Makaryan V, Bolyard AA, Rodger ER, Kelley ML, Marrero TM, Phan L, Aprikyan AA, Bonilla MA, Newburger PE, Boxer LA, Link D. ELANE Mutations in cyclic and congenital neutropenia: genotype- phenotype and structure-function relationships. (ASH Annual Meeting Abstracts). Blood. 2011;118:3398.


2011 Dale DC, Welte K. Cyclic and chronic neutropenia. Cancer Treat Res. 2011;157:97-108. PMID: 21052952. Review Dale, David C

2011Dale DC, Welte K. Cyclic and Chronic Neutropenia. In: Lyman GH, Dale DC, eds. Hematopoietic Growth Factors in Oncology. 1st ed. New York NY: Springer Science+Business Media; 2011:97-108


2011Dale DC. Cyclic and chronic neutropenia: An update on diagnosis and treatment. Clin Adv Hematol Oncol. 2011;11:868-69. PMID: 22252620

ECL Dale, David C

2011 Dale DC. Editorial: Serine proteases, serpins, and neutropenia. J Leukoc Biol. 2011 Jul;90(1):3-4. PMID: 21719462. Editorial Dale, David C

2011Dale DC. Glycogen storage disease; neutropenia and enterocolitis in GSD 1b. Am J Med Genet. 2011. (submitted); PMC Journal - In process.


2011 Dale DC. Serine proteases, serpins and neutropenia. J Leuk Biol. 2011;90(1):3-4. (Editorial) PMID: 21719462 Editorial Dale, David C

2011

de Oliveira-Junior E, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase: Primary and secondary defects affecting the microbicidal ability of phagocytes. Scand J Immunol 73:420-7, 2011.

Journal Article de Oliveira-Junior, E

2011

Donadieu J, Fenneteau O, Beaupain B, Mahlaoui N, Chantelot CB. Congenital neutropenia: diagnosis, molecular bases and patient management. Orphanet J Rare Dis. 2011 May 19;6:26. Review. PMID: 21595885; PMCID: PMC3127744


SCNIRBibliography

of 87


2011

Dror Y, Donadieu J, Koglmeier J, Dodge J, Toiviainen-Salo S, Makitie O, Kerr E, Zeidler C, Shimamura A, Shah N, Cipolli M, Kuijpers T, Durie P, Rommens J, Siderius L, Liu JM (2011) Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Ann N Y Acad Sci 2011, 1242: 40-55 PMID: 22191555.

Journal Article Dror, Yigal

2011

Ellerbeck W, Klimenkova O, Skokowa J, Welte K. mRNA and protein expression levels of secretory leukocyte protease inhibitor (slpi) are severely reduced in patients with severe congenital neutropenia (cn). Blood (ASH Annual Meeting Abstracts). 2011;118:2165.

Abstract Ellerbeck, W

2011

Finch AJ, Hilcenko C, Basse N, Drynan LF, Goyenechea B, Menne TF, González Fernández A, Simpson P, D'Santos CS, Arends MJ, Donadieu J, Bellanné-Chantelot C, Costanzo M, Boone C, McKenzie AN, Freund SM, Warren AJ. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev. 2011 May 1;25(9):917-29. PMID: 21536732; PMCID: PMC3084026

Journal Article Finch, AJ

2011

Giri N, Lee R, Faro A, Huddleston CB, White FV, Alter BP, Savage SA: Lung Transplantation for Pulmonary Fibrosis in Dyskeratosis Congenita: Case Report and Systematic Literature Review. BMC Blood Disorders. Jun 15;11(1):3, 2011. PMCID: PMC3141321

Journal Article Giri, N

2011Happle C, Germeshausen M, Zeidler C, Welte K, Skokowa J. Neutrophil extracellular traps (NETs) in patients with congenital neutropenia. Blood (ASH Annual Meeting Abstracts). 2011;118:15.

Abstract Happle, C

2011Li KW, Turner SM, Emson CL, Hellerstein MK, David DC. Deuterium and neutrophil kinetics. Blood. 2011;117:6052-3. (Letter to the Editor) PMID: 21636721.

Letter to the Editor Li, KW

2011Lyman GH, Dale DC. Long term outcomes of myeloid growth factor treatment. J Natl Compr Canc Netw. 2011;9:945-52. PMID: 21900223

Journal Article Lyman, GH

2011

Makaryan V, Kulik W, Vaz Frederic, Allen C, Dror Y, Dale DC, Aprikyan AA. Cellular and molecular mechanisms of neutropenia and possibly cardiomyopathy in Barth syndrome. American Heart Association. Scientific Sessions 2011 Nov.


2011Newburger, PE. The ENCODE Project Consortium*. A User's Guide to the Encyclopedia of DNA Elements (ENCODE). PLoS Biol 9:e1004046, 2011 (*329 Authors).

Journal Article Newburger, PE

2011

Nustede R, Kuznetsova I, Welte K, Skokowa J. Mechanism of the elevated UPR in CN patients but not in CyN patients carrying same ELANE mutations. Blood (ASH Annual Meeting Abstracts). 2011;118:14.

Abstract Nustede, R

SCNIRBibliography

of 87


2011Rochowski A, Sun C, Glogauer M, Alter BP: Neutrophil Functions in Patients with Inherited Bone Marrow Failure Syndromes. Pediatric Blood and Cancer 57:306-309, 2011. PMCID: PMC3116953.

Journal Article Rochowski, A

2011

Rosenberg PS, Tamary H, Alter BP: How High are Carrier Frequencies of Rare Recessive Syndromes? Estimates for Fanconi Anemia in the United States and Israel. American Journal of Medical Genetics Part A 155:1877-1883, 2011.

Journal Article Rosenberg, Philip S

2011

Savage SA, Giri N, Jessop L, Pike K, Plona T, Burdett L, Alter BP: Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita. Journal of Medical Genetics 48:285-288, 2011. PMID: 21209122.

Journal Article Savage, SA

2011

Schmaier AH, Petruzzelli LM, Borregaard N, Boxer LA. Myeloid Cell Physiology and Disorders. In: Schmaier AM, Lazarus HM eds. Concise Guide to Hematology. New York: Wiley-Blackwell; 2011:184-196.

Book Chapter Schmaier, AH

2011Sen S, Wang H, Nghiem CL, Zhou K, Yau J, Tailor C, Irwin M, Dror Y. The ribosome- related protein, SBDS, is critical for normal erythropoiesis. Blood,2011:8;118(24):6407- 17. PMID: 21963601

Journal Article Sen, S

2011

Shimamura A, Bolyard AA, Chakrabarti S, Bond JM, Cole T, Moore J, Boxer LA, Newburger PE, Alter BP, Harris RE, Davies SM, Dale DC. Clinical features of Shwachman-Diamond syndrome patients lacking biallelic SBDS mutation. (ASH Annual Meeting Abstracts). Blood. 2011;118:4367.

Abstract Shimamura, A

2011

Tsangaris E, et al, Klaassen R, Fernandez CV, Yanofsky R, Scherek E, Champagne J, Silva M, Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L, Hand JP, Stephen D, Odame I, Canning P, Allen C, Beyene J, Dror Y. Genetic Analysis of Inherited Bone Marrow Failure Syndromes from one prospective, comprehensive and population-based cohort and identification of novel mutations. J Med Genet, 2011:48(9):618-28. PMID: 21659346.

Journal Article Tsangaris, E

2011Walkovich K, and Boxer LA. Congenital neutropenia in a newborn. Journal of Perinatology. 31: S22-S23, 2011. PMID:21448199.

Journal Article Walkovich, K

2011

Zeidler C, Brand B, Grote UAH, Nickel A, Welte KH. Pregnancy outcome in genetic subtypes of congenital neutropenia. Blood (ASH Annual Meeting Abstracts).2011;118:4722.

Abstract Zeidler, Cornelia

2011

Zeidler C, Vandenberghe P, Schäfer I, Hoy L, Zimmermann M, Germeshausen M, Welte K. Update on the risk of secondary leukemia in genetic subgroups (ELANE, HAX1, WAS, G6PC3, p14) of congenital neutropenia in Europe. Blood (ASH Annual Meeting Abstracts). 2011;118:1106.


SCNIRBibliography

of 87


2010

Alter BP, Giri N, Savage SA, Peters JA, Loud JT, Leathwood L, Carr A, Greene MH, Rosenberg PS: Malignancies and Survival Patterns in the National Cancer Institute Inherited Bone Marrow Failure Syndromes Cohort Study. British Journal of Haematology 150:179-188, 2010. PMCID: PMC3125983.


2010

Ambekar C, Das B, Yeger H, Dror Y. SBDS- deficiency results in deregulation of reactive oxygen species leading to increased cell death and decreased cell growth. Pediatr Blood Cancer. 2010;55:1138-44. PMID 20979173.

Journal Article Ambekar, C

2010

Aprikayn AA, Makaryan V, Totrov M, Abagyan R, Dale DC. Small molecule inhibitor of neutrophil elastase normalizes myeloid differentiation and improves impaired cell survival triggered by elastase mutations in patients with severe congenital neutropenia and acute myeloid leukemia. (ASH Annual Meeting Abstracts). Blood. 2010;116:386.


2010

Borregaard N, Boxer LA. Disorders of neutrophil function. In: Kaushansky K, Lichtman MA, Bentler E, Kipps T, Seligsohn V, Prchal JT, eds. Hematology. 8th ed. New York, NY, McGraw-Hill; 2010:951-986.

Book Chapter Borregaard, N

2010

Boxer LA, Bolyard AA, Marrero TM, Alter BP, Bonilla MA, Link D, Newburger P, Rosenberg PS, Shimamura A, Dale DC. Outcomes of pregnancies for women with severe chronic neutropenia with or without G CSF treatment. Blood (ASH Annual Meeting Abstracts). 2010; 116:1490.


2010 Boxer LA. Common clinical features of inherited bone marrow failure syndromes. Hem Onc Today. 11:16, 2010. www.hemonctoday.com/ Journal Article Boxer, Laurence A

2010

Boztug K, Rosenberg PS, Bohm M, Moulton T, Curtin J, Rezael N, Corns J, Innis J, Avci Z, Tran HC, Pellier I, Gatti S, Fruge R, Parvaneh N, Darbyshire P, Buchanan G, Alter BP, Boxer LA, Donadieu J, Welte K, Klein C. Extended molecular and clinical phenotype of human G6PC3 deficiency. (ASH Annual Meeting Abstracts). 2010.

Abstract Boztug, K

2010Choi SW, Levine JE. Indications for hematopoietic cell transplantation for children with severe congenital neutropenia. Pediatr Transplant 2010, 14:937-9. PMID: 20819181.


2010

Collins S, Bolyard AA, Marrero, TM, Phan L, Dale DC for the Severe Chronic Neutropenia International Registry. Barth syndrome and severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2010;116:3787.

Abstract Collins, S

2010

Dale DC, Lyman GH. Hematopoietic growth factors. In: Gregory SA, McCrae KR, eds. American Society of Hematology - Self- Assessment Program (ASH-SAP) Question & Answer Book. 4th ed. Washington, DC: Cadmus Communications; 2010;3:11-13.


http://www.hemonctoday.com/

http://www.hemonctoday.com/

SCNIRBibliography

of 87


2010

Dale DC, Lyman GH. Hematopoietic growth factors. In: Gregory SA, McCrae KR, eds. ASH-SAP American Society of Hematology Self-Assessment Program Textbook. 4th ed. Washington, DC:American Society of Hematology; 2010;3:75-92.


2010

Dale DC, Makaryan V, Bolyard AA, Rodger E, Aprikyan A, Bonilla MA, Newburger P, Boxer LA, Link D. Neutrophil elastase mutations and the risk of leukemia in patients with cyclic and congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2010;116:3786.


2010

Dale DC. Neutropenia and Neutrophilia. In: Lichtman MA, Kipps TJ, Kaushansky K, Beutler E, Seligsohn U, Prchal JT. eds. Williams Hematology. 8th ed. New York, NY: McGraw-Hill; 2010:939-50


2010Dale DC. Neutropenia and Neutrophilia. William's Hematology. 8th ed. Lichtman MA, Kipps TJ, Kaushansky K, Beutler E, etal, eds. New York, NY: McGraw-Hill;2010. Chapter 71, 823-34.


2010Dale DC. Recent progress in understanding the congenital neutropenias. Curr Op Hematol. 2010;17:1-2. (Editorial) PMID: 19881345.


2010 Dale DC. Scaling up and producing more generalists. SGIM Forum. 2010;33:7. ECL Dale, David C

2010

Dale DC. Scaling Up and Producing More Generalists. Society of General Internal Medicine, Forum. https://www.sgim.org/file library/sgim/resource library/forum/2010/sgim-may-2010-web.pdf May 2010;Reflections,p7. (commentary)


2010

DiMeglio LA, Bolyard AA, Marrero TM, Alter BP, Bonilla MA, Boxer LA, Link D, Newburger P, Rosenberg PS, Shimamura A, Dale DC. The risk of low bone mineral density with long-term G-CSF therapy for severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2010;116:1484.

Abstract DiMeglio, LA

2010

Doherty L, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Clinton C, Schneider HE, Sieff CA, Newburger PE, Ball SE, Niewiadomska E, Matysiak M, Glader B, Arceci RF, Farrar JE, Atsidaftos E, Lipton JM, Gleizes PE, Gazda HT. Ribosomal protein genes RPS10 and RPS26 are commonly mutated in Diamond-Blackdan anemia. Am J Hum Genet 86:222-28, 2010.

Journal Article Doherty L

2010

Eash KJ, Greenbaum AM, Gopalan PK, and Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010 Jul 1;120(7):2423-31. PMCID PMC2898597

Journal Article Eash, KJ

2010 Evans JP, Dale DC, Fomous C. Preparing for a consumer-driven genomic age. N Engl J Med. 2010;363:1099-1103. PMID: 20843241 Journal Article Evans, JP

http://www.sgim.org/file




SCNIRBibliography

of 87


2010

Germeshausen M, Zeidler C, Stuhrmann M, Lanciotti M, Ballmaier M, Welte K. Digenic mutations in severe congenital neutropenia. Haematologica. 2010;95(7):1207-10. PMID:20220065. PMCID: PMC2895047.

Journal Article Germeshausen, M

2010

Hashmi SK, Klaassen R, Fernandez CV, Yanofsky R, Shereck E, Champagne J, Silva M, Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Dower N, Athale U, Jardine L, Dror Y. Comparative analysis of Shwachman-Diamond Syndrome to other Inherited Marrow Failure Syndromes. Clinic Genet 2010. PMID: 20569259.

Journal Article Hashmi, SK

2010

Huang JN and Shimamura A. Clinical spectrum and molecular pathophysiology of Shwachman-Diamond syndrome. Curr Opin Hematol. 2010 Nov 30. [Epub ahead of print] PMID: 21124213. PMCID: PMC3485416

Journal Article Huang, JN

2010

Li J-M, Newburger PE, Gounis M, Dargon P, Zhang X, Messina LM. Local arterial nanoparticle delivery of siRNA for NOX2 knockdown to prevent restenosis in an atherosclerotic rat model. Gene Ther 17:1279-87, 2010.

Journal Article Li, J-M

2010

Newburger PE, Pindyck TN, Zhu Z, Bolyard AA, Aprikyan AA, Dale DC, Smith GD, Boxer LA. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer. 2010 Aug;55(2):314-317. doi: 10.1002/pbc.22537. PubMed PMID:20582973; PubMed Central PMCID: PMC2913300.


2010

Newburger PE, Pindyck TN, Zhu Z, Bolyard AA, Aprikyan AA, Dale DC, Smith GD, Boxer LA. Cyclic neutropenia and severe congenital neutropenia in patients with a shared ELANE mutation and paternal haplotype: evidence for phenotype determination by modifying genes. Pediatr Blood Cancer. 2010;55:314-7. PMCID: PMC2913300


2010

Paczesny S, Braun TM, Levine JE, Hogan J, Crawford J, Coffing B, Olsen S, Choi SW, Wang H, Faca V, Pitteri S, Zhang Q, Chin A, Kitko C, Mineishi S, Yanik G, Peres E, Hanauer D, Wang Y, Reddy P, Hanash S, Ferrara JLM. Elafin is a biomarker of graft versus host disease of the skin. Science Translational Medicine 2010, 2:13ra2. PMCID: PMC2895410

Journal Article Paczesny, S

2010

Parmar K, Kim JM, Sykes SM, Shimamura A, Stuckert P, Zhu K, Hamilton A, DeLoach MK, Kutok JL, Akashi K, Gilliland DG, D’Andrea A. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1 stem cells. 2010;28(7):1186-95.

Journal Article Parmar, K

SCNIRBibliography

of 87


2010

Ramsingh G, Koboldt DC, Trissal M, Chiappinelli K, Wylie T, Koul S, Chang L, Nagarajan R, Fehniger T, Goodfellow P, Magrini V, Wilson RK, Ley TJ, Mardis ER, and Link DC. Complete characterization of the microRNAome of a human acute myeloid leukemia. Blood 116:5316-26, 2010 PMCID PMC3012545

Journal Article Ramsingh, G

2010

Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link D, Newburger P, Shimamura A, Welte K, Dale DC. Stable long-term risk of leukaemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J. Haematol. 2010;150:196-9. PMCID: PMC2906693


2010

Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Boxer LA, Dror Y, Kinsey S, Link DC, Newburger PE, Shimamura A, Welte K, Dale DC. Stable Long-Term Risk of Leukaemia in Patients with Severe Congenital Neutropenia Maintained on G- CSF Therapy. B J Haematol. April 29, 2010: 7-1048. PMID 20456363.

Article Rosenberg, Philip S

2010Shimamura A, Alter BP: Pathophysiology and Management of Inherited Bone Marrow Failure Syndromes. Blood Reviews 24:101- 122, 2010. PMCID: PMC3733544. PMID 20417588.

Journal Article Shimamura A

2010

Tamary H, Nishri D, Yacobovich J, Zilber R, Dgany O, Krasnov T, Aviner S, Stepensky P, Vilk-Ravel SS, Bitan M, Kaplinsky C, Ben Barak A, Ronit Elhasid R, Kapelusnik J, Koren A, Levin C, Atias D, Laor R, Yaniv I, Rosenberg PS, Alter BP: Frequency and Natural History of Inherited Bone Marrow Failure Syndromes: the Israeli Inherited Bone Marrow Failure Registry.Haematologica 95:1300-1307, 2010. PMCID: PMC2913078.

Journal Article Tamary, H

2010

Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP. Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology 117:615-622, 2010. PMCID: PMC2830377.

Journal Article Tsilou, ET

2010

Tulpule A, Lensch MW, Miller J, Austin K, D’Andrea A, Shimamura A, Daley GQ. Knockdown of Fanconi anemia genes in human embryonic stem cells reveals early developmental defects in the hematopoietic lineage. Blood.2010,115(17):3453-3462.

Journal Article Tulpule, A

2010

Wong, TE, Calicchio, ML, Fleming, MD, Shimamura, A*, and Harris, MH. SBDS protein expression patterns in bone marrow. Pediatr Blood Cancer. 2010 Sep;55(3):546-9. (*Corresponding author) PMID: 20658628. PMCID: PMC2913690.

Journal Article Wong, TE

SCNIRBibliography

of 87


2010

Yasukochi Y, Maruyama O, Mahajan MC, Padden C, Euskirchen GM, Schulz V, Hirakawa H, Kuhara S, Pan X, Newburger PE, Snyder M, Weissman SM. X chromosome-wide analyses of genomic DNA methylation states and gene expression in male and female neutrophils. Proc Natl Acad Sci USA 107:3704-3709, 2010

Journal Article Yasukochi, Y

2009

Alousi AM, Weisdorf DJ, Logan BR, Bolaños- Meade J, Carter S, DiFronzo N, Pasquini M, Goldstein SC, Ho VT, Hayes-Lattin B, Wingard JR, Horowitz MM, Levine JE. Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: A randomized phase 2 trial from the Blood and Marrow Transplant Clinical Trials Network. Blood 2009, 114:511-517. PMCID: PMC2713466

Journal Article Alousi, AM

2009Aprikyan AA, Makaryan V, Totrov M, Abagyan R, Dale DC. Small molecule inhibitor of neutrophil elastase and severe congenital neutropenia. Blood (ASH Annual Meeting Abstracts). 2009;114:552.


2009

Boztug K, Appaswamy G, Ashikov A, Schäffer AA, Salzer U, Diestelhorst J, Germeshausen M, Brandes G, Lee-Gosler J, Noyan F, Gatzke AK, Minkov M, Greil J, Kratz C, Petropoulou T, Pellier I, Bellane- Chantelot C, Rezaei N, Mönckemöller K, Irani-Hakimeh N, Bakker H, Gerardy- Schahn R, Zeidler C, Grimbacher B, Welte K, Klein C. A novel syndrome with congenital neutropenia caused by mutations in G6PC3. N Engl J Med. 2009; 360:32-43. PMCID: PMC2778311.


2009

Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin N Am. 2009;23:233-248. PMID: 19327581. PMCID: PMC2754297.

Journal Article Burroughs, L

2009

Christopher MJ, Liu F, Hilton MJ, Long F, and Link DC. Suppression of CXCL12 production by bone marrow osteoblasts is a common and critical pathway for cytokine- induced mobilization. Blood, 114:1331-9, 2009. PMCID: PMC19141863.

Journal Article Christopher, MJ

2009

Crawford J, Armitage J, Balducci L, Bennett C, Blayney DW, Cataland SR, Dale DC, Demetri GD, Erba HP, Foran J, Freifeld AG, Goemann M, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, Michaud LB, Miyata SC, Tallman MS, Vadhan-Raj S, Westervelt P, Wong MK; National Comprehensive Cancer Network. Myeloid growth factors. J Natl Compr Canc Netw. 2009 Jan;7(1):64-83. PMID: 19176207.

Journal Article Crawford, J

2009 Dale DC and Link DC: There are so many causes of neutropenia. NEJM, 360:3-5, 2009 Journal Article Dale, David C

SCNIRBibliography

of 87


2009

Dale DC, Bolyard AA, DiMeglio LA, Marrero TM, Boxer LA. Bone density measurements in patients with severe chronic neutropenia on long-term G-CSF therapy. (ASH Annual Meeting Abstracts). Blood. 2009;114:1362.


2009Dale DC, Link DC. The many causes of severe congenital neutropenia. N Engl J Med. 2009;360:3-5. PMID: 19118300. PMCID: PMC4162527


2009 Dale DC, Price TH. Granulocyte Transfusion Therapy: A New Era? Curr Opin Hematol. Curr Opin Hematol. 2009 Jan; 16(1): 1–2. Journal Article Dale, David C

2009

Dale DC, Price TH. Granulocyte transfusion therapy: a new era? Curr Opin Hematol.2009 Jan;16(1):1-2. (Editorial) PubMed PMID: 19057197. PMCID: PMC2674763.


2009 Dale DC. Advances in the treatment of neutropenia. Curr Op Support Palliat Care. 2009;3:207-12. PMCID: PMC3390973 Journal Article Dale, David C

2009Dale DC. Advances in the treatment of neutropenia. Curr Opin Support Palliat Care. 2009;3:207-12. (Review) PMCID:PMC3390973. PMD: 19550332


2009Dale DC. Neutrophil biology and the next generation of myeloid growth factors. J Natl Compr Canc Netw. 2009;7:92-8. PMCID: PMC4445720. PMID: 19176209.

Review Dale, David C

2009

Dinauer MC, Newburger, PE. The phagocyte system and disorders of granulopoiesis and granulocyte function. In: Orkin SH, Ginsburg D, Nathan DG, Look AT, Fisher DA, Lux SE, eds. Nathan and Oski’s Hematology of Infancy and Childhood. 7th ed. Philadelphia: Elsevier, Inc.;2009:1109-1220.

Book Chapter Dinauer, MC

2009

Dinauer ME, Nauseef WM, Newburger PE. Inherited Disorders of Oxidative Phagocyte Killing. In: Online Metabolic and Molecular Basis of Inherited Diseases, 2009. Available at: www.ommbid.com/OMMBID/the_online_metabolic_and_molecular_bases_of_inherited_ disease/b/abstract/part20/ch189

Book Chapter Dinauer, ME

2009

Du, H-Y, Pumbo, E, Ivanovich, J, An, P, Maziarz, RT, Reiss, UM, Chirnomas, D, Shimamura, A, Vlachos, A, Lipton, JM, Goyal, RK, Goldman, F, Wilson, DB, Mason, PJ, and Bessler, M. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood 2009; 113:309-316. PMCID: PMC2615648.

Journal Article Du, H-Y

2009

Eash KJ, Means JM, White DW, and Link DC: CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions, Blood, 113:4711-9, 2009 PMCID PMC268037

Journal Article Eash, KJ

SCNIRBibliography

of 87


2009

Errante PR, Prando C, Bustamante J, Aragao Filho WC, Pereira PV, Rehder J, Casanova JL, Newburger P, Condino-NetoA. Comment on "Impaired priming and activation of the neutrophil NADPH oxidase in patients with IRAK4 or NEMO deficiency." J Immunol. 2009;183:3559 [letter containing novel data].

Letter containing Novel Data Errante, PR

2009Germeshausen M, Kratz CP, Ballmaier M, Welte K. RAS and CSF3R mutations in severe congenital neutropenia. Blood. 2009 Oct 15;114(16):3504-5. PMID: 19833857.


2009Liles WC, Dale DC. Hematopoietic growth factors (cytokines). In: Simon TL, et al, eds. Rossi's Principles of Transfusion. 4th ed. AABB, Bethesda MD and Blackwell, Oxford UK, 2009, pp 498-507.

Book Chapter Liles, WC

2009

Mahajan MC, Karmakar S, Newburger PE, Krause DS, Weissman SM. Dynamics of alpha-globin locus chromatin structure and gene expression during erythroid differentiation of human CD34(+) cells in culture. Exp Hematol 37:1143-56, 2009.

Journal Article Mahajan, MC

2009

Makaryan V, Dror Y, Aprikyan AA. Loss of Tafazzin (TAZ) function and accelerated apoptosis of human bone marrow stem and myeloid progenitors in Barth syndrome. (ASH Annual Meeting Abstracts). Blood.2009;114:549.


2009

Makaryan V, Penate O, Dale DC, Aprikyan AA. Mutant CXCR4-induced aberrant retention and apoptosis of hematopoietic cells in myelokathexis and normalization of cell survival and mobilization with specific inhibitors. (ASH Annual Meeting Abstracts). Blood. 2009;114:237.


2009Newburger PE. 50 years ago in The Journal of Pediatrics: Infantile agranulocytosis of congenital origin. J Pediatr 154:841, 2009 [invited mini-review].

Review Newburger, Peter E

2009

Rao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T. Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS).Pediatr Blood Cancer, 52:847-52, 2009.

Journal Article Rao, VK

2009Rawls AS, Link DC. Shwachman-Diamond Syndrome. In: Lang F, ed. Encyclopedic Reference of Molecular Mechanisms of Disease. Berlin Heidelberg: Springer- Verlag;2009:1931-32.

Book Chapter Rawls, AS

SCNIRBibliography

of 87


2009

Rosenberg PS, Zeidler C, Bolyard AA, Alter BP, Bonilla MA, Dror Y, Kinsey SE, Link DC, Shimamura A, Newburger PE, Boxer LA, Welte K, Dale DC. Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. (ASH Annual Meeting Abstracts). Blood.2009;114:3206.

Abstract Rosenberg, Philip S

2009

Rujkijyanont, P, Adams S, Beyene J, Dror Y. Bone marrow cells from patients with Shwachman-Diamond Syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol. 2009;145:806-15. PMID: 19438500.

Journal Article Rujkijyanont, P

2009 Savage SA, Alter BP: Dyskeratosis congenita. Hematology/Oncology Clinics of North America 23:215-231, 2009. PMCID: PMC2702847. Journal Article Savage, SA

2009

Savage SA, Dokal I, Armanios M, Aubert G, Cowen EW, Domingo DL, Giri N, Greene MH, Orchard PJ, Tolar J, Tsilou E, Waes CV, Wong JMY, Young NS, Alter BP: Meeting Report: Dyskeratosis congenita: The first NIH clinical research workshop. Pediatric Blood and Cancer 53:520-523, 2009. PMCID: PMC2739803.


2009

Shimamura A, Bolyard AA, Marrero T, Alvendia M, Ellis L, Rommens JM, Harris RE, Durie P, Dror Y, Dale DC.. Shwachman-Diamond syndrome: development of a North American registry to assess long-term outcomes, risk of leukemia and other complications. (ASH Annual Meeting Abstracts). Blood. 2009;114:1363.

Abstract Shimamura, A

2009 Shimamura A. Clinical approach to marrow failure. Hematology Am Soc Hematol Educ Program. 2009:329-37. PMCID: PMC2867260. Journal Article Shimamura, A

2009

Skokowa J, Lan D, Thakur BK, Wang F, Gupta K, Cario G, Brechlin AM, Schambach A, Hinrichsen L, Meyer G, Gaestel M, Stanulla M, Tong Q, Welte K. Nampt is esential for the G-CSF induced myeloid differentiation via a NAD+-sirtuin-dependent pathway. Nat Med 2009, 15:15 PMID:19182797.


2009Skokowa J, Welte K. Dysregulation of myeloid-specific transcription factors in congenital neutropenia. Ann N Y Acad Sci. 2009 Sep;1176:94-100. PMID: 19796237.


2009

Ward AC, Dale DC. Genetic and molecular diagnosis of severe congenital neutropenia. Curr Opin Hematol. 2009 Jan;16(1):9-13. doi: 10.1097/MOH.0b013e32831952de.Review. PMID: 19057199; PMCID: PMC2720320.

Review Ward, AC

2009

Watanabe K, Ambekar C, Schimmer A, DrorY. SBDS-deficiency results in specific hypersensitivity to Fas stimulation and accumulation of Fas at the plasma membrane. Apoptosis 2009;14:77-89. PMID: 19009351.

Journal Article Watanabe, K

SCNIRBibliography

of 87


2009 Welte K, Zeidler C. Severe congenital neutropenia. Hematol Oncol Clin North Am. 2009 Apr; 23(2):307-20. PMID: 19327585. Journal Article Welte, Karl

2009

Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC, Link DC. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol.2009 Nov;147(4):535-42. doi:10.1111/j.1365-2141.2009.07888.x. Epub2009 Sep 22. PMID: 19775295 PMCID: PMC2783282.

Journal Article Xia, J

2009

Zeidler C, Donadieu J, Bolyard AA, Vandenberghe P, Pracht G, Beaupain B, Hoy L, Zimmermann M, Bellanné-Chantelot C, Link D, Klein C, Germeshausen M, Dale DC, Welte K, for the Severe Chronic Neutropenia International Registry (SCNIR) and the French Neutropenia Registry.Update on the risk of leukemia in genetic subgroups of congenital neutropenia (CN): comparison of patients with known gene mutations (ELA2 , HAX1, WAS, G6PC3, P14) . (ASH Annual Meeting Abstracts).Blood. 2009;114:3597.


2009

Zhang X, Lian Z, Padden C, Gerstein MB, Rozowsky J, Snyder M, Gingeras TR, Kapranov P, Weissman SM, Newburger PE. A myelopoiesis-associated regulatory intergenic non-coding RNA transcript within the human HOXA cluster. Blood 113:2526- 34, 2009.

Journal Article Zhang, X

2008Al-Rahawan MM, Alter BP, Bryant BJ, Elghetany MT: Bone marrow cell cycle markers in inherited bone marrow failure syndromes. Leukemia Research 32:1793- 1799, 2008. PMCID: PMC2716700.

Journal Article Al-Rahawan, MM

2008

Aprikayn AA, Makaryan V, Si Q, Treonze K, Markosyan N, Finke P, Manier S, Mumford R, Dale DC. Dispensable role of neutrophil elastase in survival and differentiation of human myeloid progenitor cells. (ASH Annual Meeting Abstracts). Blood.2008;112:3561.


2008

Austin, K.M., Gupta, M.L., Coats, S.A. Tulpule, A., Mostoslavsky, G., Balazs, A.B., Mulligan, R.C., Daley, G. Q., Pellman, D., and Shimamura, A. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond Syndrome. J Clin Invest. 2008;118(4):1511-1518. PMID: 18324336. PMCID: PMC2263145.

Journal Article Austin, KM

2008

Bohn G, Hardtke-Wolenski M, Zeidler C, Maecker B, Sauer M, Sykora KW, Grigull L, Welte K, Klein C. Lethal graft-versus-host disease in congenital neutropenia caused by p14 deficiency after allogeneic bone marrow transplantation from an HLA-identical sibling. Pediatr Blood Cancer. 2008 Sep;51(3):436-8. PMID: 18523989.

Journal Article Bohn, G

SCNIRBibliography

of 87


2008

Boxer LA, Bolyard AA, Newburger PE, Bonilla MA, Kannourakis G, Dror Y, Link DC, Alter BP, Rosenberg PS, Dale DC. Risk for septic death in severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2008;112:3548.


2008Boxer LA. Role of neutrophils in genetic disorders of phagocyte function leading to IBD. J Pediatr Gastroenterol Nutr.2008;46(suppl)1:E17.


2008Boztug K, Welte K, Zeidler C, Klein C. Congenital neutropenia syndromes. Immunol Allergy Clin North Am.2008;28(2):259-275. PMID: 18424332.


2008

Choi SW, Kitko CL, Braun T, Paczesny S, Yanik G, Mineishi S, Krijanovski O, Jones D, Whitfield J, Cooke K, Hutchinson RJ, Ferrara JL, Levine JE. Change in plasma tumor necrosis factor receptor 1 levels in the first week post-myeloablative allogeneic transplant correlates with severity and incidence of GVHD and survival. Blood 2008, 112:1539-1542. PMCID:PMC2515125


2008

Dale DC for the Severe Chronic Neutropenia International Registry. Granulocyte colony stimulating factor for treatment of severe chronic neutropenia. The 3rd Neutropenia Network Conference. Hematology Meeting Reports. 2008;2:18-19.


2008Dale DC, Boxer LA, and Liles WC. The phagocytes: neutrophils, and monocytes. Blood 112:935-945, 2008. PMID:18684880.


2008Dale DC, Boxer LA, and Liles WC. The phagocytes: neutrophils, and monocytes. Blood 50th Anniversary Reviews. Blood. 2008:112:935-945.


2008

Dale DC, Crawford J, Lyman GH. Neutropenia and its complications. In: Lyman GH, Crawford J, eds. Cancer Supportive Care: Advances in Therapeutic Strategies. New York, NY: Informa Healthcare USA, Inc; 2008:59-88.


2008

Dale DC, Ralston JF, Doherty RB, Ginsburg JA. Achieving a high-performance health care system: policies and positions of the American College of Physicians. Endocr Pract. 2008;14:502-4. PMID: 18558608


2008 Dale DC. ACP chapter meetings are great for CME and for collegiability too. ACP Observer 2008; Feb. ECL Dale, David C

2008 Dale DC. ACP issues recommendations for heath care system reforms. ACP Observer. 2008; Jan. ECL Dale, David C

2008 Dale DC. ACPNET brings continuing medical education into the clinic. ACP Observer 2008; Mar. ECL Dale, David C

SCNIRBibliography

of 87


2008

Dale DC. ELA2-related neutropenia. In:GeneReviews at GeneTests: Medical Genetics Information Resource. Updated July 2008. Copyright, University of Washington, Seattle. Available at http://www.genetests.org.


2008Dale DC. Neutropenia. In: Crowther MA, Ginsberg J, Holger S, Meyer RM, Lottenberg R, eds. Evidence-Based Hematology.Chichester, UK: Blackwell Publishing Ltd; 2008:215-220.


2008 Dale DC. Neutropenia. In: Encyclopedia of Life Sciences. Chichester, England: John Wiley & Sons; 2008. Book Chapter Dale, David C

2008Dale DC. Nonmalignant disorders of leukocytes. In: Dale DC, Federman DD, eds. ACP Medicine 2008. New York, NY: WebMD, Inc.; 2008;5:VII.


2008 Dale DC. Passing the baton to ACP’s next president. ACP Observer 2008; Apr. ECL Dale, David C

2008Dale DC. The molecular basis of cyclic neutropenia. The 3rd Neutropenia Network Conference. Hematology Meeting Reports. 2008;2:1.


2008

Denny CC, Alter BP, Giri N, Peters J, Wilfond BS: All in the Family: Disclosure of “Unwanted” Information to an Adolescent to Benefit a Relative. American Journal of Medical Genetics, Part A 146A:2719-2724, 2008.

Journal Article Denny, CC

2008

Donadieu J, Beaupain B, Bellanné- Chantelot C. Granulopoeisis and leukemogenesis: lessons from congenital neutropenia. Med Sci (Paris).2008;24(3):284-9. PMID: 18334177.


2008Dror Y. Shwachman-Diamond Syndrome: Implications for Understanding the Molecular Basis of Leukemia. Exp Rev in Mol Med 2008;10:1-10. PMID: 19102804.


2008Ganapathi KA, Shimamura A. Ribosomal dysfunction in inherited marrow failure. Br J Haematol. 2008;141(3):376-87. PMID:18410571.

Journal Article Ganapathi, KA

2008

Germeshausen M, Grudzien M, Zeidler C, Abdollahpour H, Yetgin S, Rezaei N, Ballmaier M, Grimbacher B, Welte K, Klein C. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008;111(10):4954-57. PMID: 18337561.


2008

Germeshausen M, Skokowa J, Ballmaier M, Zeidler C, Welte K. G-CSF receptor mutations in patients with congenital neutropenia. Curr Opin Hematol. 2008 Jul;15(4):332-7. Review. PubMed PMID: 18536571.


2008

Hochberg JC, Miron PM, Hay BN, Woda BA, Wang SA, Richert-Przygonska M, Aprikyan AA, Newburger PE. Mosaic tetraploidy and transient GFI1 mutation in a patient with severe chronic neutropenia. Pediatr Blood Cancer. 2008;50(3):630-2. PMID: 17096407.

Journal Article Hochberg, JC

http://www.genetests.org/




SCNIRBibliography

of 87


2008

Jun X, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC, Link DC. Incidence of SCN-associated gene mutations in severe congenital neutropenia patients in North America. (ASH Annual Meeting Abstracts). Blood. 2008;112:3553a.

Abstract Jun, X

2008 Jun X, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008;15:1-7. Journal Article Jun, X

2008

Kayed H, Bekasi S, Keleg S, Welsch T, Esposito I, Shimamura A, Michalski CW, Friess H, Kleeff J. Expression of the Shwachman-Bodian-Diamond syndrome (SBDS) protein in human pancreatic cancer and chronic pancreatitis. Histol Histopathol. 2008;23(7):819-26. PMID: 18437680.

Journal Article Kayed, H

2008Kitchen BJ, Boxer LA. Large granular lymphocyte leukemia (LGL) in a child with hyper IgM syndrome and autoimmune hemolytic anemia. Ped Bld Cancer 50:145- 45; 2008.

Journal Article Kitchen, BJ

2008

Levine JE, Paczesny S, Mineishi S, Braun T, Choi SW, Hutchinson RJ, Jones D, Khaled Y, Kitko CL, Bickley D, Krijanovski O, Reddy P, Yanik G, Ferrara JLM. Etanercept plus methylprednisolone as initial therapy for acute GVHD. Blood 2008, 111:2470-2475. PMCID:PMC2361693


2008

Liu F, Kunter G, Krem M, Eades W, Cain J, Tomasson M, Henninghausen L, and Link DC. G-CSF receptor mutations found in patients with severe congenital neutropenia induce hematopoietic stem self-renewal that is mediated by STAT5. JCI, 118:946-55, 2008. PMCID: PMC18292815.

Journal Article Liu, F

2008

Liu F, Kunter G, Krem M, Eades W, Cain J, Tomasson M, Henninghausen L, Link DC. Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5. J Clin Invest. 2008;118:946-55.

Journal Article Liu, F

2008

Luengo-Blanco M, Prando C, Bustamante J, Aragao-Filho WC, Soeiro Pereira PV, Rehder J, Padden C, Casanova J-L, Newburger PE,* Condino-Neto A.* Essential role of nuclear factor-kappa B for NADPH oxidase activity in normal and anhidrotic ectodermal dysplasia leukocytes. Blood 112:1453-60, 2008. *co-senior authors.

Journal Article Luengo-Blanco, M

2008

Makaryan V, Dale DC, Aprikyan AA. Knock- down of TAZ gene expression: a model of Barth syndrome with accelerated apoptosis of myeloid progenitor cells improved upon treatment with caspase-specific inhibitor. (ASH Annual Meeting Abstracts). Blood. 2008;112:3558.


2008

Marshall KK, Marrero T, Bolyard AA, Dale DC. Spontaneous recovery and normalization of blood neutrophil counts in patients with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2008;112:3560.

Abstract Marshall, KK

2008Newburger PE. Neutropenia. In: Rakel RE, ed. Conn's Current Therapy 2008. Philadelphia: W.B. Saunders, 2008, pp.

Book Chapter Newburger, Peter E

SCNIRBibliography

of 87


2008

Park IH, Arora N, Huo H, Maherali N, Ahfeldt T, Shimamura A, Lensch MW, Cowan C, Hochedlinger K, Daley GQ. Disease-specific induced pluripotent stem cells. Cell. 2008;134(3):1-10. PMCID: PMC2633781.

Journal Article Park, IH

2008

Public Policy Committee of the American College of Physicians, Ginsburg JA, Doherty RB, Ralston JF Jr, Senkeeto N, Cooke M, Cutler C, Fleming DA, Freeman BP, Gluckman RA, Liebow M, McLean RM, Musana KA, Nichols PM, Purtle MW, Reynolds PP, Weaver KM, Dale DC, Levine JS, Stubbs JW. Achieving a high- performance health care system with universal access: what the United States can learn from other countries. Ann Intern Med. 2008;148:55-75. PMID: 18056654

Journal Article Ginsburg, JA

2008

Report submitted by the French SCNIR to the French Agency for Health Safety of Health Products (AFSSAPS) and the High Authority of Health (HAS): www.ceredih.fr/documents/rapport registre neutro 2008.pdf

Journal Article SCNIR France

2008Rosenberg PS, Alter BP, Ebell W. Cancer risks in Fanconi anemia: findings from the German Fanconi Anemia Registry.Haematologica. 2008 Apr;93(4):511-17. Epub 2008 Mar 5.


2008

Rosenberg PS, Alter BP, Link DC, Stein S, Rodger E, Bolyard AA, Aprikyan AA, Bonilla MA, Dror Y, Kannourakis G, Newburger PE, Boxer LA, Dale DC. Neutrophil elastase mutations and risk of leukaemia in severe congenital neutropenia. Br J Haematol. 2008;140;2:210-13. Epub 2007 Nov 20. PMID: 18028488. PMCID: PMC3143022.


2008

Rujkijyanont P, Watanabe KI, Ambekar C, Wang H, Schimmer AD, Beyene J, Dror Y. Sbds-deficient cells undergo accelerated apoptosis through the Fas-pathway and not through the Bax/Bcl2/BclXL pathway. Haematologica 2008;93:363-71. PMID: 18268284.


2008Savage SA, Alter BP: The role of telomere biology in bone marrow failure and other disorders. Mechanisms of Aging and Development 129:35-47, 2008. PMCID: PMC2278290.


2008

Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP: TINF2, a component of the shelterin telomere protection complex, is mutated in Dyskeratosis Congenita. American Journal of Human Genetics 82:501-509, 2008.PMCID: PMC2427222.


2008

Teo JT, Klaassen R, Fernandez CV, Yanofsky R, Wu J, Champagne J, Silva M, Lipton JH, Brossard J, Samson Y, Abish S, Steele M, Ali K, Athale U, Jardine L, Hand JP, Tsangaris E, Beyene B, Dror Y. Clinical and genetic analysis of unclassified inherited marrow failure syndromes. Pediatrics 2008;122:139-48. PMID: 18595958.

Journal Article Teo, JT

http://www.ceredih.fr/documents/rapport




SCNIRBibliography

of 87


2008

Vlachos A, Ball S, Dahl N, Alter BP, Sheth S, Ramenghi U, Meerpohl J, Karlsson S, Liu JM, LeBlanc T, Paley C, Kang EM, Leder EJ, Atsidaftos E, Shimamura A, Bessler M, Glader B, Lipton JM: Diagnosing and treating Diamond Blackfan Anaemia: Results of an international clinical consensus conference. British Journal of Haematology 142:859-876, 2008.

Journal Article Vlachos, A

2008

Wang JP, Bowen GN, Padden C, Cerny A, Finberg RW, Newburger PE,* Kurt-Jones EA.* Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood.112:2028-34, 2008. *co-senior authors.

Journal Article Wang, JP

2008

Ward AC, Gits J, Majeed F, Aprikyan AA,Lewis RS, O’Sullivan LA, Freeman M, Shigdar S, Touw IP, Dale DC, Dror Y. Functional interaction between mutations in the granulocyte colony-stimulating factor receptor in severe congenital neutropenia. Br J Haematol. 2008;142:653-56. PMID: 18513286.

Journal Article Ward, AC

2008Xia J, Link DC. Severe congenital neutropenia and the unfolded protein response. Curr Opin Hematol. 2008;15:1-7. Review. PMID: 18043239.

Review Xia, J

2008

Zeidler C, Germeshausen M, Klein C, WelteK. Clinical implications of ELA2-, HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia. Br J Haematol. 2009 Feb;144(4):459-67. doi: 10.1111/j.1365-2141.2008.07425.x. Epub 2008 Dec 10. Review. PMID: 19120359.

Journal Article Zeidler, Cornelia

2007

Aprikyan AA, Makaryan V, Dale DC. Knock- down of TAZ gene expression triggers accelerated apoptosis of human myeloid progenitor cells improved upon treatment with caspase-specific inhibitor: a model of Barth syndrome. Barth Foundation Meeting; 2007 July 24-26.


2007Aprikyan AA, Makaryan V, Dale DC. Molecular studies of neutropenia in Barth syndrome. (ASH Annual Meeting Abstracts). Blood. 2007;110:3293.


2007

Aprikyan AA, Makaryan V, Si Q, Treonze K, Markosyan N, Finke P, Mumford R, Dale DC. Neutrophil elastase-specific small molecule inhibitor restores inefficient production of myeloid cells observed in severe congenital neutropenia. For Int’l.Society for Experimental Hematology, Hamburg. Stem Cells. 2007.


2007

Aprikyan AA, Makaryan V, Si Q, Treonze K, Markosyn N, Finke P, Torov M, Abagyan R, Mumford R, Dale D. Small molecule inhibitor of neutrophil elastase restores impaired production of human myeloid cells observed in severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood.2007;110:664a.


SCNIRBibliography

of 87


2007Aprikyan, AA, Makaryan V, Dale DC. Molecular studies of neutropenia in Barth Syndrome. Blood (ASH Annual Meeting Abstracts). 2007;110:3293.


2007

Beaupain B, Leblanc T, Reman O, Vannier JP, Hermine O, Suarez F, Bertrand Y, Bellannre-Chantelot C, Donadieu J. Pegfilgrastim in congenital neutropenia: an observational survey from the French SCN Registry. Blood (ASH Annual Meeting Abstracts). 2007;110:3308.

Abstract Beaupain, B

2007Bohn G, Welte K, Klein C. Severe congenital neutropenia: new genes explain an old disease. Curr Opin Rheumatol.2007;19: 644-50.

Journal Article Bohn, G

2007Boxer GJ, Boxer LA. Book report on “When Illness Goes Public”. Barron H. Lerner, author. The Johns Hopkins University Press: Baltimore, MD; J Clin Invest;2007:117:840.

Book Review Boxer, GJ

2007

Boxer LA, Bolyard AA, Newburger PE, Bonilla MA, Kannourakis G, Dror Y, Link DC, Alter BP, Rosenberg PS, Dale DC. Predictors of transformation to myelodysplasia/acute myelogenous leukemia (MDS/AML) in severe congenital neutropenia (SCN). (ASH Annual Meeting Abstracts). Blood. 2007;110:3307.


2007 Boxer LA, Coppes M. The pediatric hematologist, a vanishing breed. HemOnc today. 2007;8:5, 15. Journal Article Boxer, Laurence A

2007Boxer LA. Disorders of phagocyte function. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: W.B. Saunders; 2007:904-909.


2007Boxer LA. Eosinophils. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed.Philadelphia, PA: W.B. Saunders; 2007:902- 903.


2007Boxer LA. Leukocytosis. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed. Philadelphia, PA: W.B. Saunders; 2007:915- 917.


2007Boxer LA. Leukopenia. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed.Philadelphia, PA: W.B. Saunders; 2007:909- 915.


2007Boxer LA. Neutrophils. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF, eds. Nelson Textbook of Pediatrics. 18th ed.Philadelphia, PA: W.B. Saunders; 2007:895- 899.


SCNIRBibliography

of 87


2007

Boxer, LA, Bolyard AA, Newburger PE, Bonilla MA, Kannourakis G, Dror Y, Link DC, Alter BP, Rosenberg PS, Dale DC. Predictors of transformation to myelodysplasia/acute myelogenous leukemia (MDS/AML) in severe congenital neutropenia (SCN). Blood (ASH Annual Meeting Abstracts). 2007;110:3307.


2007

Boztug K, Baumann U, Ballmaier M, Webster D, Sandrock I, Jacobs R, Lion T, Preuner S, Germeshausen M, Hansen G, Welte K, Klein C. Large granular lymphocyte proliferation and revertant mosaicism: two rare events in a Wiskott-Aldrich syndrome patient. Haematologica. 2007;92:18-24.


2007 Christopher MJ, Link DC. Regulation of neutrophil homeostasis. Curr Opin Hematol. 2007;14(1):3-8. Review. Review Christopher, JM

2007

Cosler LE, Eldar-Lissai A, Culakova E, Kuderer NM, Dale D, Crawford J, Lyman GH. Therapeutic use of granulocyte- stimulating factors for established neutropenia: effect on costs from a hospital perspective. Pharmacoeconomics.2007;25:343-51. PMID: 17402806

Journal Article Cosler, LE

2007

Dale DC, Aprikyan AG. Cyclic and congenital neutropenia due to defects in neutrophil elastase. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases: A Molecular and Genetic Approach. 2nd ed. New York, NY: Oxford University Press; 2007:565-69.


2007

Dale DC, Bolyard AA, Newburger PE, Bonilla MA, Kannourakis G, Dror Y, Link DC, Alter BP, Roseberg PS, Boxer LA. Cyclic neutropenia is not associated with transformation to MDS and AML. (ASH Annual Meeting Abstracts). Blood.2007;110:3306.


2007Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood. 2008 Aug 15;112(4):935-45. doi:10.1182/blood-2007-12-077917. Review. PubMed PMID: 18684880.


2007

Dale DC, Crawford J, Lyman GH. Neutropenia and its complications. In: Lyman GH, Crawford J, eds. Cancer Supportive Care: Advances in Therapeutic Strategies. 2007. (in press)


2007 Dale DC. Leukocytosis and Leukopenia. In: Basto F, ed. ARS Medicinae. Lisbon, Portugal: 2007:1-10. Book Chapter Dale, David C

2007 Dale DC. What is WHIM syndrome? Blood. 2007;109:4. (Commentary) Commentary Dale, David C

SCNIRBibliography

of 87


2007

Donadieu J, Beaupain B, Beaufils S, Gandemer V, Fermant JP, Boutard P, Cezard JP, Bertrand Y, Michel G, Witz F, Morali A, Thomas C, Bordigoni P, Ginies JL, Micheau M, Paillard C, Lachaux A, Ansoborlo S, Leverger G, Socié G, Buzyn A, Blanche S, Fischer A, Schmitz J, Leblanc T, Bellanné-Chantelot C. Study of the correlation between phenotype - including acute leukemia/MDS - and genotype in Shwachman-Diamond Syndrome in 60 patients from the French SCN Registry. Blood (ASH Annual Meeting Abstracts). 2007;110:3301.

Abstract Donadieu, Jean

2007

Germeshausen M, Ballmaier M, Welte K. In vivo growth advantage of cells expressing acquired CSF3R mutations in patients with severe congenital neutropenia. Blood (ASH Annual Meeting Abstracts). 2007;110:3296.

Abstract Germeshausen, M

2007

Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey. Blood. 2007;109:93-99.


2007

Gohring G, Karow A, Steinemann D, Wilkens L, Lichter P, Zeidler C, Niemeyer C, Welte K, Schlegelberger B. Chromosomal aberrations in congenital bone marrow failure disorders-an early indicator for leukemogenesis? Ann Hematol.2007;86:733-9.

Journal Article Gohring, G

2007

Grenda DS, Murakami M, Ghatak J, Xia J, Boxer LA, Dale D, Dinauer MC, Link DC. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood.2007;110(13):4179-87. PMCID: PMC2234798

Journal Article Grenda, David S

2007

Grigull L, Kuehlke O, Beilken A, Sander A, Linderkamp C, Schmid H, Seidemann K, Sykora KW, Schuster FR, Welte K. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy. Pediatr Transplant. 2007;11:261-6

Journal Article Grigull, L

2007Link DC and Wun T. Myeloid disorders. In: Kahn MJ, Gregory S, eds. American Society of Hematology Self-Assessment Program (SAP), 3rd ed. American Society of Hematology. 2007.

Book Chapter Link, Daniel C

SCNIRBibliography

of 87


2007

Link DC, Kunter G, Kasai Y, Zhao Y, MinerT, McLellan MD, Ries RE, Kapur D, Nagarajan R, Dale DC, Bolyard AA, Boxer LA, Welte K, Zeidler C, Donadieu J, Bellanné-Chantelot C, Vardiman JW, Caligiuri MA, Bloomfield CD, DiPersio JF, Tomasson MH, Graubert TA, Westervelt P, Watson M, Shannon W, Baty J, Mardis ER, Wilson RK, Ley TJ. Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia. Blood.2007;110:1648-55. PMCID: PMC1975847

Journal Article Link, Daniel C

2007

Makaryan V, Penate O, Dale D, Aprikyan A. Accelerated apoptosis and aberrant retention of bone marrow cells in myelokathexis are two independent pathways triggered by mutant CXCR4 and normalized upon treatment with specific inhibitors. (ASH Annual Meeting Abstracts). Blood. 2007;110:3300.


2007

Murakami M, Xia J, Jordan CT, Boxer LA, Dale D, Bolyard AA, Dinauer MC, Link DC. Granulocytic precursors from patients with ELA-2-mutant severe congenital neutropenia display a transcriptional profile consistent with activation of the unfolded protein response. (ASH Annual Meeting Abstracts). Blood. 2007;110:662a.

Abstract Murakami, MA

2007Newburger PE, Boxer LA. A molecular classification of congenital neutropenia syndromes. Pediatr Blood and Cancer. 2007;49:609-614.

Journal Article Newburger, PE

2007Rawls AS, Woloszynek JR, Liu F, and Link DC. Lentiviral-mediated RNAi inhibition of SBDS in murine hematopoietic progenitors impairs their hematopoietic potential. Blood. 2007;110:2414-22.

Journal Article Rawls, AS

2007

Rujkijyanont P, Beyene J, Wei K, Khan F, Dror Y. Leukaemia-related gene expression in bone marrow cells from patients with the preleukaemic disorder Shwachman- Diamond syndrome. Br J Haematol. 2007;137(6):537-44.


2007

Sauer M, Zeidler C, Meissner B, Rehe K, Hanke A, Welte K, Lohse P, Sykora KW. Substitution of cyclophosphamide and busulfan by fludarabine, treosulfan and melphalan in a preparative regimen for children and adolescents with Shwachman-Diamond syndrome. Bone Marrow Transplant. 2007;39(3):143-7. Epub 2007 Jan 8.

Journal Article Sauer, M

2007

Skokowa J, Germeshausen M, Zeidler C, Welte K. Severe congenital neutropenia: inheritance and pathophysiology. Curr Opin Hematol. 2007;14(1):22-8. Review. Erratum in: Curr Opin Hematol. 2007;14(2):181.

Review Skokowa, J

2007 Skokowa J, Welte K. LEF-1 is a decisive transcription factor in neutrophil granulopoiesis. Ann N Y Acad Sci. 2007;1106:143-51. Journal Article Skokowa, J

SCNIRBibliography

of 87


2007

Woloszynek JR, Kunter GM, Ley T, Link DC, (Intro by Daniel C. Link). G-CSFSR mutations present in patients with severe congenital neutropenia cooperate with PML- RARα to induce acute myeloid leukemia in mice. Blood (ASH Annual Meeting Abstracts). 2007;110:2193.

Abstract Woloszynek, JR

2007

Xiang Z, Zhao Y, Mitaksov V, Fremont DH, Kasai Y, Molitoris A, Ries RE, Miner TL, McLellan MD, DiPersio JF, Link DC, Payton JE, Graubert TA, Watson M, Shannon W, Heath SE, Nagarajan R, Mardis ER, Wilson RK, Ley TJ, Tomasson MH. Identification of somatic JAK1 mutations in patients with acute myeloid leukemia. Blood. 2008 May 1;111(9):4809-12. Epub 2007 Dec 26.

Journal Article Xiang, Z

2007

Zeidler C, Welte K. Congenital bone marrow failure syndromes. The last 20 years by the example of congenital neutropenia.Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(12):1564-8. Review.

Review Zeidler, Cornelia

2007Zeidler C, Welte K. Hematopoietic growth factors for the treatment of inherited cytopenias. Semin Hematol. 2007;44(3):133-7. Review.


2006

Boxer LA, Stein S, Buckley D, Bolyard AA, Dale DC. Strong evidence for autosomal dominant inheritance of severe congenital neutropenia associated with ELA2 mutations. J Pediatr. 2006;148:633-6. PMID: 16737875.


2006

Carlsson G, Aprikyan AA, Ericson KG, Stein S, Makaryan V, Dale DC, Nordenskjöld M, Fadeel B, Palmblad J, Henter JI. Neutrophil elastase and granulocyte colony-stimulating factor receptor mutation analyses and leukemia evolution in severe congenital neutropenia patients belonging to the original Kostmann family in northern Sweden. Haematologica. 2006;91:589-95.PMID: 16670064.

Journal Article Carlsson, G

2006Colijn C, Dale DC, Foley C, Mackey MC. Observations on the pathophysiology and mechanisms for cyclic neutropenia. Math Model Nat Phenom. 2006;1:45-69.

Journal Article Colijn, C

2006

Dale DC, Bolyard AA, Schwinzer BG, Pracht G, Bonilla MA, Boxer L, Freedman MH, Donadieu J, Kannourakis G, Alter BP, Cham BP, Winkelstein J, Kinsey SE, Fier CJ, Zeidler C, Welte K. The Severe Chronic Neutropenia International Registry: 10-year follow-up report. Support Cancer Ther.2006;3:220-31. PMID: 18632498


2006 Dale DC, Rosenberg PS, Alter BP. Lineage- specific hematopoietic growth factors. N Engl J Med. 2006;355:526-7. PMID: 16888846 ECL Dale, David C

2006Dale DC. Approach to hematologic disorders. In: Dale DC, Federman DD, eds. ACP Medicine 2006. New York, NY: WebMD, Inc.; 2006;1:1030-1037.


SCNIRBibliography

of 87


2006 Dale DC. Authors, Editors and publishers conflict of interest. What’s new in medicine. ACP Medicine. Nov 2006. ECL Dale, David C

2006

Dale DC. ELA2-related neutropenia in:GeneReviews at GeneTests: Medical Genetics Information Resource. Updated July 2006. Copyright, University of Washington, Seattle. Available at http://www.genetests.org


2006

Dale DC. Neutropenia and Neutrophilia. In: Lichtman MA, Kipps TJ, Kaushansky K, Beutler E, Seligsohn U, Prchal JT. eds. Williams Hematology. 7th ed. New York, NY: McGraw-Hill; 2006:907-919.


2006Dale DC. Nonmalignant disorders of leukocytes. In: Dale DC, Federman DD, eds. ACP Medicine 2006. New York, NY: WebMD, Inc.; 2006;1:1030-1037.


2006Dale DC. Supplying neutrophils from the bone marrow to the tissues. Blood.2006;108:1.

ECL Dale, David C

2006 Dale DC. Update on the management of neutropenia. Clin Adv Hematol Oncol. 2006;4:187-9. PMID: 16728927. Journal Article Dale, David C

2006Dale DC. Updated ASCO recommendations for the use of white blood cell growth factors. Clin Adv Hematol Oncol. 2006;4:664 6. PMID: 17099622


2006

Grenda DS, Link DC. Mechanisms of disordered granulopoiesis in congenital neutropenia, in Chatten G. (eds): Current topics in developmental biology, Elsevier Inc. Publishers. 2006;74:133-176.

Book Chapter Grenda, David S

2006

Klein C, Grudzien M, Appaswamy G, Germeshausen M, Sandrock I, SchÃffer AA, Rathinam C, Boztug K, Schwinzer B, Rezaei N, Bohn G, Melin M, Carlsson G, Fadeel B, Dahl N, Palmblad J, Henter JI, Zeidler C, Grimbacher B, Welte K. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39(1):86-92. Epub 2006 Dec 24.

Journal Article Klein, C

2006

Murakami MA, Grenda DS, Ghatak J, Boxer LA, Dale DC, Dinauer MC, Bolyard AA, Link DC. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. (ASH Annual Meeting Abstracts). Blood. 2006;108:499.

Abstract Murakami, MA

2006

Rosenberg PS, Stein S, Rodger E, Bolyard AA, Bonilla MA, Dror Y, Kannourakis G, Newburger PE, Boxer LE, Alter, BP, Dale DC. Genotype-phenotype associations in patients with severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2006;108:152a, (A502).


2006Watanabe JM, Dale DC. Congenital Neutropenia. In: Young NS, Gerson SL, High KA, eds. Clinical Hematology.Philadelphia, PA: Mosby-Elsevier; 2006:181- 191.

Book Chapter Watanabe, JM

2006 Welte K, Zeidler C, Dale DC. Severe congenital neutropenia. Semin Hematol. 2006;43:189-95. PMID: 16822461. Journal Article Welte, Karl





SCNIRBibliography

of 87


2006

Yanay O, Brzezinski M, Christensen J, Liggitt D, Dale DC, Osborne W. An adult dog with cyclic neutropenia treated by lentivirus-mediated delivery of granulocyte colony-stimulating factor. Hum Gene Ther. 2006;17:464-9. PMID: 16610934.

Journal Article Yanay, O

2005

Alter BP, Rosenberg PS, Dale DC, for the Severe Chronic Neutropenia International Registry. MDS/AML in patients with Schwachman-Diamond syndrome receiving long-term G-CSF. Schwachman Diamond Annual Meeting 2005.

Abstract Alter Blanche, P

2005

Boxer LA, Bolyard AA, Schwinzer B, Glaser D, Dougan K, Bonilla MA, Alter BP, Cham B, Kinsey SE, Zeidler C, Welte K, Dale DC. Antineutrophil antibodies lead to mistaken identity in severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood.2005;106:385.


2005

Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, Liles WC, Li X, Graham-Evans B, Campbell TB, Calandra G, Bridger G, Dale DC, Srour EF. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. J Exp Med. 2005;201:1307-18. PMID: 15837815

Journal Article Broxmeyer, HE

2005

Cario G, Skokowa J, Wang Z, Bucan V, Zeidler C, Stanulla M, Schrappe M, Welte K. Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol. 2005 Apr;129(2):275-8.

Journal Article Cario, G

2005

Choi SW, Boxer LA, Pulsipher MA, Roulston D, Hutchinson RJ, Yanik GA, Cooke KR, Ferrara JL, Levine JE. Stem cell transplantation in patients with severe congenital neutropenia with evidence of leukemic transformation. Bone Marrow Transplant. 2005 Mar;35(5):473-7


2005

Donadieu J, Leblanc T, Bader Meunier B, Barkaoui M, Fenneteau O, Bertrand Y, Maier-Redelsperger M, Micheau M, Stephan JL, Phillipe N, Bordigoni P, Babin-Boilletot A, Bensaid P, Manel AM, Vilmer E, Thuret I, Blanche S, Gluckman E, Fischer A, Mechinaud F, Joly B, Lamy T, Hermine O, Cassinat B, Bellanne-Chantelot C, Chomienne C; French Severe Chronic Neutropenia Study Group. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica. 2005 Jan;90(1):45- 53.


SCNIRBibliography

of 87


2005

Donadieu J, Michel G, Merlin E, Bordigoni P, Monteux B, Beaupain B, Leverger G, Laporte JP, Hermine O, Buzyn A, Bertrand Y, Casanova JL, Leblanc T, Gluckman E, Fischer A, Stephan JL. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant. 2005 Nov;36(9):787-92


2005 Dror Y. Shwachman-Diamond syndrome. Pediatr Blood Cancer. 2005 Dec;45(7):892- 901. Journal Article Dror, Yigal

2005

Ferry C, Ouachee M, Leblanc T, Michel G, Notz-Carrere A, Tabrizi R, Flood T, Lutz P, Fischer A, Gluckman E, Donadieu J. Hematopoietic stem cell transplantation in severe congenital neutropenia: experience of the French SCN register. Bone Marrow Transplant. 2005 Jan;35(1):45-50

Journal Article Ferry, C

2005

Germeshausen M, Schulze H, Kratz C, Wilkens L, Repp R, Shannon K, Welte K, Ballmaier M. An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia. Leukemia. 2005 Apr;19(4):611-7


2005Grenda DS, Link DC. A comparison of cyclic neutropenia in childhood and severe congenital neutropenia. Haematologica.2005 Aug;90(8):1010A

Abstract Grenda, David S

2005

Hübel K, Rodger E, Gaviria JM, Price TH, Dale DC, Liles WC. Effective storage of granulocytes collected by centrifugation leukapheresis from donors stimulated with G-CSF. Transfusion. 2005;45:1876-89.PMID: 16371040

Journal Article Hübel, K

2005

Lack NA, Green B, Dale DC, Calandra GB, Lee H, MacFarland RT, Badel K, Liles WC, Bridger G. A pharmacokinetic / pharmacodynamic model for the mobilization of CD34+ hematopoietic progenitor cells by AMD3100. Clin Pharmacol Ther. 2005;77:427-36. PMID: 15900288

Journal Article Lack, NA

2005

Laurence A. Boxer, Audrey Anna Bolyard, Beate Schwinzer, Darryl Glaser, Kenneth Dougan, Mary Ann Bonilla, Blanche P. Alter, Bonnie Cham, Sally E. Kinsey, Connie Zeidler, Karl Welte, David C. Dale. Antineutrophil Antibodies Lead to Mistaken Identity in Severe Congenital Neutropenia. Blood 2005 106;11:385a

abstract Boxer, Laurence A

SCNIRBibliography

of 87


2005

Liles WC, Rodger E, Broxmeyer HE, Dehner C, Badel K, Calandra G, Christensen J, Wood B, Price TH, Dale DC. Augmented mobilization and collection of CD34+ hematopoietic cells from normal human volunteers stimulated with G-CSF by single- dose administration of AMD3100, a CXCR4 antagonist. Transfusion. 2005;45:295-300.PMID: 15752146

Journal Article Liles, WC

2005

Makaryan V, Dale DC, Aprikyan AA. Mutant CXCR4 identified in neutropenic patients with myelokathexis impairs survival of human myeloid cells. (ASH Annual Meeting Abstracts). Blood. 2005;106:3071


2005Newburger PE: Neutropenia. In: Conn's Current Therapy 2005, Rakel RE (Ed.), Philadelphia, W.B. Saunders, 2005, pp. 463-465.

Book Chapter Newburger, Peter E

2005

Philip S. Rosenberg, Blanche P. Alter, Audrey A. Bolyard, Mary A. Bonilla, Laurence A. Boxer, Bonnie Cham, Carol Fier, Melvin Freedman, George Kannourakis, Sally Kinsey, Beate Schwinzer, Connie Zeidler, Karl Welte, David C. Dale. The Incidence of Leukemia and Mortality from Sepsis in Patients with Severe Congenital Neutropenia Receiving Long-Term G-CSF Therapy. Blood. 2006 Jun 15;107(12):4628-35. Epub 2006 Feb 23. PMID: 16497969. PMCID: PMC1895804.


2005

Rosenberg PS, Alter BP, Bolyard AA, Bonilla MA, Boxer LA, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey S, Schwinzer B, Zeidler C, Welte K, Dale DC. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. (ASH Annual Meeting Abstracts). Blood.2005;106;669:197a.


2005

Zeidler C, Schwinzer B, Bolyard AA, Pracht G, Alter BP, Bonilla MA, Cham B, Fier C, MH Freedman, Kannourakis G, Kinsey S, Boxer L, Dale DC, Welte K. Genetic and phenotypically heterogeneity of patients with congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2005;106:95.


2005 Zeidler C. Congenital neutropenias. Hematology. 2005 Sep-Oct;10 Suppl 1:306-11. Journal Article Zeidler, Cornelia

2005

Zeidler C., Beate Schwinzer, Audrey A. Bolyard, Gusal Pracht, Blanche P. Alter, Mary A. Bonilla, Bonnie Cham, Carol Fier, Melvin H. Freedman, George Kannourakis, Sally Kinsey, Lawrence Boxer, David C. Dale, Karl Welte. Genetic and Phenotypically Heterogeneity of Patients with Congenital Neutropenia. Blood 2005


2004 Liles WC, Starkebaum G, Dale DC. Neutropenia in systemic lupus erythematosus. Blood. 2004;104:2. ECL Liles, WC

SCNIRBibliography

of 87


2004

Aprikyan AAG, Pritchard D, Liles CW, Schwartz S, Dale DC. Gene expression profiles for normal human bone marrow- derived CD34+ stem cells and CD34-/CD33+ myeloid-committed progenitor cells in response to daily granulocyte colony- stimulating factor (G-CSF) treatment. (ASH Annual Meeting Abstracts). Blood.2004;104;4162.


2004

Aprikyan AAG, Stein S, Markosyan NA, Totrov M, Abagyan R, Dale DC. Diversity and molecular modeling of neutrophil elastase mutations in patients with severe congenital neutropenia and acute myelogenous leukemia. (ASH Annual Meeting Abstracts). Blood. 2004;104;.1454.


2004Aprikyan AG, Markosyan NS, Clark CE, Dale DC. Tet-regulated expression of mutant neutrophil elastase in HL-60 cells: A cellular model of severe congenital neutropenia. Keystone Conference 2004.


2004

Bellanne-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier- Redelsperger M, Chomienne C, Donadieu J. Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register. Blood. 2004 Jun 1;103(11):4119-25. Epub 2004 Feb 12

Journal Article Bellanne-Chantelot, C

2004

Boxer LA, Stein S, Buckley D, Subramanian S, Bolyard AA, Olson M, Dale DC. Unique evidence for autosomal dominant inheritance of severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2004;104;1457.


2004

Carlsson G, Aprikyan AG, Tehranchi R, Dale DC, Porwit A, Hellstrom-Lindberg E, Palmblad J, Henter JI, Fadeel B. Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl- 2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood.2004;103:3355-61. PMID: 14764541

Journal Article Carlsson, G

2004

Cassinat B, Bellanne-Chantelot C, Notz- Carrere A, Menot ML, Vaury C, Micheau M, Bader-Meunier B, Perel Y, Leblanc T, Donadieu J, Chomienne C. Screening for G- CSF receptor mutations in patients with secondary myeloid or lymphoid transformation of severe congenital neutropenia. A report from the French neutropenia register. Leukemia. 2004 Sep;18(9):1553-5

Journal Article Cassinat, B

2004

Dale DC, Bolyard AA, Schwinzer B, Pracht G, Bonilla MA, Boxer L, Freedman M, Donadieu J, Kannourakis G, Alter BP, Cham B, Winkelstein J, Kinsey SE, Fier C, Zeidler C, Welte K. The Severe Chronic Neutropenia International Registry - 10 years of follow up. (ASH Annual Meeting Abstracts). Blood. 2004;104;1458.


SCNIRBibliography

of 87


2004

Dale DC. ELA2-related neutropenia. In: GeneReviews at GeneTests: Medical Genetics Information Resource. Updated July 2004. Copyright, Seattle, WA: University of Washington; Available at http://www.genetests.org


2004 Dale DC. Neutrophil elastase and neutropenia. Blood. 2004;103:3993-3994. ECL Dale, David C

2004Dale DC. The Febrile Patient. In: Goldman L, et al, eds. Cecil Textbook of Medicine. 22nd ed. Philadelphia, PA: Saunders (Elsevier); 2004:1729-1730.


2004Dror Y, Sung L. Update on childhood neutropenia: molecular and clinical advances. Hematol Oncol Clin North Am. 2004 Dec;18(6):1439-58, x. Review

Review Dror, Yigal

2004

Hübel K, Liles WC, Broxmeyer HE, Rodger E, Wood B, Cooper S, Hangoc G, MacFarland R, Bridger GJ, Henson GW, Calandra G, Dale DC. Leukocytosis and mobilization of CD34+ hematopoietic progenitor cells by AMD3100, a CXCR antagonist. Support Canc Ther. 2004;1:165- 172. PMID: 18628138


2004

Starkebaum G, Dale DC. Autoimmune neutropenia. In: Lichenstein L, Busse W, Jeha R, eds. Current therapy in Allergy, Immunology and Rheumatology. 6th ed. Phildalephia, PA: Mosby; 2004:339-342.

Book Chapter Starkebaum, G

2004

Stein S, Paddock M, Bolyard AA, Raymond C, Olson M, Aprikyan A, Dale DC. Mutations in the gene for neutrophil elastase in severe congenital neutropenia are heterozygous and of male origin. (ASH Annual Meeting Abstracts). Blood. 2004;104;1455.

Abstract Stein, Steve M

2004

Woloszynek JR, Rothbaum RJ, Rawls AS, Minx PJ, Wilson RK, Mason PJ, Bessler M, Link DC. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood. 2004 Dec 1;104(12):3588-90. Epub 2004 Jul 29

Journal Article Woloszynek, JR

2004 Zeidler C, Schwinzer B, Welte K. (2004) Congenital neutropenias. Rev Clin Exp Hematol. 7(1):72-83 Review PMID:14692235 Review Zeidler, Cornelia

2003

Aprikyan AA, Kutyavin T, Stein S, Aprikian P, Rodger E, Liles WC, Boxer LA, Dale DC. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol. 2003 May;31(5):372-81.

Journal Article Aprikyan, Andrew AG

2003

Aprikyan AG, Clark CE, Markosyan NA, Vaisar T, Heinecke JW, Dale DC. Cellular model of severe congenital neutropenia with inducible expression of mutant neutrophil elastase. (ASH Annual Meeting Abstracts). Blood. 2003;102:17a.






SCNIRBibliography

of 87


2003

Aprikyan AG, Kutyavin T, Stein S, Aprikyan P, Rodger E, Liles WC, Boxer LA, Dale DC. Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol. 2003;31:372-81. PMID: 12763135


2003

Bolyard AA, Pracht G, Schwinzer B, Zeidler C, Bonilla MS, Boxer LA, Cham B, Donadieu J, Fier C, Freedman M, Kannourakis G, Kinsey SE, Winkelstein J, Alter BP, Reeves L, Welte K, Dale DC. Severe chronic idiopathic neutropenia in adults: long-term follow-up of 358 patients. (ASH Annual Meeting Abstracts). Blood. 2003;102:966a.


2003 Boxer LA. Neutrophil abnormalities. Pediatr Rev. 2003 Feb;24(2):52-62. Review Review Boxer, Laurence A

2003

Clark O, Djulbegovic B, Dale D, Crawford J, Lyman GH. Treatment with colony- stimulating factors improves clinical outcomes in patients with established febrile neutropenia: a meta-analysis of the randomized clinical trials. Proc Am Soc Clin Oncol. 2003;22:172.

Abstract Clark, O

2003

Cosler, L, Djulbegovic B, Kuderer NM, Dale D, Lyman GH. Colony-stimulating factor treatment of established febrile neutropenia reduces overall costs: results of an economic model based on a meta-analysis of randomized controlled trials. Proc Am Soc Clin Oncol. 2003;22:526.

Abstract Cosler, LE

2003

Dale DC, Bolyard AA, Aprikyan A, Stein S, Boxer L, Schwinzer B, Zeidler C, Welte K. Autosomal-dominant severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2003;102:976a.


2003

Dale DC, Cottle TE, Fier CJ, Bolyard AA, Bonilla, MA, Boxer LA, Cham B, Freedman MH, Kannourakis G, Kinsey SE, Davis R, Scarlata D, Schwinzer B, Zeidler C, Welte K. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry. Am J Hematol. 2003;72:82-93. PMID: 12555210


2003

Dale DC, Liles WC. Neutrophils and monocytes: normal physiology and disorders of neutrophil and monocyte production. In: Handin RI, Lux SE, Stossel TP, eds. Blood: Principles and Practice of Hematology. Phildadelphia, PA: Lippincott, Williams & Wilkins; 2003:455-482.


2003

Dale DC, Rodger E, Christensen JJ, Dehner C, Badel K, Calandra GB, Liles WC. Optimizing the use of AMD3100, a CXCR-4 antagonist, for mobilization of hematopoietic progenitor cells: studies in healthy volunteers. (ASH Annual Meeting Abstracts). Blood. 2003;102:123a.


2003Dale DC. Myeloid disorders. American Society of Hematology, Self-Assessment Project. Program edited by George JN, Williams ME. 2003;116-126.


2003 Dale DC. New insights into chronic idiopathic neutropenia. Blood. 2003;101:2450a. Abstract Dale, David C

SCNIRBibliography

of 87


2003Dale DC. Nonmalignant disorders of leukocytes. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York, NY; 2003:1086-1101.


2003 Donadieu J. Evaluation of neutropenia in children. Arch Pediatr. 2003 Sep;10 Suppl 4:521s-523s. French Journal Article Donadieu, Jean

2003

Hübel K, Dale DC, Root RK, Liles WC. Clinical applications of G-CSF and GM-CSF in the treatment of infectious diseases. In: Kotb M, Calandra T, eds. Cytokines and Chemokines in Infectious Diseases Handbook. Totowa, NJ: Humana Press Inc.; 2003:361-78.

Book Chapter Hübel, K

2003

Lack NA, Dale DC, Calandra G, MacFarland RT, Badel K, Liles WC. AMD3100: A pharmacokinetic / pharmacodynamic profile of the CXCR-4 antagonist AMD3100 for the mobilization of hematopoietic progenitor cells. Blood. (ASH Annual Meeting Abstracts). 2003;102:391a.

Abstract Lack, NA

2003

Lesesve JF, Dugue F, Gregoire MJ, Witz F, Dror Y. Shwachman-Diamond syndrome with late-onset neutropenia and fatal acute myeloid leukaemia without maturation: a case report. Eur J Haematol. 2003 Nov;71(5):393-5

Journal Article Lesesve, JF

2003

Liles WC, Broxmeyer HE, Rodger E, Wood B, Hübel K, Cooper S, Hangoc G, Bridger GJ, Henson GW, Calandra G, Dale DC. Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist. Blood. 2003;102:2728- 30. PMID: 12855591


2003Mackey MC, Aprikyan AA, Dale DC. The rate of apoptosis in post mitotic neutrophil precursors of normal and neutropenic humans. Cell Prolif. 2003 Feb;36(1):27-34. PMID: 12558658

Journal Article Mackey, MC

2003

Mackey MC, Liu F, Iwasaki H, Akashi K, Link DC. Pivotal role of granulocyte colony- stimulating factor in the development of progenitors in the common myeloid pathway. Blood. 2003 Nov 15;102(10):3562-8. Epub 2003 Jul 31

Journal Article Mackey, MC

2003Nichols WG, Dale DC. Granulocyte Transfusions. In: Bowden RA, Ljungman P, Paya CV, eds. Transplant Infections.Philadelphia, PA: Lippincott; 2003.

Book Chapter Nichols, WG

2003

Quinton LJ, Dale DC, Nelson S. Use of colony-stimulating factors for treatment of neutropenia and infectious diseases. In: Gabrilovich DI, ed. The Neutrophils, New Outlook for Old Cells. 2nd ed. London, England: Imperial College Press; 2003:301- 306.

Book Chapter Quinton, LJ

2003

Rosenberg PS, Alter BP, Bolyard AA, Freedman M, Welte K, Boxer LA, Dale DC. MDS/AML in patients with congenital neutropenia receiving long term G-CSF. (ASH Annual Meeting Abstracts). Blood.2003;102:1267a.


SCNIRBibliography

of 87


2003

Schwinzer BG, Zeidler C, Bolyard AA, Pracht G, Bonilla MA, Boxer LA, Cham B, Donadieu J, Fier C, Freedman MH, Kannourakis G, Kinsey S, Winkelstein J, Alter BP, Reeves L, Dale DC, Welte K. Pregnancies in neutropenia. (ASH Annual Meeting Abstracts). Blood. 2003;102:963a.

Abstract Schwinzer, BG

2003

Srour EF, Plett AP, Dale DC, Liles WC, Calandra GB, Orschell CM. Enhancement of G-CSF mobilization of human MB CD34+ cells with AMD3100: Substantial increase in the frequency of repopulating cells through tandem administration of G-CSF and AMD3100. (ASH Annual Meeting Abstracts). Blood. 2003;102:1660a.

Abstract Srour, EF

2003Stein S, Dale DC. The molecular basis and therapy of disorders associated with chronic neutropenia. Curr Allergy Asthma Rep.2003;3:385-8. PMID: 12906773

Journal Article Stein, Steve M

2003

Stein S, Makaryan V, Zhu Q, Ochs H, Aprikyan A, Dale DC. The frequency of mutations of the genes for neutrophil elastase, proteinase 3, Wiskott-Aldrich protein, and GFI-1 in patients with severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2003;102:972a.

Abstract Stein, Steve M

2003Stein SM, Dale DC. Molecular basis and therapy of disorders associated with chronic neutropenia. Curr Allergy Asthma Rep. 2003 Sep;3(5):385-8. Review

Review Stein, Steve M

2003

Zeidler C, Schwinzer B, Pracht G, Dale DC, Levine JE, Sykora KW, Welte K. Hematopoietic stem cell transplantation in congenital neutropenias: recommendation for patients refractory to G-CSF treatment and secondary MDS or leukemias. (ASH Annual Meeting Abstracts). Blood.2003;102:971a.


2003 Zeidler C, Schwinzer B, Welte K. Congenital neutropenias. Rev Clin Exp Hematol. 2003 Mar;7(1):72-83. Review Review Zeidler, Cornelia

2002

Agboola O, Balducci L, Dale DC, Crawford J, Lyman GH. Efficacy of the colony- stimulating factors (CSFs) in elderly patients with aggressive non-Hodgkin’s lymphoma (NHL): a meta-analysis. (ASH Annual Meeting Abstracts). Blood. 2002;100:779a.

Abstract Agboola, O

2002 Alter, BP. Bone marrow failure syndromes in children. Pediatr Clin North Am. 2002 Oct;49(5):973-88. Review Review Alter Blanche, P

2002Aprikyan A, Stein S, Kutyavin T, Rodger E, Bolyard A, Dale DC. The casual role of mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Experimental Hematology 2002;30:209a.


2002Aprikyan AA, Liles WC, Boxer LA, Dale DC. Mutant elastase in pathogenesis of cyclic and severe congenital neutropenia. J Pediatr Hematol Oncol. 2002 Dec;24(9):784-6. Review


SCNIRBibliography

of 87


2002Aprikyan AAG, Liles WC, Boxer LA, Dale DC. Mutant elastase in pathogenesis of cyclic and congenital neutropenia. J Pediatr Hematol Oncol. 2002;24:784-6. PMID: 12468929


2002Aprikyan AG, Clark CE, Markosyan NA, Dale DC. Role of mutant neutrophil elastase in pathogenesis of congenital neutropenia and leukemia. 2002.


2002

Aprikyan AG, Garwicz D, Aprikyan PG, Dale DC. Impaired survival and proteolytic activity of human but not murine myeloid progenitor cells expressing mutant neutrophil elastase. (ASH Annual Meeting Abstracts). Blood.2002;100:340a.


2002Aprikyan AG, Oganesian A, Dale DC. Aberrant subcellular localization of neutrophil elastase in cyclic neutropenia. Blood . (ASH Annual Meeting Abstracts). 2002;100:294a.


2002 Boxer L, Dale DC. Neutropenia: causes and consequences. Semin Hematol, 2002;39:75- 81. PMID: 11957188 Journal Article Boxer, Laurence A

2002Cham B, Bonilla MA, Winkelstein J. Neutropenia associated with primary immunodeficiency syndromes. Semin Hematol. 2002 Apr;39(2):107-12. Review

Review Cham, Bonnie

2002Cottle TE, Fier CJ, Donadieu J, Kinsey SE. Risk and benefit of treatment of severe chronic neutropenia with granulocyte colony- stimulating factor. Semin Hematol. 2002 Apr;39(2):134-40. Review

Review Cottle, Tammy E

2002 Dale DC, Bolyard AA, Aprikyan A. Cyclic neutropenia. Semin Hematol. 2002;39:89- 94. PMID: 11957190 Journal Article Dale, David C

2002Dale DC, Harris Jr ED. Alpha Omega Alpha: encouraging excellence in medicine for more than a century. The Pharos Alpha Omega Alpha Honor Med Soc. 2002;65:4- 21. PMID: 12592976


2002

Dale DC, Wolff D, Agboola O, Crawford J, Lyman GH. Prospective patient registry for the development of risk models of neutropenic complications including febrile neutropenia (FN). (ASH Annual Meeting Abstracts). Blood. 2002;100:502b.


2002 Dale DC. Introduction: severe chronic neutropenia. Semin Hematol. 2002 Apr;39(2):73-4 Journal Article Dale, David C

2002

Dale DC. (updated July 2002) ELA2-relatedneutropenia. In: GeneReviews at GeneTests: Medical Genetics Information Resource. Copyright, University of Washington, Seattle. Available at http://www.genetests.org.


2002

Dale DC. ELA2-related neutropenia. In: GeneReviews: Genetic Disease Online Reviews at GeneTests-GeneClinics [database online]. Copyright, University of Washington, Seattle. Available at http://www.geneclinics.org.






http://www.geneclinics.org/




SCNIRBibliography

of 87


2002

Dale DC. ELANE-related neutropenia. In:Pagon RA, Bird TC, Dolan CR, Stephens K. eds. GeneReviews at GeneTests: Medical Genetics Information Resource. 2002 Jun 17 [updated 2011 Jul 14; 2018 Jan 17].Copyright, University of Washington, Seattle. Available at http://www.ncbi.nlm.nih.gov/books/NBK1533/. PMID: 20301705


2002 Dale DC. Introduction: severe chronic neutropenia. Semin Hematol. 2002;39:73- 74. PMID: 11957187 Journal Article Dale, David C

2002 Dale DC. Update on hematopoietic growth factors 2002. Curr Opin Hematol. May 2002. ECL Dale, David C

2002

Dror Y, Durie P, Ginzberg H, Herman R, Banerjee A, Champagne M, Shannon K, Malkin D, Freedman MH. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. Exp Hematol. 2002 Jul;30(7):659-69.


2002 Dror Y, Freedman MH. Shwachman-Diamond syndrome. Br J Haematol. 2002 Sep;118(3):701-13. Review Review Dror, Yigal

2002

Elghetany MT, Alter BP. p53 protein overexpression in bone marrow biopsies of patients with Shwachman-Diamond syndrome has a prevalence similar to that of patients with refractory anemia. Arch Pathol Lab Med. 2002 Apr;126(4):452-5.

Journal Article Elghetany, MT

2002

Fadeel B, Carlsson G, Aprikyan AG, Dale DC, Porwit A, Hellstrom-Lindberg E, Palmblad J, Henter J. Accelerated apoptosis and defective Bcl-2 expression in the bone marrow of severe congenital neutropenia patients of the original Kostmann kindred: evidence for anti-apoptotic effects of recombinant granulocyte colony-stimulating factor. (ASH Annual Meeting Abstracts).Blood. 2002;100:1175a.

Abstract Fadeel, B

2002Freedman MH, Alter BP. Malignant myeloid transformation in congenital forms of neutropenia. Isr Med Assoc J. 2002 Nov;4(11):1011-4.

Journal Article Freedman, Mel H

2002Freedman MH, Alter BP. Risk of myelodysplastic syndrome and acute myeloid leukemia in congenital neutropenias. Semin Hematol. 2002 Apr;39(2):128-33. Review

Review Freedman, Mel H

2002Germeshausen M, Ballmaier M, Schulze H, Welte K. Heterogeneity in expression of mutated versus wild type neutrophil elastase mRNA in patients with congenital and cyclic neutropenia. Blood 2002:922a


2002

Hübel K, Carter RA, Liles WC, Dale DC, Price TH, Bowden RA, Rowley SD, Chauncey TR, Bensinger WI, Boeckh M. Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42:1414-21. PMID: 12421213


http://www.ncbi.nlm.nih.gov/books/NBK1533







SCNIRBibliography

of 87


2002

Hübel K, Dale DC, Liles WC. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of G-CSF, GM- CSF, M-CSF, and IFNg. J Infect Dis.2002;185:1490-501. PMID: 11992286


2002Hübel K, Liles WC, Dale DC. 35: Hematopoietic growth factors (cytokines). In: Simon TL, et al, eds. Rossi's Principles of Transfusion. 3rd ed. 2002;513-521.

Book Chapter Hübel, K

2002Kannourakis G. Glycogen storage disease. Semin Hematol. 2002 Apr;39(2):103-6.Review

Review Kannourakis, G

2002

Latger-Cannard V, Marchand-Arvier M, Vidailhet M, Donadieu J, Vigneron C, Bordigoni P. Neutrophil adherence receptor deficiency regressing with granulocyte- colony stimulating factor therapy in a case of glycogen storage disease type Ib. Eur J Pediatr. 2002 Feb;161(2):87-93.

Journal Article Latger-Cannard, V

2002

Liles WC, Rodger E, Broxmeyer HE, Srour EF, Dehner C, Badel K, Calandra G, Christensen J, Wood B, Price TH, Dale DC. Mobilization and collection of CD34+ progenitor cells from normal human volunteers with AMD-3100, a CXCR4 Antagonist, and G-CSF. (ASH Annual Meeting Abstracts). Blood. 2002;100:404a.

Abstract Liles, WC

2002 Palmblad JE, von dem Borne AE. Idiopathic, immune, infectious, and idiosyncratic neutropenias. Semin Hematol 39:113-120, 2002. Journal Article Palmblad, JE

2002

Rothbaum R, Perrault J, Vlachos A, Cipolli M, Alter BP, Burroughs S, Durie P, Elghetany MT, Grand R, Hubbard V, Rommens J, Rossi T. Shwachman-Diamond syndrome: report from an international conference. J Pediatr. 2002 Aug;141(2):266-70. Review

Review Rothbaum, R

2002 Smith, OP. Shwachman-Diamond Syndrome. Semin Hematol 39:95-102, 2002. Journal Article Smith, OP

2002 Starkebaum G. Chronic neutropenia associated with autoimmune disease. Sem Hematol. 2002. 39(2):121-127 Journal Article Starkebaum, G

2002Thornley I, Dror Y, Sung L, Wynn RF, Freedman MH. Abnormal telomere shortening in leucocytes of children with Shwachman-Diamond syndrome. Br J Haematol. 2002 Apr;117(1):189-92

Journal Article Thornley, I

2002 Zeidler C, Welte K. Kostmann syndrome and severe congenital neutropenia. Sem in Hematol. 2002 Apr;39(2):82-8. Review. Review Zeidler, Cornelia

2001

A.A. Bolyard, T. Cottle, M.A. Bonilla, L. Boxer, B. Cham, J. Donadieu, C. Fier, M. Freedman, G. Kannourakis, S.E. Kinsey, B. Liang, B.Schwinzer, C. Zeidler, K. Welte,D.C. Dale. Long term treatment of chronic idiopathic neutropenia in women with G- CSF. Blood 2001;98:300a.

Abstract Bolyard, A.A.

SCNIRBibliography

of 87


2001Aprikyan AA, Dale DC. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol. 2001 Oct;13(5):535-8. Review

Review Aprikyan, Andrew AG

2001

Aprikyan AAG, Chau A, Bolyard AA, Dale DC. Clinical and molecular studies of families with severe congenital neutropenia positive for mutations in the neutrophil elastase gene. Blood (ASH Annual Meeting Abstracts). 2001;98:20a


2001

Aprikyan AAG, Karlson G, Swedish B, Dale DC, Palmblad J, Henter JI. Caspase- independent apoptosis of bone marrow progenitor cells and neutrophil elastase mutations in the original kostmann patients. Blood (ASH Annual Meeting Abstracts).2001;98:440a.


2001Aprikyan AG, Dale DC. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr Opin Immunol. 2001;13:535-8.


2001Aprikyan AG, Liles WC, Rodger ER, Person RE, Dale DC. Impaired survival of bone marrow progenitor cells in cyclic neutropenia. Blood. 2001;97:147-53.


2001

Aprikyan AG, Rodger E, Stein S, Liles WC, Dale DC. Cellular and molecular abnormalities in severe congenital neutropenia and leukemia. 30th Annual Scientific Meeting of the International Society for Experimental Hematology.August 25-28, 2001a.


2001

Bolyard AA, Cottle T, Bonilla MA, Boxer B, Cham C, Donadieu J, Fier C, Freedman M, Kannourakis G, Kinsey SE, Liang B, Schwinzer B, Zeidler C, Welte K, Dale DC. Long term treatment of chronic idiopathic neutropenia in women with G-CSF. (ASH Annual Meeting Abstracts). Blood.2001;98:1265a.


2001

Bolyard AA, Cottle T, Bonilla MA, Boxer B, Cham C, Donadieu J, Fier C, Freedman M, Kannourakis G, Kinsey SE, Liang B, Schwinzer B, Zeidler C, Welte K, Dale DC. Long term treatment of chronic idiopathic neutropenia in women with G-CSF. Blood 2001;98:300a.


2001

Bonilla MA, Bolyard AA, Boxer L, Cham B, Cottle T, Dale DC, Donadieu J, Freedman M, Kannourakis G, Kinsey SE, Liang B, Zeidler C, Welte K. Clinical outcome in myelokathexis: a report of 6 patients enrolled in the severe chronic neutropenia international registry. (ASH Annual Meeting Abstracts). Blood. 2001;98:4262a.

Abstract Bonilla, Mary Ann

2001 Commentaries, Medical Education Network; May 2001. Commentary Dale, David C

2001

Dale DC, Aprikyan A. Significance of neutrophil elastase mutations versus G-CSF receptor mutations for leukemic progression of congenital neutropenia. Blood.2001;97:2185-6.

ECL Dale, David C

SCNIRBibliography

of 87


2001Dale DC, Liles WC, Garwicz D, Aprikyan AG. Clinical implications of mutations of neutrophil elastase in congenital and cyclic neutropenia. J Pediatr Hematol Oncol. 2001; 23:208-10. PMID: 11846296


2001Dale DC. Neutropenia and neutrophilia. In: Williams WJ, et al, eds. Williams Hematology. 6th ed. New York, NY: McGraw Hill. 2001;823-834.


2001 Dale DC. Neutropenia. In: Encyclopedia of Life Sciences. London, England: Macmillan Reference Ltd; 2001. Book Chapter Dale, David C

2001Dror Y, Freedman MH. Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood. 2001 May 15;97(10):3011-16.

Journal Article Dror, Y

2001

Dror Y, Ginzberg H, Dalal I, Cherepanov V, Downey G, Durie P, Roifman CM, Freedman MH. Immune function in patients with Shwachman-Diamond syndrome. Br J Haematol. 2001 Sep;114(3):712-7


2001Gavrikova N, Zeidler C, Stanulla M, Germeshausen M, Schwinzer B, Welte K. TNF and lymphotoxin-alpha polymorphisms in patients with severe chronic neutropenia. Int J Hematol. 2001 Dec;74(4):477-8

Journal Article Gavrikova, N

2001

Gavrikova N, Zeidler C, Stanulla M, Germeshausen M, Schwinzer B, Welte K. TNF and lymphotoxin-alpha polymorphisms in patients with severe chronic neutropenia.neutropenia. Int J Hematol.2001 Dec;74(4):477-8. PMID: 11794710.

Journal Article Gavrikova, N

2001

Germeshausen M, Ballmaier M, Schulze H, Welte K, Flohr T, Beiske K, Storm-Mathisen I, Abrahamsen TG. Granulocyte colony- stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001 Feb 1;97(3):829-30


2001Germeshausen M, Ballmaier M, Welte K. Implications of mutations in hematopoietic growth factor receptor genes in congenital cytopenias. Ann N Y Acad Sci. 2001 Jun;938:305-20; discussion 320-1. Review

Review Germeshausen, M

2001

Germeshausen M, Schulze H, Ballmaier M, Zeidler C, Welte K. Mutations in the gene encoding neutrophil elastase (ELA2) are not sufficient to cause the phenotype of congenital neutropenia. Br J Haematol.2001 Oct;115(1):222-4.


2001Hübel K, Dale DC, Engert A, Liles WC. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. J Infect Dis. 2001;183:321-328.


2001Hübel K, Dale DC, Liles WC. Granulocyte transfusion therapy: update on potential clinical applications. Curr Opin Hematol. 2001;8:161-4.


SCNIRBibliography

of 87


2001

Liles WC, Broxmeyer H, Rodger E, Hübel K, Cooper S, Hangoc G, Bridger GJ, Henson GW, Calandra G, Dale DC. Leukocytosis and mobilization of pluripotent hematopoietic progenitor cells in healthy volunteers induced by single dose administration of AMD-3100, a CXCR4 antagonist. (ASH Annual Meeting Abstracts). Blood.2001;98:737a.

Abstract Liles, WC

2001Lininger L, Crawford J, Dale D, Chen H, Agboola Y, Stump E, Evans P, Lyman GH. Predicting risk of neutropenic complications: a point-of-care assessment tool. ASCO. May, 2001. Abstract.

Abstract Lininger, L

2001

Manuela Germeshausen, Matthias Ballmaier, Harald Schulze, Karl Welte, Thomas Flohr, Klaus Beiske, Ingebjørg Storm-Mathisen and Tore G. Abrahamsen. Granulocyte colony-stimulating factor receptor mutations in a patient with acute lymphoblastic leukemia secondary to severe congenital neutropenia. Blood. 2001 Feb 1;97(3):829-30. PMID: 11227095

Correspondence Germeshausen, Manuela

2001

Schiller M, Bohm M, Zeidler C, Germeshausen M, Welte K, Luger TA, Bonsmann G. [Cyclic neutropenia.Detection of a mutation in the gene for neutrophil elastase (ELA2)] Hautarzt. 2001 Sep;52(9):790-6. German

Journal Article Schiller, M

2001

Tschan CA, Pilz C, Zeidler C, Welte K, Germeshausen M. Time course of increasing numbers of mutations in the granulocyte colony-stimulating factor receptor gene in a patient with congenital neutropenia who developed leukemia. Blood. 2001 Mar 15;97(6):1882-4.

Journal Article Tschan, CA

2001

Zeidler C, Barth PG, Bonilla MA, Boxer L, Dale DC, Fier C, Freedman M, Kannourakis G, Kinsey S, Liang B, Schwinzer B, Welte K, Cham B. Neutropenia in Barth syndrome: clinical course and treatment of neutropenia. (ASH Annual Meeting Abstracts). Blood.2001;98:1264a.


2001

Zeidler C, Barth PG, Bonilla MA, Boxer L, Dale DC, Fier C, Freedman M, Kannourakis G, Kinsey S, Liang B, Schwinzer B, Welte K, Cham B. Neutropenia in Barth syndrome: clinical course and treatment of neutropenia. Blood 2001;98:300a


2000Allen RC, Dale DC, Taylor F. Blood phagocyte luminescence: gauging systemic immune activation. Methods Enzymol. 2000; 305:591-629.

Journal Article Allen, RC

2000Aprikyan A, Germeshausen M, Rodger E, Stein S, Zeidler C, Welte K, Dale DC. The diversity of neutrophil elastase mutations in congenital neutropenia. Blood 2000;96 (11): 445a.


SCNIRBibliography

of 87


2000

Aprikyan AAG, Liles WC, Person RE, Rodger E, Dale DC. Accelerated apoptosis of bone marrow progenitor cells in severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood. 2000;96:482a.


2000

Aprikyan AG, Germeshausen M, Rodger ER, Stein S, Zeidler C, Welte K, Dale DC. The diversity of neutrophil elastase mutations in congenital neutropenia. (ASH Annual Meeting Abstracts). Blood.2000;96:445a.


2000Aprikyan AG, Liles WC, Dale DC. Emerging role of apoptosis in the pathogenesis of severe neutropenia. Curr Opin Hematol.2000;7:131-132.


2000

Aprikyan AG, Liles WC, Park JR, Jonas M, Chi EY, Dale DC. Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors. Blood. 2000; 95:320-7.


2000

Aprikyan AG, Liles WC, Person RE, Rodger ER, Dale DC. Apoptosis and leukemia in congenital neutropenia. Acta Hematol (Symposium on Molecular Biology of Hematopoiesis and Treatment of Leukemia and Cancer Abstracts). 2000;103(S1):25a.


2000Aprikyan AG, Liles WC, Rodger ER, Person RE, Dale DC. Impaired survival of bone marrow progenitor cells in cyclic neutropenia. (ASH Annual Meeting Abstracts). Blood. 2000.


2000

Aprikyan AG, Rodger ER, Dale DC. Novel mutations in G-CSF receptor implicated in pathogenesis of acute myelogenous leukemia in severe congenital neutropenia. (ASH Annual Meeting Abstracts). Blood.2000;96:820a.


2000

Aprikyan AG, Rodger ER, Jeha S, Boxer LA, Dale DC. Acquired substitution mutation in G-CSF receptor underlying evolution of severe congenital neutropenia to acute myelogenous leukemia. (ASH Annual Meeting Abstracts). Blood. 2000;96.


2000

Boxer L, Dale D, Bonilla MA, Bolyard A, Cham B, Freedman M, Kannourakis G, Kinsey S, Mori P, Brown S, Fier C, Welte K. Administration of r-metHuG-CSF during pregnancy in patients with severe chronic neutropenia (SCN). Presented at Pediatric Academic Societies, Bostom, MA. Pediatric Research 47(Supplement):390a, 2000


2000

Boxer L, Fier C, Bolyard A, Bonilla M, Brown S, Cham B, Freedman M, Kannourakis G, Kinsey S, Mori P, Zeidler C, Welte K, Dale DC. Development of glomerulonephritis in patients with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood.2000;96:298a.


SCNIRBibliography

of 87


2000

Boxer LA, Fier C, Bolyard AA, Bonilla MA, Brown S, Cham B, Freedman M, Kannourakis G, Kinsey S, Mori PG, Zeidler C, Welte K, Dale DC. Development of glomerulonephritis in patients (pts) with severe chronic neutropenia (SCN). Blood 2000;96 (11): 298a.


2000Dale DC, Aprikyan AG, Person RE, Benson KF, Horwitz M. The genetic and molecular basis for cyclic and congenital neutropenia. Acta Hematol. 2000;103:35a.


2000 Dale DC, Liles WC. The return of granulocyte transfusions. Curr Opin Pediatr. 2000; 12:18-22. Journal Article Dale, David C

2000

Dale DC, Person RE, Bolyard AA, Aprikyan AG, Bos C, Bonilla MA, Boxer LA, Kannourakis G, Zeidler C, Welte K, Benson KF, Horwitz M. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood. 2000; 96:2317-22. PMID: 11001877


2000Dale DC. Approach to hematologic disorders. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York, NY: WebMD; 2000;5 Hema I 1-5.


2000Dale DC. Biological and clinical effects of recombinant human granulocyte colony- stimulating factor/filgrastim. Swedish Symposium on the Hematopoietic Growth Factors, Arlanda, Sweden. 2000.


2000Dale DC. Nonmalignant disorders of leukocytes. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York, NY; 2000;5 Hema VI.


2000Dale DC. Severe chronic neutropenia: update on pathophysiology and therapy. Swedish Symposium on the Hematopoietic Growth Factors. Arlanda, Sweden; 2000.


2000

Dinauer MC, Leckstrom-Himes JA, Dale DC. Inherited neutrophil disorders: molecular basis and new therapies. In: Schechter GP, Berliner N, Telen MJ. Eds. Hematology 2000: Am Soc of Hematology. Washington DC; 2000:303-318.

Book Chapter Dinauer, MC

2000

Engelfriet CP, Reesink HW, Klein HG, Murphy MF, Pamphilon D, Devereaux S, Hocker P, Adkins D, Boyce N, Tobin S, Grigg A, Strauss RG, Liles WC, Price TH, Dale DC, Norol F. International forum: granulocyte transfusions. Vox Sang. 2000; 79:59-66.

Journal Article Engelfriet, CP

2000

Freedman MH, Bonilla M, Fier C, Bolyard AA, Scarlata D, Boxer LA, Welte K, Brown S, Chan B, Kannourakis G, Kinsey SE, Mori PG, Cottle T, Dale DC, for the Severe Chronic Neutropenia International Registry. Improved survival from granulocyte-colony- stimulating factor therapy for congenital neutropenia unmasks predisposition to myelodysplasia and acute myeloid leukemia. Blood. 2000;96:429-436.


SCNIRBibliography

of 87


2000

Freedman MH, Bonilla M, Fier C, Bolyard AA, Scarlata D, Boxer LA, Welte K, Brown S, Chan B, Kannourakis G, Kinsey SE, Mori PG, Cottle T, Dale DC. Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood. 2000; 96:429-36.


2000

G. Kannourakis, T. Cottle, A.A. Bolyard,M.A. Bonilla, L.A. Boxer, B. Cham, D.C. Dale, C. Fier, S.E. Kinsey, B. Liang, P.G. Mori, K. Welte. Long term follow up on patients with glycogen storage disease 1b and severe chronic neutropenia treated with G-CSF. Blood, 2000;96:294a, Abstract 1267.

Abstract Kannourakis, G

2000

Germeshausen M, Schulze H, Ballmaier M, Lang S, Schaper Y, Zeidler C, Welte K. Decreased neutrophil elastase activity in patients with severe congenital neutropenia is not correlated to mutations in ELA2.Blood 2000;96 (11): 609a.


2000

Hübel K, Carter R, Liles WC, Dale DC, Bensinger WI, Price TH, Bowden RA, Boeckh M. Community donors vs. related donors for granulocyte transfusion therapy in hematopoietic transplantations: a comparative analysis of feasibility and outcome. (ASH Annual Meeting Abstracts). Blood. 2000;96:63a.

Abstract Hübel, K

2000 Hübel K, Dale DC, Engert A, Liles WC. Use of G-CSF for granulocyte transfusion therapy. Cytokines Cell Mol Ther. 2000; 6:89 95. Journal Article Hübel, K

2000

Hübel K, Dale DC, Rodger ER, Gaviria JM, Price TH, Liles WC. Preservation of function in granulocyte concentrates collected from donors stimulated with G- CSF/dexamethasone during storage at reduced temperature. (ASH Annual Meeting Abstracts). Blood. 2000;96:820a.

Abstract Hübel, K

2000

Jeha S, Chan KW, Aprikyan AG, Hoots WK, Culbert S, Zietz H, Dale DC, Albitar M. Spontaneous remission of granulocyte- colony stimulating factor associated leukemia in a child with severe congenital neutropenia. Blood. 2000; 96:3647-9.

Journal Article Jeha, S

2000

Kannourakis G, Cottle T, Bolyard AA, Bonilla MA, Boxer LA, Brown S, Cham B, Dale DC, Fier C, Kinsey SE, Mori PG, Welte K. Long term follow up on patients with glycogen storage disease 1b and severe chronic neutropenia treated with G-CSF. (ASH Annual Meeting Abstracts). Blood.2000;96:294a.


2000

Liles WC, Dale DC, Price TH, Gaviria M, Turner T, Saoud J, Yu A, Frumkin L. Inhibition of in vivo neutrophil transmigration by a novel humanized anti-CD11/CD18 monoclonal antibody. Cytokines, Cellular & Mol Ther. 2000; 6:121-6.


SCNIRBibliography

of 87


2000

Liles WC, Rodger E, Dale DC. Combined administration of granulocyte colony- stimulating factor (G-CSF) and dexamethasone for the mobilization of granulocytes in normal donors: Optimization of dosing. Transfusion. 2000; 40:642-644.


2000Link DC. Mechanisms of granulocyte colony- stimulating factor-induced hematopoietic progenitor mobilization. Seminars in Hematology, 2000; 37(1)suppl.2:25-32.

Journal Article Link, Daniel C

2000

Price TH, Bowden RA, Boeckh M, Bux J, Nelson K, Liles WC, Dale DC. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation.Blood. 2000; 5:3302-3309.

Journal Article Price, TH

2000

Root R, Nelson S, Dale DC, Martin T, WelchW. A multicenter, double blind, placebo- controlled study of filgrastim (R- METHUGCSF) in the treatment of patients with multilobar community-acquired pneumonia (MLCA). ALT/ATS International Conference. 2000.

Abstract Root, RK

2000

Root RK, Nelson S, Dale DC, Martin T, Welch W. Filgrastim (R-METHUGCSF) as adjunctive therapy in the treatment of patients with pneumonia and severe sepsis: results of a placebo-controlled trial.ALA/ATS International Conference. 2000.

Abstract Root, RK

2000Stevens DL, Root RK, Rosen H, Dale DC. Differential white blood cell count: underutilized or overrated. [Editorial review] Curr Opin Infect Dis. 2000;13(3):205-207. PMID: 11964787

Editorial Stevens, DL

2000Zeidler C, Boxer L, Dale DC, Freedman MH, Kinsey S, Welte K. Management of Kostmann syndrome in the G-CSF era. Br J Haematol. 2000; 109:490-5.


2000

Zeidler C, Dale DC, Welte K. Stem cell transplantation (HCST) in severe congenital neutropenia (CN). Acta Hematol (Symposium on Molecular Biology of Hematopoiesis and Treatment of Leukemia and Cancer Abstracts). 2000;103(S1):46a


2000

Zeidler C, Germeshausen M, Aprikyan A, Touw I, Dale DC, Welte K. Mutations of the G-CSF receptor gene in AML secondary to severe congenital neutropenia (CN). (ASH Annual Meeting Abstracts). Blood.2000;96:501a.


2000Zeidler C, Schwinzer B, Welte K (2000). Severe congenital neutropenia: Trends in diagnosis and therapy. Klim Padiatr.212:145-52. Review.


SCNIRBibliography

of 87


2000

Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L, Cornu G, Cowan MJ, Dale DC, Flood T, Freedman M, Gadner H, Mandel H, O’Reilly RJ, Ramenghi U, Reiter A, Skinner R, Vermylen C, Levine JE. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood. 2000; 95:1195-1198.


2000

Zeidler C, Welte K, Barak Y, Bolyard AA, Boxer L, Cornu G, Cowan MJ, Dale DC, Freedman M, Gadner H, Mandel H, O’Reilly RJ, Ramenghi U, Reiter A, Skinner R, Vermylen C, and Levine JE. Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. (ASH Annual Meeting Abstracts). Blood. 2000:95;1195a.


1999

Boxer LA, Dale DC, Bonilla MA, Bolyard AA, Cham B, Freedman M, Kannourakis G, Schwinzer B, Fier C, Brown S, Welte K. Administration of r-metHuG-CSF during pregnancy in patients with severe chronic neutropenia (SCN). (ASH Annual Meeting Abstracts). Blood. 1999;94:173b.


1999

Boxer LA. Commentary on Diagnosis and clinical course of autoimmune neutropenia in infancy: Analysis of 240 cases by Bux J, et al. Blood 91:181-186, 1998. In Yearbook of Pediatrics, 1999. GJA Storkman, III, (ed). Mosley, St. Louis, pp404-405, 1999.

Commentary Boxer, Laurence A

1999 Dale DC. Biological therapies for pneumonia. In: Cytokines and Pulmonary Infection part III. Ruder-Finn. 1999; 44-46. Book Chapter Dale, David C

1999Dale DC. Nonmalignant disorders of leukocytes. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York, NY; 1999;5 Hema VI, 1-5.


1999

Freedman MH, Bonilla MA, Fier C, Boylard AA, Scarlatta D, Boxer LA, Brown S, Cham B, Kannourakis G, Kinsey SE, Mori PG, Cottle T, Welte K, DC Dale. Improved survival from granulocyte-colony stimulating factor therapy for congenital neutropenia unmasks predisposition to myelodysplasia and acute myeloid leukemia. (European Society for Paediatric Research) Pediatr Res. 1999;45: 942

Abstract Freedman, Mel H

1999Gaviria JM, Dale DC, Root RK. Neutrophils: function and role in sepsis syndrome.Sepsis. 1999; 2:107-117.

Journal Article Gaviria, JM

1999

Gaviria JM, Garrido SM, vanBurik JJ, Dale DC, Root RK, Liles WC. Impaired neutrophil- mediated activity against Aspergillus fumigatus following allogeneic stem cell transplantation: restoration of function by IFN-(, G-CSF, or GM-CSF in vitro . InfectDis Soc Amer meeting; 1999.

Abstract Gaviria, JM

SCNIRBibliography

of 87


1999

Gaviria JM, Liles WC, Dale DC. The influence of colony stimulating factor on neutrophil production, distribution, and function. In: Wingard JR, Demetri G, eds. Clinical Applications of Cytokines and Growth Factors. Norwell, MA: Kluwer Academic Publishers; 1999:118-136.

Book Chapter Gaviria, JM

1999

Gaviria JM, van Burik JH, Dale DC, Root RK, Liles WC. Comparison of interferon-g (IFN-g), granulocyte colony-stimulating factor (G-CSF), and granulocyte- macrophage colony-stimulating factor (GM- CSF) for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis. 1999;179:1038-1041.


1999

Gaviria JM, van Burik JH, Dale DC, Root RK, Liles WC. Modulation of neutrophil- mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo. J Infect Dis.1999;179:1301-1304.


1999

Germeshausen M, Tidow N, Pilz C, Tschan C, Zeidler C, Welte K. G-CSF receptor mutations in patients with severe congenital neutropenia: frequency and implications in leukemic development.Blood 1999;94 (10): 45a


1999

Haurie C, Dale DC, Mackey MC. Occurrence of periodic oscillations in the differential blood counts of congenital, idiopathic and cyclical neutropenic patients before and during treatment with G-CSF. Exper Hematol. 1999; 27:401-409.

Journal Article Haurie, C

1999

Head DR, Boxer LA, Bolyard AA, Dale DC. Morphologic assessment of marrow aspirates in severe congenital neutropenia (CN) fails to predict evolution to myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML). Blood(ASH Annual Meeting Abstracts). 1999;94:430a.

Abstract Head, DR

1999 Horwitz M, Benson K, Person R, Aprikyan A, Dale D. The molecular genetic basis of cyclic hematopoiesis. Blood, 1999;94:650a. Abstract Horwitz, Marshall

1999

Horwitz M, Benson KF, Person RE, Aprikyan AG, Dale DC. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.Nat Genet. 1999; 23:433-36. PMID:10581030

Journal Article Horwitz, Marshall

1999

Kinsey SE, Bolyard AA, Bonilla MA, Boxer L, Brown S, Dale DC, Cham B, Fier C, Freedman M, Kannourakis G, Mori P, Welte K, Zeidler C. Algorithm for the management of Kostmann's neutropenia based on data from the severe chronic neutropenia international registry. (ASH Annual Meeting Abstracts). Blood. 1999;94:174b.

Abstract Kinsey, Sally E

SCNIRBibliography

of 87


1999

Root RK, Dale DC. Granulocyte colony- stimulating factor and granulocyte- macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in non-neutropenic patients. J Infect Dis. 1999;179:S352-352. PMID: 10081506

Journal Article Root, RK

1999

Zeidler C, Levine JE, Bolyard AA, Bonilla MA, Boxer L, Brown S, Dale DC, Cham B, Freedman M, Kannourakis G, Kinsey SE, Mori P, Welte K, for the Severe Chronic Neutropenia International Registry.Outcomes for hematopoietic stem cell transplantation (HSCT) in severe congenital neutropenia (CN). (ASH Annual Meeting Abstracts). Blood. 1999 566a.


1998

Aprikyan AG, Liles WC, Rodger E, Dale DC. Cyclic neutropenia: Proliferative and survival characteristics of bone marrow hematopoietic cells. (ASH Annual Meeting Abstracts). Blood. 1998;92:699a.


1998

Bowen JD, Petersdorf SH, Richards TL, Maravilla KR, Price TH, Dale DC, Carey MM, St John TP, Yu AS. Phase I study of a humanized anti-CD11/CD18 monoclonal antibody in multiple sclerosis. Clin Pharm Ther. 1998; 64:339-346.

Journal Article Bowen, JD

1998Dale DC, Federman DD. On being a physician. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York, NY; 1998; 3:I, 2-3.


1998

Dale DC, Fier C, Welte K. Use of filgrastim (r-metHuG-CSF) in severe chronic neutropenia. In: George Morstyn G, MichaelDexter TM, eds. Filgrastim (r- metHuG-CSF) in Clinical Practice. 2nd ed. Marcel Dekker, Inc.; 1998:121-147.


1998

Dale DC, Liles WC, Llewellyn C, Price TH. The effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on neutrophil kinetics and function in normal human volunteers. Am J Hematol.1998;57:7-15. PMID: 9423810


1998

Dale DC, Liles WC, Llewellyn C, Rodger E, Price TH. Neutrophil transfusions: kinetics and functions of neutrophils mobilized with granulocyte colony-stimulating factor (G- CSF) and dexamethasone. Transfusion.1998; 38:713-721.


1998Dale DC, Liles WC. Assessing the clinical consequences of neutropenia: how many neutrophils are enough? The Lancet.1998;351:1752-1753.

ECL Dale, David C

1998Dale DC, Nelson S. Use of colony- stimulating factors for treatment of neutropenia and infectious disease. In: Monograph on Neutrophils. The Vanderbilt Cancer Center; 1998:321-346.


1998 Dale DC. Advance notice: Vancomycin- resistant Staphylococci and Enterococci. Bulletin, Sci Am Med. June 1998. ECL Dale, David C

SCNIRBibliography

of 87


1998 Dale DC. AΩA – Defining its mission: comments from the board of directors. The Pharos. 1998;61:53. ECL Dale, David C

1998 Dale DC. Granulocyte transfusions. In: Bowden R, Ljungman P, Paya C, eds. Transplant Infections. Philadelphia, PA; 1998:359-365. Book Chapter Dale, David C

1998 Dale DC. Hematopoietic growth factors. Curr Opin Hematol. 1998;5:161-162. ECL Dale, David C

1998

Dale DC. Host defense mechanisms: the role of the hematopoietic growth factors. In:Immune Enhancement in Serious Infections, Monograph. American College of Chest Physicians; 1998:14-21.


1998Dale DC. Immune and idiopathic neutropenia. Curr Opin Hematol. 1998; 5:33-36.


1998Dale DC. Leukocytosis and leukopenia. In: Bone R, et al, eds. Current Practice of Medicine. 2nd ed. Philadelphia, PA: Current Medicine; 1998; XI:11.1-11.8.


1998Dale DC. The discovery, development and clinical applications of granulocyte colony- stimulating factor. Transactions of the American Clinical and Climatological Association. 1998;109:27-38.


1998 Dale DC. The Febrile Patient. In: Bennett JC, Plum F, eds. Cecil Textbook of Medicine. 21st ed. Philadelphia; 1998:1532- 1533. Book Chapter Dale, David C

1998Gaviria JM, van Burik JH, Dale DC, Root RK, Liles WC. Effect of in vivo administration of G-CSF on neutrophil- mediated hyphal damage of opportunistic fungi. J Infect Dis. 1998.


1998Gaviria JM, van Burik JH, Dale DC, Root RK, Liles WC. Leukocyte-mediated hyphal damage of opportunistic fungal pathogens are enhanced by IFN, G-CSF and GM-CSF. J Infect Dis. 1998.


1998Haurie C, Dale DC, Mackey MC. Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models. Blood. 1998 92:2629-2640.

Journal Article Haurie, C

1998

Kinsey SE, Bonilla MA, Boxer L, Brown S, Dale DC, Cham B, Freedman M, Kannourakis G, Mori P, Welte K, Cottle T, Fier C. Long term safety of filgrastim (G- CSF) therapy for chronic neutropenias.Presented at Am Soc of Hematol, Miami, FL. Dec 1998. Blood 92(Suppl 1):379a, 1998.

Abstract Kinsey, Sally E

1998

Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahhed H, Root R, Wilson J for the CAP Study Group. A randomized controlled trial of Filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community- acquired pneumonia. J Infect Dis. 1998; 178:1075-1080.

Journal Article Nelson, S

SCNIRBibliography

of 87


1998

Osborne WRA, Lejnieks DV, Barry S, Seppen J, Ramesh N, Clowes AW, Dale DC. Vascular smooth muscle cells as targets for long-term in vivo gene expression. (ASH Annual Meeting Abstracts). Blood. 1998;92.

Abstract Osborne, WRA

1998Zeidler C, Vogel R, Wyres M, Welte K. Beneficial effects of stem cell factor (SCF) in children with severe congenital neutropenias refractory to G-CSF. Blood 1998; 92:380a (abstract).


1998

Ziedler C., Levine JE, Bolyard A, Bonilla MA, Boxer L, Brown S, Dale DC, Cham B, Fier C, Freedman M, Kannourakis G, Kinsey SE, Mori P and Welte K. Bone Marrow transplantation (BMT) in patients with severe congenital neutropenia (SCN) refractory to G-CSF. Presented at Am Soc of Hematol, Miami, FL, Dec 1998. Blood 92 (Suppl 1):136a, 1998.


1997

Allen RC, Stevens PR, Price TH, Chatta GS, Dale DC. In vivo effects of recombinant human granulocyte colony-stimulating factor on neutrophil oxidative functions in normal human volunteers. J Infect Dis. 1997; 175:1184-1192. PMID: 9129083

Journal Article Allen, RC

1997

Anderlini P, Korbling M, Stoncek D, Horowitz M, Gratwohl A, Schmitz N, Dale DC, Champlin R. Allogeneic blood stem cell transplantation: considerations for donors.Blood. 1997;90:903-908.

ECL Anderlini, P

1997

Bowden R, Price T, Boeckh M, Liles C, Cays M, Dale D. Phase I/II study of granulocyte transfusions from G-CSF-stimulated unrelated donors for treatment infections in neutropenic blood and marrow transplant (BMT) patients. (ASH Annual Meeting Abstracts). Blood. 1997;90:435a.

Abstract Bowden, R

1997

Boxer L, Mori PG, Bonilla MA, Dale D, Cham B, Kinsey S, Welte K, Fier C, Catalano P, Cottle T, Kannourakis G, Freedman M for the Severe Chronic Neutropenia International Registry. Report on patients with Schwachman-Diamond syndrome with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood.1997;90:182a.


1997 Boxer LA, Dale D. Congenital neutropenia and the risk of leukemia [letter; comment]. J Pediatr. 1997;130:335. ECL Boxer, Laurence A

1997 Brown SL, Dale DC. Splenic rupture following G-CSF. [letter to Editor]. Biol Blood Marrow Transplantation. 1997;3:1. Letter to Editor Brown, SL

1997

Dale DC, Cottle T, Bolyard AA, Fier C, Atchison R, Bonilla MA, Boxer L, Catalano P, Cham B, Freedman M, Kannourakis G, Kinsey S, Mori P, Welte K for the Severe Chronic Neutropenia International Registry. Long-term treatment of chronic idiopathic neutropenia with G-CSF. (ASH Annual Meeting Abstracts). Blood. 1997;90:173a.


SCNIRBibliography

of 87


1997 Dale DC, Liles WC, Price TH. Renewed interest in granulocyte transfusion therapy. Br J Haematol. 1997; 98:497-501. Journal Article Dale, David C

1997 Dale DC, Osborne WRA. Erythropoietin: A good candidate for successful gene therapy. Molecular Medicine. Today 2:III, 1997. ECL Dale, David C

1997 Dale DC. Advance notice: clinical studies of thrombopoietin begin. Bulletin, Sci Am Med. April 1997. ECL Dale, David C

1997Dale DC. Approach to hematological disorders. In: Dale DC, Federman DD, eds. Scientific American Medicine. New York, NY; 1997;5:1-8.


1997

Dale DC. Colony-stimulating factors (CSFs) to prevent opportunistic infections. In: Heidt PJ, Rusch V, van der Waaij D, eds. New Antimicrobial Strategies, Old Herborn University Seminar Monograph. 1997;10:60- 68.


1997Dale DC. Commentary: Hematopoietic growth factors. Curr Opin Hematol.1997;4:3;155-156.

ECL Dale, David C

1997

Dale DC. Cytokines in the treatment of infection. In: Sibinga CTS, Das PC, Wenberg BL, eds. Cytokines and Growth Factors in Blood Transfusion. 21st International Symposium on Blood Transfusion, Groningen; Dordrecht, The Netherlands: Kluwer Academic Publishers; 1997.


1997

Dong F, Dale DC, Bonilla MA, Freedman , Fasth A, Neijens HJ, Palmblad J, Briars GL, Carlsson G, Veerman AJP, Welte K, Löwenberg, Touw IP. Mutations in the granulocyte-colony stimulating factor receptor in patients with congenital neutropenia. Leukemia. 1997;11:120-125.


1997

Liles WC, Huang JE, Llewellyn C, SenGupta D, Price TH, Dale DC. A comparative trial of granulocyte colony-stimulating factor (G- CSF) and dexamethasone alone and in combination for the mobilization of neutrophils in the peripheral blood of normal human volunteers. Transfusion.1997;37:182-187.


1997

Liles WC, Huang JE, van Burik JH, Bowden RA, Dale DC. Granulocyte colony- stimulating factor (G-CSF) administered in vivo augments neutrophil-mediated activity against opportunistic fungal pathogens. J Infect Dis. 1997;175:1012-1015.


1997Liles WP, Dale DC. Causes, clinical consequences, and treatment of neutropenia. In: Morstyn G, Dexter TM. Filgrastim (r-metHuG-CSF) in Clinical Practice. 2nd ed. Marcel Dekker, Inc. 1997:93-120.

Book Chapter Liles, WC

1997

Price TH, Bowden RA, Boeckh M, Liles WC, Llewellyn C, Fuller F, Dale DC. Neutrophil collection from community apheresis donors after granulocyte colony-stimulating factor and dexamethasone stimulation: feasibility and efficacy. (ASH Annual Meeting Abstracts). Blood. 1997;90:137b.

Abstract Price, TH

SCNIRBibliography

of 87


1997

Rusthoven JJ, deVries EGE, Dale DC, Piccart M, Glaspy J. Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint. Intl J Antimicrob.1997;8:263-275.

Journal Article Rusthoven, JJ

1997 Welte K, Boxer LA. Severe Chronic Neutropenia: Pathophysiology and Therapy. Seminars in Hematology, 34:1-13, 1997. Journal Article Welte, Karl

1997

Welte K, Touw IP for the Severe Chronic Neutropenia International Registry. G-CSF receptor mutations in patients with severe chronic neutropenia: a step in leukemogenesis? (ASH Annual Meeting Abstracts). Blood. 1997;90:433a.

Abstract Welte, Karl

1996

Boxer L, Bonilla MA, Cham B, Freedman M, Kanourakis G, Brown S, Fier C, Welte K, Dale, DC, for the SCN International Data Registry. Severe chronic neutropenia: From the laboratory to the Clinic. Prog Int'l Soc Hematol 1996.


1996Chatta GS, Dale DC. Aging and hematopoiesis: implications for treatment with hematopoietic growth factors. Drugs and Aging. 1996; 9:37-47.

Journal Article Chatta, GS

1996

Dale DC, Liles WC, Llewellyn C, Rodger E, Bowden R, Price TH. Neutrophil transfusion therapy: characteristics and kinetics of cells from donors treated with a combination of G- CSF and dexamethasone. (ASH Annual Meeting Abstracts). Blood. 1996;88:627a.


1996Dale DC. Historical notes on graduate medical education in Washington, Alaska, Montana, and Idaho. King County Medical Society Bulletin; May 1996.


1996Dale DC. Infections in the compromised host. In: Beers MH, Berkow R, eds. Merck Manual. 17th ed. Whitehouse Station, NJ: Merck Research Labs; 1996.


1996Dale DC. Leukocytosis and Leukopenia. In: Bone R, et al, eds. Current Practice of Medicine. Philadelphia, PA: Current Medicine; 1996 XI:11.1-11.8.


1996Dale DC. Recent advances in understanding and clinical applications of the hematopoietic growth factors. [Commentary] Curr Opin Hematol. 1996;3:173-174.


1996 Dale DC. Severe chronic neutropenia: causes, consequences and therapy. Helix. 1996;5:36-41. Journal Article Dale, David C

1996Dale DC. The Febrile Patient. In: Bennett JC, Plum, F, eds. Cecil Textbook of Medicine. 20th ed. Philadelphia, PA; 1996:1532-1533.


1996Dale, D.C. Hematopoietic Growth Factors. In: Rossi EC, et al, eds. Principles of Transfusion Medicine. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996:345-351.


SCNIRBibliography

of 87


1996

Davis RL, Cottle T, Bonilla MA, Box L, Catalano P, Cham B, Fier C, Freedman MH, Kannourakis G, Kinsey S, Mori PG, Welte, Dale DC. Growth among patients with severe chronic neutropenia treated with Filgrastim (G-CSF). Fed Clin Res J Invest Med. 1996;45:101A.

Abstract Davis, RL

1996

Freedman MH, Bonilla MA, Boxer L, Catalano P, Cham B, Fier C, Kannourakis G, Kinsey S, Mori PG, Shannon K, Touw I, Welte K, Dale DC, for the Severe Chronic Neutropenia International Registry.MDS/AML in patients with severe chronic neutropenia (SCN) receiving G-CSF. (ASH Annual Meeting Abstracts). Blood.1996;88:448a.

Abstract Freedman, Mel H

1996 Frumkin L, Dale DC. The role of colony- stimulating factors in HIV disease. The Aids Reader Nov/Dec. 1996;185-193. Journal Article Frumkin, L

1996

Huang JE, Liles WC, Dale DC. Granulocyte colony-stimulating factor (G-CSF) administered to normal human volunteers in vivo augments neutrophil host defenses against opportunistic fungal pathogens. J Invest Med. 1996;44:111A.

Abstract Huang, JE

1996

Huang JE, Liles WC, Llewellyn C, Price TH, Dale DC. A comparative trial of granulocyte colony-stimulating factor (G-CSF) and dexamethasone alone and in combination for the mobilization of neutrophils in the peripheral blood of normal volunteers. J Invest Med. 1996;44:109A.

Abstract Huang, JE

1996

Kannourakis G, Kurtzberg J, Bonilla MA, Boxer L, Catalano P, Cham B, Fier C, Kinsey S, Marty J, Freedman MH, Mori PG, Thompson B, Dale DC, Welte K. Report on patients with glycogen storage disease 1b with severe chronic neutropenia (SCN) treated with Filgrastim. (ASH Annual Meeting Abstracts). Blood. 1996;88:349a.


1996

Maakestad K, Mazanet R, Liles WC, Dale DC. Neutrophil transfusions for treatment of infections. In: George Morstyn G, Sheridan WP, eds. Cell Therapy. 1st ed. Cambridge, England: Cambridge University Press; 1996:510-526.

Book Chapter Maakestad, K

1996Palmer SE, Stephens K, Dale DC. Anticipation in autosomal dominant cyclic hematopoiesis. Am J Hum Genet.1996;59:A37.

Abstract Palmer, S

1996Palmer SE, Stephens K, Dale DC. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. Am J Med Gen. 1996;66:413-422.

Journal Article Palmer, S

1996

Price TH, Gurkamal S, Chatta GS, Dale DC. The effect of recombinant granulocyte colony-stimulating factor on neutrophil kinetics in normal young and elderly humans. Blood. 1996; 88:335-340.


1996 Sievers EL, Dale DC. Non-malignant neutropenia. Blood Reviews. 1996;10:95- 100. Journal Article Sievers, EL

SCNIRBibliography

of 87


1996Starkebaum G, Dale DC. Autoimmune Leukopenia. In: Current Therapy In Allergy, Immunology, and Rheumatology. 5th ed.Philadelphia, PA: Mosby Inc.; 1996:325-328.

Book Chapter Starkebaum, G

1996 Welte K, Dale DC. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol. 1996;72:158-165. Journal Article Welte, Karl

1996

Zeidler C, Bonilla MA, Boxer L, Catalano P, Cham B, Fier C, Freedman MH, Kannourakis G, Kinsey S, Mori PG, Dale DC, Welte K for the Severe Chronic Neutropenia International Registry. Report on patients with severe chronic neutropenia (SCN) refractory to G-CSF. (ASH Annual Meeting Abstracts). Blood. 1996;88:349a.


1995

Boxer L, Dale DC, Bonilla MA, Cham B, Freedman M, Kannourakis G, Brown S, Fier C, Welte K. Administration of r-metHuG- CSF during pregnancy in patients with severe chronic neutropenia (SCN). (ASH Annual Meeting Abstracts). Blood.1995;86:508a.


1995

Chatta GS, Dale DC. Alterations of host- defense mechanisms and the susceptibility to infections in the elderly. In: Stenchever MA, Aagaard GA, eds. Health Care for the Older Woman. Chapman and Hall. 1995;37- 53.

Book Chapter Chatta, GS

1995

Dale DC, Cottle T, Bolyard AA, Fier C, Bonilla MA, Boxer L, Brown SL, Cham B, Freedman M, Kannourakis G, Welte K. Severe chronic neutropenia: report on treatment and outcome from a new international registry. (ASH Annual Meeting Abstracts). Blood. 1995;86:425a.


1995Dale DC, Liles WC, Summer W, Nelson S. Granulocyte-colony-stimulating factor: role and relationships in infectious diseases. J Infect Dis. 1995;172-1061-1075.


1995 Dale DC. Hematopoietic growth factors and the functions of blood cells. Curr Opin Hematol. 1995;2:164-166. ECL Dale, David C

1995 Dale DC. Hematopoietic growth factors for the treatment of severe chronic neutropenia. Stem Cells. 1995;13:94-100. Journal Article Dale, David C

1995Dale DC. Is there a role for granulocyte transfusions in the hematopoietic growth factor era? In: Hematopoietic Therapy. 1995; Index & Review 1 and 15.


1995Dale DC. Lymphadenopathy. In: Fihn SD, McGee SR, Saunders WB, eds. Outpatient Medicine. 2nd ed. New York, NY: W.B. Saunders. 1995.


1995 Dale DC. Neutropenia. In: Williams WJ, et al, eds. Hematology. 5th ed. New York, NY; McGraw-Hill; 1995:1815-824. Book Chapter Dale, David C

1995 Dale DC. Neutrophilia. In: Williams WJ, et al, eds. Hematology. 5th ed. New York, NY; McGraw-Hill; 1995:824-828. Book Chapter Dale, David C

SCNIRBibliography

of 87


1995 Dale DC. Where now for colony-stimulating factors? The Lancet. 1995;346:135-136. ECL Dale, David C

1995Heimfeld S, Thompson P, Liles C, Dale D, Baldwin G, Adkins D, Berenson R. Maintenance of in vitro granulocyte function after cryopreservation. ISEH 1995.

Abstract Heimfeld, S

1995

Kalra R, Dale DC, Freedman M, Bonilla MA, Weinblatt M, Ganser A, Bowman P, Abish S, Priest J, Oseas RS, Olson, K, Paderanga D, Shannon K. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood. 1995;86:4579-4586.

Journal Article Kalra, R

1995 Liles WC, Dale DC, Klebanoff SJ. Glucocorticoids inhibit apoptosis of human neutrophils. Blood. 1995;86:3181-3188. Journal Article Liles, WC

1995 Liles WC, Dale DC. Current approach to the management of neutropenia. J Int Care Med. 1995;10:283-293. Journal Article Liles, WC

1995

Liles WC, Huang JE, Llewellyn C, Price TH, Dale DC. A comparative trial of granulocyte colony-stimulating factor (G-CSF) and dexamethasone alone and in combination for the mobilization of neutrophils in the peripheral blood of normal human volunteers. (ASH Annual Meeting Abstracts). Blood. 1995;86:609a.

Abstract Liles, WC

1995

Liles WC, Park JR, Chi EY, Dale DC. Myelokathexis (a congenital form of neutropenia characterized by accelerated apoptosis and defective expression of BCL- X in neutrophil precursors. (ASH Annual Meeting Abstracts). Blood. 1995;86:259a.

Abstract Liles, WC

1995Osborne WRA, Ramesh N, Lau S, Dale DC, Clowes AW. Gene therapy for long term expression of erythropoietin in rats. Proc Nat’l Acad Sci. 1995;92:8055-8058.

Journal Article Osborne, WRA

1995

Petersdorf SH, Dale DC. The biology and clinical applications of erythropoietin and the colony-stimulating factors. In: Robert W. Schrier RW, ed. Advances in Internal Medicine. Chicago, IL: Mosby-Year Book; 1995;40:395-428.

Book Chapter Petersdorf, SH

1995Romanick-Schmiedl SG, Bolyard AA, Dale DC, Gauthier VJ. Bone pain in rhG-CSF recipients. Arthritis Rheumatol.1995;38:S326.

Abstract Romanick-Schmiedl, SG

1994

Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A, Reihm H, O’Reilly R, Welte K. Long-term safety of treatment with recombinant human granulocyte colony- stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. Br J Haematol. 1994;88:723- 30.

Journal Article Bonilla, Mary Ann

1994

Chatta G, Price T, Allen RC, Dale DC. The effects of in vivo recombinant human granulocyte colony-stimulating factor (rhG- CSF) on the neutrophil (PMN) response in healthy young (Y) and elderly (O) volunteers. J Am Ger Soc. 1994.

Abstract Chatta, GS

SCNIRBibliography

of 87


1994

Chatta GS, Price TH, Allen RC, Dale DC. The effects of in vivo recombinant methionyl human granulocyte colony stimulating factor (rhG-CSF) on the neutrophil response and peripheral blood colony-forming cells in healthy young and elderly volunteers. Blood. 1994; 84:2923-2929. PMID: 7524759


1994 Chatta GS, Price TH, Stratton JR, Dale DC. Aging and marrow neutrophil reserves. J Am Geriat Soc. 1994;42:77-81. Journal Article Chatta, GS

1994

Dale DC, Bonilla MA, Boxer L, Freedman M, Brown S, Fier C, Welte K. Development of AML/MDS in a subset of patients (PTS) with severe chronic neutropenia (SCN). (ASH Annual Meeting Abstracts). Blood.1994;84(Suppl 1):518a.


1994

Dale DC, Davis MW, Vincent M. Use of Filgrastim (r-metHuG-CSF) in severe chronic neutropenia. In: G. Morstyn G, Dexter M, eds. G-CSF in Clinical Applications. New York, NY: Marcel Dekker; 1994:83-101.


1994 Dale DC. Asthma, socioeconomic status and health care reform. JGIM. 1994;9:178. ECL Dale, David C

1994 Dale DC. Beginning and finishing. JGIM. 1994;9:708. ECL Dale, David C

1994Dale DC. Hematopoietic growth factors in the treatment of neutropenia. Proceedings of the Congress of the International Society of Hematology. Cancun, Mexico; 1994.


1994Dale DC. Hematopoietic growth factors. [Commentary] Curr Opin Hematol.1994;1:177-179.


1994Dale DC. Physiology, function and role of the neutrophil in host defense. Monograph, Scientific Therapeutics Information, Inc.1994.


1994Dale DC. Potential role of colony-stimulating factors in the prevention and treatment of infectious diseases. Clin Infect Dis. 1994; 18:S180-188.


1994Dale DC. Results of the ABIM exam: is internal medicine slipping? JGIM.1994;9:418.

ECL Dale, David C

1994Dale DC. Severe chronic neutropenia: long- term therapy and quality of life issues. New York, NY: Triclinica Communications, Monograph; 1994:1-24.


1994Gamson JG, Dale DC, Rosen H. Granulocyte colony-stimulating factor (G- CSF) therapy decreases neutrophil lactoferrin content. Clin Res. 1994;42:78a.

Abstract Gamson, JG

SCNIRBibliography

of 87


1994

Geary RL, Clowes AW, Lau S, Vergel S, Dale DC, Osborne WRA. Gene transfer in baboons using prosthetic vascular grafts seeded with retrovirally-transduced smooth muscle cells: a model for local and systemic gene therapy. Hum Gene Therapy.1994;5:1211-1216.

Journal Article Geary, RL

1994

Kalra R, Dale DC, Freedman M, Shannon K, et al. Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia (CN) treated with recombinant human granulocyte colony stimulating factor (rh-G-CSF). (ASH Annual Meeting Abstracts). Blood. 1994;84:313a.

Abstract Kalra, R

1994Liles WC, Dale DC, Klebanoff SJ. FAS (APO-1; CD95) activation induces apoptosis in human phagocytes. (ASH Annual Meeting Abstracts). Blood. 1994;84:1468.

Abstract Liles, WC

1994

Liles WC, Rodger ER, Dale DC. Differential regulation of human neutrophil surface expression of CD14, CD11b, CD18, and L- selectin following the administration of G- CSF in vivo and in vitro . Clin Res.1994;42:237a.

Abstract Liles, WC

1994

Liles WC, Rodger ER, Dale DC. In vivo administration of granulocyte colony- stimulating factor (G-CSF) to normal human subjects: priming of the respiratory burst and inhibition of apoptosis in neutrophils. Blood . (ASH Annual Meeting Abstracts) 1994;84:24a.

Abstract Liles, WC

1994 Lowenberg B, Dale DC, Sheridan WP. Clinical use of hematopoietic growth factors. Rev Invest Clin. 1994: (Suppl)33-40. PMID: 7886306 Journal Article Lowenberg, B

1994

Medlock ES, Andresen J, Kaplan DL, del Castillo J, Ulich TK, Modanlou HD, Trebasky L, Dale DC, Dicato M. Placental transfer of granulocyte colony-stimulating factor induces fetal granulopoiesis: Discussions of a model system. Proceedings of III International Congress on the Immune Consequences of Trauma, Shock and Sepsis. Munich, Germany. March 1994.

Abstract Medlock, ES

1994Noble J, Goldman J, Marvinney SL, Dale DC. The Society of General Internal Medicine from conception to maturity: 1970s to 1994. J Gen Int Med (Suppl). 1994;9:1- 44.

Journal Article Noble, J

1994

Osborne WRA, Ramesh N, Lau S, Clowes MM, Clowes AW, Dale DC. Long-term therapeutic expression of erythropoietin in rats treated with transduced vascular smooth muscle cells. Clin Res.1994;42:304a.


1994

Palmer SE, Dale DC, Livingston RJ, Wijsman EM, and Stephens K. Autosomal dominant cyclic hematopoiesis: exclusion of linkage to the major hematopoietic regulatory gene cluster on chromosome 5. Hum Genet. 1994; 93:195-197.

Journal Article Palmer, S

SCNIRBibliography

of 87


1994Palmer SE, Stephens K, Dale DC. Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis. Am J Hum Gen. 1994;55:A8.

Abstract Palmer, S

1993

Bensinger WI, Price TH, Dale DC, Clift R, Lilleby K, Williams B, Thomas ED, Buckner CD. The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis. Blood.1993;81:1883-1888.

Journal Article Bensinger, WI

1993

Chatta GS, Andrews RG, Rodger E, Shragg M, Hammond, WP, Dale DC. Hematopoietic progenitors and aging: alterations in granulocytic precursors and responsiveness to recombinant human G-CSF,GM-CSF, and IL-3. J Gerontol. 1993;48:M207-212.


1993Dale DC, Bolyard AA, Hammond WP. Cyclic neutropenia: natural history of long-term treatment with recombinant human granulocyte stimulating factor. Cancer Invest. 1993;11:219-223.


1993

Dale DC, Bonilla MA, Davis MW, Nakanishi A, Hammond WP, Kurtzberg J, Wang W, Jakubowski A, Winton E, Lalezari P, Robinson W, Glaspy JA, Emerson S, Gabrilove J, Vincent M, and Boxer LA. A randomized controlled phase III trial of recombinant human G-CSF for treatment of severe chronic neutropenia. Blood.1993;81:2496-2502. PMCID: PMC4120868


1993

Dale DC, Price TH, Chatta GS, Allen RC, Stevens P. The effect of recombinant granulocyte colony stimulating factor (G- CSF) on neutrophil kinetics and function in normal young and elderly subjects. Ann Hematol. 1993;66(suppl II):A85.


1993Dale DC, Welte K. Severe Chronic Neutropenia: The Role of Haematopoietic Growth Factors. Gardiner-Caldwell Communications Ltd. 1993.


1993 Dale DC. Colony stimulating factors for the treatment and prevention of infectious diseases. J Cell Biochem. 1993;17(Suppl B):58. Abstract Dale, David C

1993Dale DC. G-CSF for congenital and chronic neutropenia: present treatment regimens and long-term effects. Proceedings of the 18th International Congress of Chemotherapy. Stockholm, Sweden. 1993.


1993 Dale DC. Granulocyte colony stimulating factor in infectious diseases. Curr Opin Infect Dis. 1993;6:369-373. Journal Article Dale, David C

1993Dale DC. Hematopoietic growth factors in non-malignant cytopenias. Proceedings 12th Meeting of International Society of Hematology (European and African Division). 1993;105-119.


1993Dale DC. Lymphadenopathy and lymphoproliferative disorders. In: Altman LC, ed. Autoimmune Diseases. Philadelphia, PA: W. B. Saunders; 1993:359-369.


SCNIRBibliography

of 87


1993 Dale DC. The clinical examination revisited. JGIM. 1993;8:638. ECL Dale, DC

1993Jones E, Bolyard A, Dale DC. Effect of granulocyte colony-stimulating factor on quality of life in patients with severe chronic neutropenia. Clin Res. 1993;41:65a.

Abstract Jones, E

1993Jones E, Bolyard AA, Dale DC. Quality of life in patients receiving granulocyte colony stimulating factor for treatment of severe chronic neutropenia. JAMA. 1993;270:1132- 1133.

Journal Article Jones, E

1993Palmer SE, Dale DC, Livingston RJ, Wijsman EM, Stephens K. Role of pleiotropic cytokine signal transducers in autosomal dominant cyclic hematopoiesis. Am J Hum Genet. 1993;53:A1747.

Abstract Palmer, S

1992

Allen RC, Stevens P, Price TH, Chatta GS, Dale DC. Effects of rhG-CSF in normal human volunteers: relationship between increased neutrophil oxidative activity and emergence time. (ASH Annual Meeting Abstracts). Blood. 1992;80:959a.

Abstract Allen, RC

1992

Bensinger WI, Price TH, Dale DC, Appelbaum FR, Clift RA, Storb R, Thomas ED, Buckner CD. Daily G-CSF administration in normal granulocyte donors undergoing leukapheresis. (ASH Annual Meeting Abstracts). Blood. 1992;80:291a.

Abstract Bensinger, WI

1992

Chatta GS, Price TH, Dale DC. Aging and the neutrophil response to r-metHuG-CSF in healthy young and elderly individuals. (ASH Annual Meeting Abstracts). Blood.1992;80:290a.

Abstract Chatta, GS

1992 Dale DC. Acquired chronic and cyclic neutropenia. Interferons and Cytokines. 1992;22:10-12. Journal Article Dale, David C

1992Dale DC. Growth regulation of hematopoietic cells. Proceedings of the 20th International Symposium, Korean Academy of Medical Sciences. Seoul, Korea; 1992.


1992 Dale DC. Infections in the compromised host. In: Merck Manual. 16th ed. West Point, PA: Merck and Co; 1992:74-77. Book Chapter Dale, David C

1992 Dale DC. Leukopenia; Neutropenia. In: Merck Manual. 16th ed. West Point, PA: Merck and Co; 1992:1225-1229. Book Chapter Dale, David C

1992 Dale DC. Lymphadenopathy. In: Fihn SD, McGee SR, eds. Outpatient Medicine. New York, NY: W.B. Saunders; 1992:619-623. Book Chapter Dale, David C

1992 Dale DC. Management of severe chronic neutropenia with recombinant G-CSF. Clinician. 1992;10:26-32. Journal Article Dale, David C

1992 Dale DC. Mengert JT. When is hospitalization necessary? JGIM 1992;7:371. ECL Dale, David C

1992Dale DC. The Febrile Patient. In: Wyngaarden JB, et al, eds. Cecil Textbook of Medicine. Philadelphia, PA: W.B. Saunders; 1992:1567-1568.


1992 Dale DC. Wilkes R. Whither the journal? JGIM. 1992;7:466. ECL Dale, David C

SCNIRBibliography

of 87


1992Hammond WP, Chatta GS, Andrews RG, Dale DC. Abnormal responsiveness of granulocyte-committed progenitor cells in cyclic neutropenia. Blood. 1992;79:2536- 2539.

Journal Article Hammond, WP

1992Osborne WRA, Lynch CM, Clowes MM, Clowes AW, Dale DC, Miller AD. Vascular smooth muscle cells as target tissue for gene therapy. Clin Res. 1992;40:192a.


1992

Palmer S, Wijsman E, Livingston RL, Dale DC, Stephens K. Exclusion of the gene for autosomal dominant cyclic hematopoiesis from the major hematopoietic gene cluster on chromosome 5, including the hematopoietic gene cluster on 5q. 43rd Annual Meeting of the American Society of Human Genetics. San Francisco, CA; November 8-12, 1992.

Abstract Palmer, S

1992

Price TH, Chatta GS, Dale DC. The effect of recombinant granulocyte colony-stimulating factor (G-CSF) on neutrophil kinetics in normal human subjects. (ASH Annual Meeting Abstracts). Blood. 1992;80:350a.

Abstract Price, TH

1991

Chatta G, Dale DC. Alterations of host- defense mechanisms and the susceptibility to infections. In: Stenchever MA, Aagaard GA, eds. Caring for the Older Woman. New York, NY: Elsevier Science Publishing Co; 1991:665-668.

Book Chapter Chatta, GS

1991

Chatta GS, Rodger E, Hammond WP, Andrews RG, Bernstein ID, Dale DC. Hematopoietic progenitors and aging: alterations in granulocytic progenitors and responsiveness to recombinant human G- CSF, GM-CSF and IL-3. Clin Res.1991;39:87a.

Abstract Chatta, GS

1991Dale DC, Bolyard AA, Michel BR, Rosen H, Scott CR. Long-term G-CSF therapy for neutropenia in glycogen storage disease - type 1b. Blood . (ASH Annual Meeting Abstracts) 1991;78:426a.


1991 Dale DC. A new feature for the journal: Brief Reports. JGIM. 1991;6:259. ECL Dale, David C

1991 Dale DC. A new look at an old laboratory test: the WBC count. JGIM. 1991;6:264. ECL Dale, David C

1991 Dale DC. Alumni surveys for evaluation of innovations in medical education. J Gen Intern Med. 1991;6:587. ECL Dale, David C

1991 Dale DC. Defining the role and responsibilities of the general internist. JGIM. 1991;6:176. ECL Dale, David C

1991 Dale DC. Do leukemic cells constituitively produce growth factors? In: Focus on Growth Factors. 1991;2:3-5. Journal Article Dale, David C

1991Dale DC. Leukocytosis, leukopenia and eosinophilia. In: RK Root RK, et al, eds. Harrison’s Principles of Internal Medicine. 12th ed. New York, NY: McGraw-Hill; 1991:359-362.


SCNIRBibliography

of 87


1991

Dale DC. Myelopoietic factors in the prevention and treatment of infections in neutropenic patients. In: Sande MA, Root RK, eds. Treatment of Serious Infections in the 1990’s. New York, NY: Churchill Livingstone; 1991;65:76-128.


1991 Dale DC. The use of colony stimulating factors to combat infection. Biotherapy Report. 1991;1:4-7. Journal Article Dale, David C

1991Stephens K, Livingston RJ, Wijsman E, Dale DC. Mapping the gene for autosomal dominant cyclic hematopoiesis. Northwest Genetics Exchange. May 10, 1991.

Abstract Stephens, K

1990

Bonilla M and the Severe Chronic Neutropenia Study Group. Clinical efficacy of recombinant human granulocyte colony stimulating factor (r-met-G-CSF) in patients with severe chronic neutropenia. (ASH Annual Meeting Abstracts). Blood.1990;76:133a.

Abstract Bonilla, Mary Ann

1990 Chatta GS, Hammond WP, Stratton JR, Price TH, Dale DC. Aging and bone marrow neutrophil reserves. Clin Res. 1990;38:80A. Abstract Chatta, GS

1990

Chatta GS, Rodger E, Hammond WP, Andrews RG, Bernstein ID, D.C. Dale. Hematopoietic progenitors and aging: alterations in granulocytic progenitors and responsiveness to recombinant hematopoietic growth factors. (ASH Annual Meeting Abstracts). Blood. 1990;76:87a.

Abstract Chatta, GS

1990

Dale DC, Hammond WP, Gabrilove J, Jakubowski A, Bonilla MA, O’Reilly R, Anderson CZ, Vincent M, Welte K. Long term treatment of severe chronic neutropenia with recombinant human granulocyte colony stimulating factor (r- metHuG-CSF). Blood . (ASH Annual Meeting Abstracts) 1990;76:139a.


1990

Dale DC, Hammond WP. The therapeutic role of recombinant human granulocyte stimulating factor (rhG-CSF) in cyclic and chronic neutropenia. In: R. Mertelsmann R, Herrmann F, eds. Hematopoietic Growth Factors and Their Clinical Application. New York, NY: Marcell Dekker; 1990:237-246.


1990Dale DC, Hammond WP: Neutropenia. In: Rakel RE, Saunders WB, eds. Conn’s Current Therapy. Philadelphia, PA: Saunders; 1990:333-336.


1990 Dale DC. Declining interest in internal medicine residencies: a crisis or quirk? JGIM. 1990;5:453. ECL Dale, David C

1990 Dale DC. Neutropenia. In: WJ Williams WJ, et al, ed. Hematology. 4th ed. New York, NY: McGraw-Hill; 1990:807-816. Book Chapter Dale, David C

1990 Dale DC. Neutrophilia. In: WJ Williams WJ, et al. Hematology. 4th ed. New York, NY: McGraw-Hill; 1990:816-820. Book Chapter Dale, David C

SCNIRBibliography

of 87


1990 Dale DC. New editors for JGIM. JGIM. 1990;5:88. ECL Dale, David C

1990Hammond WP and DC Dale. Cyclic and chronic neutropenia: overlap shown with G- CSF therapy. Program of the Int’l Society Exp Hematol; 1990.

Abstract Hammond, WP

1990

Migliaccio AR, Migliaccio G, Dale DC, Hammond WP. Hematopoietic progenitors in cyclic neutropenia: effect of granulocyte colony stimulating factor in vivo. Blood.1990;75:1951-1959.

Journal Article Migliaccio, AR

1990

Stephens K, Wijsman E, Livingston RJ, and DC Dale. Identification, diagnoses, and power analyses of pedigrees segregating cyclic neutropenia for genetic linkage studies. J Hum Genet. 1990;47:A0786.


1990

Stephens K, Wijsman E, Livingston RJ, Dale DC. Identification, diagnoses, and power analyses of pedigrees segregating cyclic neutropenia for genetic linkage studies. Am J Hum Genet. 1990;47:0786a.


1989Dale DC. A brief history of graduate medical education in Washington, Alaska, Montana and Idaho. West J Med. 1989;150:473-477. PMCID: PMC1026603


1989 Dale DC. Western medical schools - a breed apart. West J Med. 1989;150:602- 603. PMCID: PMC1026691 Journal Article Dale, David C

1989

Hammond WP, Chatta G, Andrews RG, Bernstein ID, Dale DC. Human cyclic neutropenia (CN): abnormal progenitor cell response to G-CSF and GM-CSF. (ASH Annual Meeting Abstracts). Blood.1989;74:17a.


1989Hammond WP, Price TH, Souza LM, Dale DC. Treatment of cyclic neutropenia with granulocyte colony stimulating factor. N Engl J Med. 1989;320:1306-1311.


1988Dale DC, Belknap BH, Chase JD, Haviland JW. The regional graduate medical education program of the University of Washington. J Med Ed. 1988;63:347-355.


1988 Dale DC. Hammond WP. Cyclic neutropenia: a clinical review. Blood Rev. 1988;2:178-185. Journal Article Dale, David C

1988Hammond WP, Canin AR, Csiba E, Souza LM, Dale DC. Evidence that granulocyte colony stimulating factor (G-CSF) is neutropoietin. (ASH Annual Meeting Abstracts). Blood. 1988;72:1199.


1988

Hammond WP, Miller JE, Starkebaum G, Zweerink HJ, Rosenthal AS, Dale DC. Suppression of in vitro granulocytopoiesis by captopril and penicillamine. Exp Hematol.1988;16:674-680.


1988Hammond WP, Price TH, Souza LM, Dale DC. Cyclic hematopoiesis treated with recombinant human G-CSF. (ASH Annual Meeting Abstracts). Blood. 1988;72:87a.


SCNIRBibliography

of 87


1987 Dale DC. Infections in the compromised host. In: Merck Manual. 15th ed. Rahway, NJ: Merck & Co.; 1987:67-70. Book Chapter Dale, David C

1987 Dale DC. Leukopenia. In: Merck Manual. 15th ed. Rahway, NJ: Merck & Co.; 1987:1173-1177. Book Chapter Dale, David C

1987Dale DC. Septic shock. In: E. Braunwald E, et al, eds. Principles of Internal Medicine. 11th ed. New York, NY: McGraw-Hill; 1987:474-478.


1986Ramsey PG, Shannon NF, Fleming L, Wenrich M, Peckham PD, Dale DC. The use of objective examinations in clinical clerkships: a ten year experience. Am J Med. 1986;81:669-674.

Journal Article Ramsey, PG

1985

Dale DC, Hammond WP. Diseases of the hematopoietic system: leukocyte disorders. In: Andres R, Bierman EL, Hazzard WR, eds. Principles of Geriatric Medicine. New York, NY: McGraw-Hill; 1985:702-708.


1985Dale DC. Autoimmune leukopenia. In: Fauci AS, Lichtenstein LM, eds. Current Therapy in Allergy Immunology and Rheumatology. Toronto, ON: Decker; 1985:177-120.


1985Dale DC. First Zlinkoff Lecture of the Society for Research and Education in Primary Care Internal Medicine (SREPCIM). SREPCIM Newsletter. 1985;7:6-11.


1985

Finch CA, English E, Dale DC, Thompson AR. Hematologic alterations with age. In: Andres R, Bierman EL, Hazzard WR, eds. Principles of Geriatric Medicine. New York, NY: McGraw-Hill; 1985:372-386.

Book Chapter Finch, CA

1985 Hammond WP, Dale DC. A novel mechanism for drug-induced neutropenia. Clin. Res. 1985;33:341a. Abstract Hammond, WP

1985Osborne WRA, Hammond WP, Dale DC. Human cyclic hematopoiesis is associated with aberrant purine metabolism. J. Lab Clin Med. 1985;105:403-409.

Journal Article Osborne, WRA

1984Gray L, Rodriguez K, Dale DC. Medical schools of the west–University of Washington School of Medicine. West J Med. 1984;140:803-811. PMCID: PMC1011114

Journal Article Gray, L

1983

Dale DC, Petersdorf RG. Gram-negative bacteremia and septic shock. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD., eds. Harrison’s Principles of Internal Medicine. 10th ed. New York, NY: McGraw-Hill; 1983:859-863.


1983

Dale DC. Abnormalities of leukocytes. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD., eds. Harrison’s Principles of Internal Medicine. 10th ed. New York, NY: McGraw-Hill; 1983:304-310.


1983

Dale DC. Infections in compromised host. In: Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD., eds. Harrison’s Principles of Internal Medicine, 10th ed. New York, NY: McGraw- Hill; 1983:850-854.


SCNIRBibliography

of 87


1983

Dale DC. Neutrophil and monocyte kinetics. In: Research Needs in Hematology.Bethesda, MD: National Institute of Arthritis, Diabetes, and Digestive and Kidney Diseases, Division of Kidney, Urologic, and Hematologic Diseases, 1983. U.S. Dept of Health and Human Services publication NIH 83-2630:265-269.


1983Hammond WP, Berman B, Wright DG, Dale DC. Lithium is an ineffective therapy for human cyclic neutropenia. Blood.1983;61:1024-1026, 1983.


1983Hammond WP, Roger ER, Dale DC. Lithium normalizes cyclic hematopoiesis by enhancing local generation of colony stimulating activity. Blood (ASH Annual Meeting Abstracts) 1983;62:136a.


1982

Dale DC. Infections in the compromisedhost. In: Robert Berkow, Ed. Merck Manual. 14th ed. Whitehouse Station, NJ: Merck, Sharp & Dohme Research Laboratories; 1982:57-60.


1982Hammond WP, Osborne WRA, Dale DC. Human cyclic hematopoiesis is associated with abnormal purine and pyrimidine metabolism. Clin Res. 1982;30:318a.


1982

Osborne WRA, Hammond WP, Dale DC. Human cyclic hematopoiesis is associated with abnormal purine and pyrimidine metabolism. IV International Symposium on Human Purine and Pyrimidine Metabolism; 1982.


1981Adamson JA, Dale DC, Klebanoff SJ. Hormones and blood cells. In: Williams RH, Saunders WB, eds. Textbook of Endocrinology. Philadelphia, PA: WB Saunders; 1981:1099-1106.

Book Chapter Adamson, JA

1981

Dale DC, Wallace JF, Clark H, Rockey PH, Featherstone HJ, Petersdorf RG. Restructuring an internal medicine residency program to meet regional and national needs for general internists. Am J Med.1981;70:1085-1090.


1981

Dale DC. Defects in host defense mechanisms in immunocompromised patients. In: Rubin RG, Young L, eds. Clinical Approach to Infection in the Immunocompromised Host . New York, NY: Plenum Press; 1981:35-68.


1981Dale DC. Family practice and primary care: Another internist’s perspective. [Editorial] Arch Int Med. 1981;141:982-983. PMID: 7247603

ECL Dale, David C

1981 Dale DC. Neutrophil Kinetics: Host responses to inflammation and infection. In: Microbiology. 1981. Book Chapter Dale, David C

1981Hammond WP, Osborne WRA, Dale DC. Cyclic hematopoiesis is associated with abnormal purine metabolism. (ASH Annual Meeting Abstracts). Blood. 1981;58:110a.


SCNIRBibliography

of 87


1981Hammond WP, Robertson RP, Dale DC. Prostaglandin E modulates macrophage not neutrophil proliferation in vitro . Clin Res.1981;29:41a.


1981Lee MY, Dale DC, Wolf NS. Stem cell differentiation in tumor induced neutrophilia. (ASH Annual Meeting Abstracts). Blood.1981;58:112a.

Abstract Lee, MY

1981

Taylor RF, Price TH, Schwartz SM, Dale DC. Endothelial monolayers on polycarbonate filters: a technique for measuring endothelial cell function and neutrophil endothelial cell interaction. Clin Res. 1981;29:351a.

Abstract Taylor, RF

1981

Taylor RF, Price TP, Schwartz SM, Dale DC. Neutrophil endothelial cell interactions on endothelial monolayers grown on micropore filters. J Clin Invest.1981;67:584-587. PMCID: PMC370604

Journal Article Taylor, RF

1981Wright DG, Dale DC, Fauci AS, Wolff SM. Human cyclic neutropenia: clinical review and long-term follow-up of patients.Medicine. 1981;60:1-13.

Journal Article Wright, DG

1980Dale DC. Abnormalities of leukocytes. In: Petersdorf RG, et al, eds. Principles of Internal Medicine. 9th ed. New York, NY: McGraw-Hill; 1980:283-290.


1980

Dale DC. Disorders caused by biologic agents. In: Isselbacher KJ, et al, eds. Harrison’s Principles of Internal Medicine, Pretest Self-Assessment and Review. New York, NY: McGraw-Hill; 1980:227-256.


1980Dale DC. Infections in the compromised host. In: Petersdorf RG, et al, eds. Principles of Internal Medicine. 9th ed. New York, NY: McGraw-Hill; 1980:552-556.


1980Hammond WP, Dale DC. Lithium treatment of cyclic hematopoiesis in the gray collie.Adv Exp Med Biol. 1980;127:167-73. PMID: 7405719


1980Lee MY, Sperlin A, Dale DC. Distribution of granulocytopoietic committed stem cell in mice with tumor induced neutrophilia. Expl Hematol. 1980;8:249-255.

Journal Article Lee, MY

1980Petersdorf RG, Dale DC. Gram-negative bacteremia and septic shock. In: Petersdorf RG, et al, eds. Principles of Internal Medicine. 9th ed. New York, NY: McGraw- Hill; 1980:561-566.

Book Chapter Petersdorf, RG

1980Rockey PH, Dickstein DA, Wallace JF, Dale DC. Follow-up on an internist training program: ten years experience. Clin Res 1980;28:34A.

Abstract Rockey, PH

1980Rosenschein MS, Farwell VT, Price TH, Larson EB, Dale DC. The cost effectiveness of therapeutic and prophylactic leukocyte transfusion. N Engl J Med. 1980;302:1058- 1062.

Journal Article Rosenschein, M

SCNIRBibliography

of 87


1979

Aduan RP, Fauci AS, Dale DC, Herzberg JH and Wolff SM. Factitious fever and self- induced infection: A report of 32 cases and a review of the literature. Annals Int Med.1979;90:230-242. PMID: 443658

Journal Article Aduan, RP

1979 Dale DC, Guerry D, Werwerka JR, Bull JM, Chusid MH. Chronic neutropenia. Medicine. 1979;58:128-144. PMID: 431399 Journal Article Dale, David C

1979Dale DC. Neutrophils and the acute inflammatory response in chronic renal failure. Dialysis and Transplantation.1979;8:314-317.


1979 Dale DC. White Blood Cell Syllabus. University of Washington, Seattle. 1979. Journal Article Dale, David C

1979Hammond WP, Dale DC. Effect of lithium on granulopoiesis in cyclic hematopoiesis.Blood. 1979;54:391a.


1979Hammond WP, Dale DC. Lithium interrupts feedback inhibition in granulopoiesis mediated by protaglandins. (ASH Annual Meeting Abstracts). Blood. 1979;54:392a.


1979 Lee M, Durch S, Dale DC and Finch CA. Kinetics of tumor-induced murine neutrophilia. Blood. 1979;53:619-632. Journal Article Lee, MY

1979

Price TH, Dale DC. Blood kinetics and in vivo chemotaxis of transfused neutrophils: effect of collection method donor corticosteroid treatment and short-term storage. Blood. 1979;54:977-986.


1979 Price TH, Lee MY, Dale DC, Finch CA. Neutrophil kinetics in chronic neutropenia. Blood. 1979;54:581-594. PMID: 465730 Journal Article Price, TH

1979Rosenschein MS, Price TH, Dale DC. Neutropenia, inflammation and the kinetics of transfused neutrophils in rabbits. J Clin Invest. 1979;64:580-585. PMCID: PMC372153

Journal Article Rosenschein, M

1978Aduan RP, Fauci AS, Dale DC and Wolff SM. Prolonged fever of unknown origin (FUO): a prospective study of 347 patients. Clin Res. 1978;26:558.

Abstract Aduan, RP

1978 Dale DC. Neutropenia. In: Conn HF, ed. Current Therapy. Philadelphia, PA: WB Saunders; 1978:272-274. Book Chapter Dale, David C

1978

Featherstone HJ, Dale DC. Managing infections in immunosuppressed patients. Postgrad Med. 1978;64:141-144, 147-148.PMID: 704492

Journal Article Featherstone, HJ

1978 Hammond WP, Dale DC. Infections in the compromised host. Hosp Med. 1978;14:87- 119. Journal Article Hammond, WP

1978Price TH, Dale DC. Neutrophil transfusion: effect of storage and of collection method on neutrophil blood kinetics. Blood.1978;51:789-798. PMID: 638247


1978Price TH, Dale DC. Neutrophil transfusion: the effect of collection technique and storage on in vivo chemotaxis. Proceedings of Interleukocyte National Society of Experimental Hematology. 1978.

Abstract Price, TH

SCNIRBibliography

of 87


1978 Price TH, Dale DC. The selective neutropenias. Clin Hematol. 1978;7:501- 521. PMID: 363325 Journal Article Price, TH

1978Rosenschein M, Larson E, Price T, Dale DC. Cost effectiveness of leukocyte transfusion. (ASH Annual Meeting Abstracts). Blood. 1978;(suppl 1):302.

Abstract Rosenschein, M

1978Rosenschein M, Price TP, Dale DC. Neutropenia, inflammation and the kinetics of transfused neutrophils. Clin Res.1978;6:507A.

Abstract Rosenschein, M

1978Wright DG, Fauci AS, Dale DC, Wolff SM. Correction of human cyclic neutropenia with prednisolone. N Engl J Med. 1978;298:295- 300. PMID: 622086

Journal Article Wright, DG

1977Besa EC, Dale DC, Wolff SW, Gardner FJ. Aetiocholanolone and prednisolone therapy in patients with severe bone marrow failure. Lancet. 1977;1:728-730. PMID: 66522

Journal Article Besa, EC

1977

Dale DC, Guerry D, Wolff SM. Neutrophil- releasing activity in plasma of normal human subjects injected with etiocholanolone. Proc Soc Exp Biol Med. 1977;156:192-195.PMID: 909889


1977Dale DC. Abnormalities of leukocytes. In: Thorn GW, et al, eds. Principles of Internal Medicine. 8th ed. New York, NY: McGraw- Hill; 1977:304-311.


1977 Dale DC. Host defense mechanisms in shock. In: Thompson L, ed. The Cell in Shock – II. New York, NY: Infor Media; 1977:72-74. Book Chapter Dale, David C

1977Lee MY, Durch S, Dale DC, Finch CA. Kinetics of tumor-induced neutrophilia. (ASH Annual Meeting Abstracts). Blood.1977;50:S153.

Abstract Lee, MY

1977Petersdorf RG, Dale DC. Infections in the compromised host. In: Thorn GW, et al, eds. Principles of Internal Medicine. 8th ed. New York, NY: McGraw-Hill; 1977:764-769.

Book Chapter Petersdorf, RG

1977Price TH, Dale DC. Neutrophil preservation: the effect of short-term storage on in vivo kinetics. J Clin Invest. 1977;59:476-480.PMCID: PMC333384


1977Price TH, Dale DC. Neutrophil transfusion: the effect of collection technique and storage on in vivo chemotaxis. (ASH Annual Meeting Abstracts). Blood. 1977;50:S309.

Abstract Price, TH

1977 Wright DG, Fauci AS, Dale DC, Wolff SM. Correction of human cyclic neutropenia with prednisolone. Clin Res. 1977;25:481. Abstract Wright, DG

SCNIRBibliography

of 87


1976

Chusid MJ, Gallin JI, Dale DC, Fauci AS, Wolff SM. Defective polymorphonuclear leukocyte chemotaxis and bactericidal capacity in a boy with recurrent pyogenic infections. Pediatrics. 1976;58:513-520.PMID: 9619

Journal Article Chusid, MJ

1976Dale DC, Hubert RT, Fauci AS. Eosinophil kinetics in the hypereosinophilic syndrome. J Lab Clin Med. 1976;87:487-495. PMID: 1249478


1976

Dinarello CA, Chusid MJ, Fauci AS, Gallin JI, Dale DC, Wolff SM. The effect of prophylactic colchicine therapy on leukocyte functions in patients with familial Mediterranean fever. Arthritis Rheum.1976;19:618-622. PMID: 779797

Journal Article Dinarello, CA

1976Eschbach JW, Harker L, Dale DC. The hematologic consequences of renal failure. In: Rector F, Brenner BM, eds. The Kidney. Philadelphia, PA: WB Saunders; 1976:1522- 1537.

Book Chapter Eschbach, JW

1976Fauci AS, Dale DC, Balow JE. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. Ann Intern Med. 1976;84:304-315. PMID: 769625

Journal Article Fauci, AS

1976

Gardner FH, Besa ED, Dale DC and Wolff SM. Treatment of refractory anemia with etiocholanolone and prednisolone: initial clinical experience. In: Hibino S, Takaku F, Shahidi NY, eds. Proceedings of the First International Symposium on Aplastic Anemia. 1976;415-424.

Book Chapter Gardner, FH

1976Price TH, Dale DC. Neutrophil transfusion: Effect of collection method and storage on blood kinetics. (ASH Annual Meeting Abstracts). Blood. 1976;48:1005.

Abstract Price, TH

1976

Price TH, Dale DC. The effect of storage on the in vivo function of neutrophils in the rabbit. Second International Symposium on Leukocyte Separation and Transfusion.London, England. 1976.

Abstract Price, TH

1976Price TH, Lee MY, Dale DC, Finch CA. Granulocytopoiesis in patients with chronic neutropenia. (ASH Annual Meeting Abstracts). Blood. 1976;48:971.

Abstract Price, TH

1976 Wewerka JF, Dale DC. Colony stimulating factor in patients with chronic neutropenia. Blood. 1976;47:861-867. PMID: 1083265 Journal Article Wewerka, JF

1975Besa EC, Dale DC, Wolff SM and Gardner FH. Treatment of refractory anemia with etiocholanolone and prednisone (Etio-Pred): initial clinical experience in 8 patients. Am Soc Hematol. 1975.

Abstract Besa, EC

1975Chusid MJ, Dale DC, West BR, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine. 1975;54:1-27. PMID: 1090795


SCNIRBibliography

of 87


1975Chusid MJ, Dale DC. Eosinophilic leukemia: remission with vincristine and hydroxyurea. Am J Med. 1975;59:297-300. PMID: 1155486


1975

Dale DC, Fauci AS, Guerry D, Wolff SM. Comparison of agents producing a neutrophilic leukocytosis in man: hydrocortisone, prednisone, endotoxin and etiocholanolone. J Clin Invest. 1975;56:808- 813. PMCID: PMC301935


1975Dale DC, Petersdorf RG. Corticosteroids and infectious diseases. In: DL Azarnoff, WB Saunders, eds. Steroid Therapy.Philadelphia, PA: Saunders; 1975;209-222.


1975Fauci AS, Dale DC. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest. 1975;55:22-32. PMCID: PMC301713


1975Fauci AS, Dale DC. Effect of hydrocortisone (OHC) on the recirculating lymphocyte pool in humans. American Academy of Allergy Program. 1975.

Abstract Fauci, AS

1975Fauci AS, Dale DC. Letter: Monocytopenia after prednisone. N Engl J Med.1975;292:928. PMID: 1117923

ECL Fauci, AS

1975Fauci AS, Dale DC. The effect of hydrocortisone on the kinetics of normal human lymphocytes. Blood. 1975;46:235- 243. PMID: 1139040


1975Pennington JE, Dale DC, Reynold HY, MacLowry JD. Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever. J Infect Dis. 1975;132:270-275. PMID: 1159330

Journal Article Pennington, JE

1975 Price TH, Dale DC. Neutrophil transfusion: storage conditions affecting viability. Am Soc Hematol. 1975. Abstract Price, TH

1975Reynolds HY, Levine AS, Wood RS, Zierdt CH, Dale DC, Pennington JE. Pseudomonas infections: persisting problems and current research to find new therapies. Ann Intern Med. 1975;82:819- 831.

Journal Article Reynolds, HY

1975 Wolff SM, Fauci AS, Dale DC. Unusual etiologies of fever and their evaluation. Annu Rev Med. 1975;26:277-281. PMID: 1096764 Journal Article Wolff, SM

1974

Besa EC, Dale DC, Gorshein D, Wolff SM, Gardner FH. A hematologic response to etiocholanolone-hydrocortisone combination in a patient with myelofibrosis. Clin Res.1974;22:383a.

Abstract Besa, EC

1974 Borer JS, Henry WL, Dale DC, Wolff SM. Eosinophilia and the heart. American College of Physicians. 1974. Abstract Borer, JS

1974 Bull JM, Carbone PP, Dale DC. The circulating colony forming cell in chronic neutropenic patients. Amer Soc Hematol Program. 1974. Abstract Bull, JM

SCNIRBibliography

of 87


1974Dale DC, Fauci AS, Wolff SM. Alternate-day prednisone. Leukocyte kinetics and susceptibility to infections. N Engl J Med.1974;291:1154-8. PMID: 4609038


1974Dale DC, Fauci AS, Wolff SM. Daily and alternate-day prednisone: granulocyte kinetics and susceptibility to infections. Clin Res. 1974;22:439.


1974

Dale DC, Reynolds HY, Pennington JE, Elin RJ, Herzig GP, Graw RG. Granulocyte transfusion therapy in experimental pseudomonas pneumonia: comparison of granulocytes procured by centrifugation and filter adherence. International Symposium on Leukocyte Separation and Transfusion. 1974.


1974

Dale DC, Reynolds HY, Pennington JE, Elin RJ, Herzig GP, Graw RG. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia: comparison of granulocytes procured by centrifugation and filter adherence. Proceedings International Symposium of Leukocyte Separation Transfusion, London, 1974; London: Academic Press; 1976:279-284.


1974

Dale DC, Reynolds HY, Pennington JE, Elin RJ, Pitts TW, Graw RG. Granulocyte transfusion therapy of experimental Pseudomonas pneumonia. J Clin Invest.1974;54:664-671. PMCID: PMC301600


1974

Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever: a double blind trial. N Engl J Med. 1974;291:934-937.PMID: 4606353

Journal Article Dinarello, CA

1974Fauci AS, Dale DC, Wolff SM. Cyclophosphamide and lymphocyte subpopulations in Wegener’s granulomatosis. Arthritis Rheum.1974;17:335-361. PMID: 4604290


1974 Fauci AS, Dale DC. Effect of alternate-day prednisone therapy on human lymphocyte subpopulations. Clin Res. 1974;22:417a. Abstract Fauci, AS

1974Fauci AS, Dale DC. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974;53:240-246. PMCID: PMC301459


1974Guerry D, Adamson JW, Dale DC, Wolff SM. Human cyclic neutropenia: urinary colony stimulating factor and erythropoietin levels. Blood. 1974;44:257-262. PMID: 4852306

Journal Article Guerry, D

1974Hoffman HF, Guerry D, Dale DC. Analysis of cyclic neutropenia using digital band pass filtering techniques. J Interdiscip Cycle Res. 1974;5:1-18.

Journal Article Hoffman, HF

SCNIRBibliography

of 87


1974Wolff SM, Dinarello CA, Dale DC, Goldfinger SE, Alling DW. Colchicine therapy in familial Mediterranean fever. Trans Assoc Am Physicians. 1974;87:186- 194. PMID: 4617366

Journal Article Wolff, SM

1974Wolff SM, Dinarello CA, Dale DC, Goldfinger SE, Alling DW. Colchicine therapy of familial Mediterranean fever. Trans Assoc Am Physicians. 1974;2:567.

Abstract Wolff, SM

1974 Wolff SM, Fauci AS, Horn RH, Dale DC. Wegener’s granulomatosis. Ann Intern Med. 1974;81:513-525. PMID: 4416890 Journal Article Wolff, SM

1973 Borer JS, Henry WL, Dale DC. Echocardiographic findings in patients with idiopathic hypereosinophilia syndrome. Clin Res. 1973;21:406. Abstract Borer, JS

1973

Dale DC, Alling DW, Wolff SM. Application of time series analysis to serial blood neutrophil counts in normal individuals and patients receiving cyclophosphamide. Br J Hematol. 1973;24:57-64. PMID: 4715138


1973

Dale DC, Fauci AS, Wolff SM. The effect of cyclophosphamide on leukocyte kinetics and susceptibility to infection in patients with Wegener’s granulomatosis. Arthritis Rheum. 1973;16:657-664. PMID: 4742843


1973Dale DC, Guerry D, Wolff SM. Chronic idiopathic neutropenia: response to prednisone therapy. J Clin Invest.1973;52:22a.


1973 Dale DC, Petersdorf RG. Corticosteroids and infectious diseases. Med Clin N Am. 1973;57:1277-1287. PMID: 4593200 Journal Article Dale, David C

1973

Dale DC, Reynolds HY, Pennington JE, Pitts TW, Graw RG. Granulocyte transfusion therapy in experimental pseudomonas pneumonia. 13th Interscience Conf. Antimicrob. Agents and Chemotherapy. 1973;30.


1973Fauci AS, Dale DC. In vivo hydrocortisone and its relationship to lymphocyte function in normal humans. 8th Leukocyte Culture Conf. 1973.

Abstract Fauci, AS

1973 Fauci AS, Dale DC. The effect of in vivo hydrocortisone on in vitro lymphocyte function in humans. Clin Res. 1973;21:478. Abstract Fauci, AS

1973

Geelhoed GW, Kane MA, Dale DC, Wells SA. Colon ulceration and perforation in cyclic neutropenia: report of a survivor with peritonitis and clostridial septicemia. J Pediatr Surg. 1973;8:379-382. PMID: 4715743

Journal Article Geelhoed, GW

1973Guerry D, Dale DC, Omine M, Perry S. Wolff SM. Periodic hematopoiesis in human cyclic neutropenia. J Clin Invest. 1973;52:3220- 3230. PMCID: PMC302598

Journal Article Guerry, D

1972Dale DC, Alling DW, Wolff SM. Cloxacillin chemoprophylaxis in the Chediak-Higashi syndrome. J Infect Dis. 1972;125:393-397. PMID: 4553082


SCNIRBibliography

of 87


1972Guerry D, Dale DC, Omine M, Perry S, Wolff SM. Studies on the mechanism of human cyclic neutropenia. (ASH Annual Meeting Abstracts). Blood. 1972;40:951.

Abstract Guerry, D

1972Wolff SM, Dale DC, Clark RA, Root RK, Kimball HR. The Chediak-Higashi syndrome: studies of host defenses. Ann Intern Med. 1972;76:293-306.

Journal Article Wolff, SM

1971 Dale DC, Guerry D, Ward SB. Wolff SM. Neutrophil kinetics in malaria. Clin Res. 1971;19:415. Abstract Dale, David C

1971Dale DC, Guerry D, Wolff SM. Chronic idiopathic neutropenia responding to alternate-day methylprednisolone. Amer Soc of Hematol. 1971.


1971Dale DC, Wolff SM. Skin window studies of the acute inflammatory responses of neutropenic patients. Blood. 1971;36:138- 142. PMID: 4933314


1971Green I, Kirkpatrick CH, Dale DC. Lactoferrin-specific localization in nuclei of human polymorphonuclear neutrophilic leukocytes. Proc Soc Exp Biol. 1971;137:1311-1317. PMID: 5003007

Journal Article Green, I

1968Dale DC, Mata LJ. Studies of diarrheal disease in Central America. XI. Intestinal bacterial flora in malnourished children with shigellosis. Am J Trop Med and Hyg. 1968;17:397-403.


1965 Dale DC, Roth SE, Garcia GE. Effect of calcium on parathyroid secretion. Lab Invest. 1965; 14:562. Abstract Dale, David C

1965 Dale DC, Roth SI, Garcia GE. Effect of calcium on parathyroid secretion. Endocrinol. 1965;77:725-730. Journal Article Dale, David C

18.08.16 Bibliography Master List · Steward CG, Groves SJ, Spence CT, Maisenbacher MK, Versluys B,...

Documents

Transcript of 18.08.16 Bibliography Master List · Steward CG, Groves SJ, Spence CT, Maisenbacher MK, Versluys B,...